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Abstract 
 Amyloidosis is of serious concern within the modern world with an ageing 
global population, there is a significant drive to understand how amyloid forms in 
order to research and develop new therapeutics to combat this threat. This thesis 
proposes using a cross-disciplinary collaborative approach to determine multiple 
aspects within the amyloid-like fibrillation pathway for human insulin (HI) at acidic 
and neutral pH conditions. 
 Chapter 2 uses Reflection Anisotropy Spectroscopy to obtain fibrillar 
orientation information with the goal to investigate whether structural morphology 
can direct fibril growth. Lack of reproducibility at the surfaces and the observation of 
a ‘blue-haze’ on the silicon wafers led to the method development in Chapter 3. 
 Chapter 4 uses conventional biophysical techniques, fluorescence 
spectroscopy and electron microscopy to study hydrophobic functionalised 
mesoporous silica microparticles provides a scaffold for human insulin fibrillation to 
occur. These results show that the microparticles induced fibril morphology changes 
and inhibited or enhanced the fibrillation process, with respect to the human insulin 
control. 
 Chapter 5 explores the mass and structural changes of adsorbed human 
insulin at a hydrophobic surface, by QCM-D and Raman spectroscopy. The results of 
which showed variable human insulin adsorption to the two differing 
hydrophobically functionalised surfaces at pH 2 and pH 7 conditions. 
 Chapter 6 is the result of a collaboration with the Department of Physics and 
provides the first images obtained from infrared scanning near-field optical 
microscopy in reflection with a quantum cascade laser source of human insulin 
adsorbed to gold surfaces to obtain both structural and locational information. These 
preliminary results provide exciting opportunities for future development of this 
technique at other surfaces and proteins. 
 Chapter 7 uses fluorescence excitation – emission matrices to uncover the 
origin of the deep-blue autofluorescence phenomenon, with human insulin, 
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Chapter 1: Introduction 
1.1. Introduction 
Amyloid proteins are clinically important since the accumulations of amyloid 
fibrils, termed amyloid plaques,1,2 are hallmarks of ‘amyloidosis diseases’;3 
Alzheimer’s,4 Parkinson’s5 and Type II diabetes.6 Treating these diseases is a growing 
worldwide problem for social welfare and the associated financial expenditure.7,8 For 
example, Alzheimer’s, which is often diagnosed late in life, is becoming endemic as 
life expectancy increases, leading to a greater demand on social welfare for ageing 
populations. Unfortunately, there is currently no cure for amyloidosis, but rather 
therapeutics have been designed to reduce disease progression9 or symptomatic 
alleviation.10,11 There are a whole host of reasons as to why there is no cure, such as 
variations between associated diseases,12 genetic diversity,13 diagnostic issues,14 but 
fundamentally the necessity to gain a better understanding of the disease is 
paramount.10 
Amyloidosis is the misfolding of proteins, from their native states, into 
insoluble fibril-like supramolecular structures. Understanding how these proteins 
misfold into fibril structures is critical in pharmaceutical development, which has so 
far been plagued with clinical trial failures.15 These failures indicate more research is 
necessary to understand the various fibrillation mechanisms, which are important for 
medicinal drug targets.16 An immediate consideration is to tackle this fibrillation 
problem by investigation of; the bulk solution and surface adsorption, as these can 
give rise to varying fibrillation pathways.17–19 
Human insulin (HI), a key physiological hormone for glucose regulation, is a 
model protein that can be used for amyloid research. Firstly, HI is highly prone to 
form amyloid-like fibrils in vitro (outside the living organism), which are termed 
amyloid-like as the fibrils are formed in vitro as opposed to in vivo, and are therefore 
able to be studied within laboratory conditions. Secondly, induced-amyloidosis at 
injection sites, has been reported as a long-term effect of insulin therapy.20 Thirdly, 
HI is widely available and insulin analogues have been extensively studied due to the 
clinical importance of insulin as a drug for diabetes treatment. The high propensity 
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for insulin fibrillation in vitro, whilst beneficial in this work, is detrimental to the drug 
delivery system in regard to storage and logistical concerns.21,22 Issues arising from 
these concerns are insulin aggregation, which affects the controlled therapeutic 
dosage to the patient, or physical obstruction and restriction within the flow devices. 
Investigating amyloid-like fibrillation from an interdisciplinary perspective is 
exciting, as the use of biological and chemical techniques can provide a coherent 
assessment of fibrillation pathways. These techniques are important since current 
research suggests that whilst mature fibrils are markers of disease pathology, the 
clinical toxicity is driven in the pre-fibrillar oligomeric phase.23,24 There is a growing 
need in amyloid research for therapeutic development and earlier clinical detection, 
but first understanding how fibrillation is affected by surface architecture is 
important for medical treatment design. Hydrophobic surfaces are known to induce 
fibrillation, but how does this interface affect typical fibrillation pathways? Is it 
possible to reduce amyloid toxicity through interfacial architecture? This thesis uses 
chemical principles to alter the interfacial composition of the surface to investigate 
whether the biological components are affected by utilising a range of biophysical 
techniques. These spectroscopic techniques will be used to investigate any effect 
that hydrophobic functionalisation has on HI fibrillation pathways from bulk solution 
to adsorption and rearrangement, through to desorption and fibrillation events. 
The primary objective for this thesis was to study the effect of hydrophobic 
functionalised interfaces on HI fibrillation under measurable conditions using an 
ensemble of spectroscopic techniques, to gain insight into structural and kinetic 
properties of HI fibrillation. Particular attention will be given to the pre-fibrillar 
events because protein adsorption at the surface can induce fibrillation through an 
autocatalytic effect17 into the bulk solution, which participates in primary nucleation 
events by a seeded-growth mechanism.19 A secondary objective is to consider how 
the physical and chemical composition of amyloid-like fibrils are affected by the 
hydrophobic modifications of the surface interface hence a range of spectroscopic 
techniques are utilised. 
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1.2. What are proteins? 
 To be able to understand amyloid mechanics, the biophysical properties of 
proteins / peptides and their fundamental chemistry should first be considered. 
 Proteins and peptides are biochemical assemblies composed of amino 
acid (aa) residues linked together through peptide bonding, which is termed the 
peptide backbone. The specific terminology used to describe the architecture, 
protein or peptide, is classified by the specific assembly size. A protein consists of 
fifty or more amino acid residues, whereas a peptide ranges between two to fifty 
amino acid residues. Furthermore, a peptide can also be designated as an ‘oligo-’ or 
‘poly-’ peptide, whereby the prefix refers to; ‘oligo-’ a small (less than twenty 
residues) or ‘poly-’ any length peptide but of a single-linear chain. The species studied 
in this thesis; Insulin and α-synuclein (αS) are proteins, since their assemblies are 
larger than fifty residues, at 51 and 140 amino acid residues respectively. 
 Peptides and proteins are biologically critical in physiology, whereby their 
functions are typically regulation and maintenance of cellular systems.25 An 
important physiological protein is HI, which is a human metabolic hormone essential 
for blood sugar regulation.26 A protein’s functionality is influenced by its overall 
three-dimensional (3D) structure and the exhibited biophysical properties, which are 
attributed to the amino acid residue side chains diverging from the backbone.27 
1.2.1. What are amino acids? 
 There are twenty-one known essential proteinogenic amino acid residues, 
which occur naturally and can be incorporated within a protein. Chemically, an amino 
acid is an organic molecule comprised of three distinct regions; amine, carboxyl and 
side chain, which are illustrated in Figure 1. The amino acid side group (R-group), 
gives rise to the residue’s biophysical properties, which are distinct for each of the 
twenty-one known proteinogenic residues. Whilst each of these residues have their 
own distinct biophysical properties, when encoded into a larger assembly, the 
properties give rise to both a localised and overall ensemble effect. 
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Figure 1: A chemical schematic showing a generalised amino acid residue, with functional groups 
colour-coded; (green) amine, (blue) carboxyl and (red) side chain. 
 Figure 2 shows the four different classes of the amino acid residues, these 
are; electronically charged, hydrophobic, polar and miscellaneous (stated in Figure 2 
as “special cases”). The electronically charged class is subdivided into positively 
charged (basic) and negatively charged (acidic) for example; arginine (Arg, R) and 
glutamic acid (Glu, E). Hydrophobic is also subdivided into aliphatic and aromatic for 
example; alanine (Ala, A) and phenylalanine (Phe, F). The polar category represents 
residues with hydrophilic side chain groups, whereas the miscellaneous category 
refers to four residues, which do not conform to the other categories.  
 The four amino acid residues categorised as miscellaneous are; 
glycine (Gly, G), proline (Pro, P), cysteine (Cys, C) and selenocysteine (Sec, U). Glycine 
is unique since the side chain is a proton and as such this residue is not sterically 
hindered and can be found anywhere within a polypeptide chain. Conversely, proline 
is structurally hindered because the amino functionality is part of the side chain 
group, thus restricting the spatial orientation of the residue within the polypeptide 
chain. Cysteine can also modify the structural arrangement of the polypeptide chain, 
since it is able to form disulfide bridges with another cysteine residue through its 
terminal sulfhydryl group. Selenocysteine, an uncommon residue, is an analogue of 
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Figure 2: The 21 proteinogenic amino acid residues are arranged alphabetically, the colours are 
coordinated to the amino acid class; (red) polar uncharged, (yellow) special cases, 
(green) electronically charged and (blue) hydrophobic. The electronically charged and hydrophobic 
classes are further subdivided into (solid green) positively or (dashed green) negatively charged and 
either (solid blue) aliphatic or (dashed blue) aromatic. The amino acid abbreviations in three letter and 
one letter forms are displayed in the top left and right corners, respectively. Adapted from 
Cooper et al.29 
 Each of the residues are designated a full name and two abbreviated forms; 
consisting of one or three letters. This thesis will utilise the one letter code. The 
biophysical properties of these residues are critical in determining the overall 
properties of the protein. 
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1.2.2. How are proteins formed? 
 The polypeptide chain can lead to numerous protein configurations both 
structurally and chemically because of their amino acid residue makeup. Proteins are 
formed through a polymerisation reaction, which links the differing amino acid 
residues together through the peptide backbone into a singular linear chain. 
This reaction scheme, Figure 3, is a reversible condensation / dehydration 
reaction, whereby the leading residue’s hydroxy (-OH) group in the carboxyl (-COOH) 
region reacts with a proton from the lagging residue’s amine (-NH2) group. A covalent 
bond is therefore formed between the carbonyl carbon and the nitrogen of the 
amine, with the loss of one water molecule. This covalent bond is termed a ‘peptide 
bond’ because it is the central bond within the amide group. 
 
Figure 3: A generalised reversible condensation / dehydration reaction, showing the removal of 
(blue) water, formation of (purple) peptide bond and the (R, red) side chain groups. 
 The singular uninterrupted chain from the N-terminus through amide groups 
to the C-terminus, is defined as the protein backbone and is the core of the protein. 
The spatial arrangement of the protein backbone is dependent upon the biophysical 
properties of the side chain groups. 
1.2.3. What is the protein structure? 
 A protein can have up to four levels of structure; primary, secondary, tertiary 
and quaternary as demonstrated by HI in Figure 4, HI will be discussed further (1.4. 
Human insulin: The model protein for amyloid research, page 45). The primary 
structure is defined as the linear amino acid sequence, which is read from 
nitrogen- to carbon-termini. The secondary structure is how the protein residues are 
arranged locally with the main features such as; α-helical, β-sheet, β-turns and 
random coil. These features are particularly important for biochemical spectroscopic 
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tertiary structure is how these secondary structural components are spatially 
arranged within the protein, as determined through structural analysis such as; 
crystallography, nuclear magnetic resonance (NMR) and cryogenic electron 
microscopy (cryo-EM). The final level is quaternary, which is not present in all 
proteins because it is the spatial arrangement of two or more non-bonded protein 
strands.30 
 
Figure 4: Levels of protein structure, as represented by human insulin (HI) showing (green) chain A and 
(blue) chain B. (a) The primary amino acid sequence of both chains drawn in the conventional method. 
(b) Secondary structure illustrates the three α-helices. (c) Tertiary structure illustrates how the three 
α-helices are connected, by random coils / turns and three (red) disulfide bridges. (d) Quaternary 
structure shows the hexameric configuration of how the six insulin monomers interact. Adapted from 
protein data bank (PDB) files; monomeric (PDB: 2JV1)31 and hexameric (PDB: 3AIY),32 using visual 
molecular dynamics (VMD).33 
 Figure 4 shows the primary, secondary and tertiary levels of the monomeric 
state and for the quaternary level the hexamer oligomeric state of HI. HI is a 51 amino 
acid globular protein consisting of two strands, Chains A and B, which consist of 
21 and 30 amino acid residues respectively. In Figure 4 the chains are coloured green 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 1 
Page 37 
and blue for A and B respectively. The primary sequence gives residue designations 
within the peptide chain and can deduce their absolute biophysical properties but 
does not illustrate the spatial arrangement of the residues within the protein. The 
other three levels; secondary, tertiary and quaternary, are represented here using a 
ribbon graphic, which renders the peptide backbone only. This representation is used 
to improve visibility of the protein’s spatial arrangement, which is determined by the 
side-groups (not shown). The secondary structure is the local arrangement of 
residues within the protein, which is structurally stabilised by extensive hydrogen 
bonding between the peptide backbone. There are three main types of secondary 
structure architecture; α-helix, β-sheet and random coils. 
 Helices are coiled structures, and contain three sub-groups; α-, π- and 
310-helices. The most common class is the α-helix, shown in Figure 5, which is 
moderately sized containing approximately 3.6 aa residues per turn.34 The 310-helix 
is often located at the termini to the α-helix, and has been considered as an 
intermediate structural feature due to its smaller size (~3 aa residues per turn).35 The 
π-helix is the rarest, due to its much larger size (~4.4 aa residues per turn) and is often 
only partially observed within protein structures.36 
 
Figure 5: Illustration of hydrogen bonding within an α-helix, showing the (black bonds) backbone of 
(black) carbon atoms, (red) oxygen atoms and (green) nitrogen atoms involved in (dashed black 
lines) hydrogen bonding within the helical structure. Reproduced from Feher et al.37 
 The β-sheet structural features, as illustrated in Figure 6, are derived from at 
least two adjacent β-strands and are typically parallel or anti-parallel which arises 
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from the peptide backbone directionality. The parallel arrangement leads to 
staggered hydrogen bonding interactions, whereas the anti-parallel leads to planar 
interactions, which has the greatest stability.38 These features are important for 
amyloid research for two reasons; firstly, due to the steric zipper effect39 (see 1.3.1. 
What is protein fibrillation?, page 40), which is an assumed spontaneous assembly 
process for amyloid fibrils, and secondly since it is an essential component of a 
cross-β structure which defines amyloid.40 
 
Figure 6: Illustration of hydrogen-bonding within different ß-sheet secondary structure orientations 
composed of; (a) parallel and (b) anti-parallel ß-strands. The various functional groups are 
represented; (green) amine group, (red) side chains, (blue) hydrogen bonds and (black wavy bond) the 
repeater unit. 
 The final structural element and possibly the most widespread are random 
coils. This component category is defined as random, since there is no conformation 
to regular structural characteristics or hydrogen bonding networks. These features 
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 In the secondary structure example (Figure 4b), HI is represented with three 
disjointed α-helices within the protein. There are two α-helices in chain A and these 
are arranged parallel to each other, whilst the α-helix in chain B is arranged 
perpendicular to the other two. This fails to address how the isolated structural 
features are connected to the rest of the protein. As shown in Figure 4c, the tertiary 
representation shows the entirety of the peptide backbone’s spatial arrangement 
and also the three disulfide bridges (red) are drawn, which highlight that there are 
two inter- and one intra-chain (A7:B7, A20:B19 and A6:A11).  
 Figure 4d is a quaternary representation showing the HI hexamer formed 
from six monomer subunits, which are firstly associated into dimers by hydrogen 
bonding between chain B’s C-termini. These dimer components associate together 
to form a hexameric complex in the presence of zinc ions.41 
 Protein structure is a critical part of amyloid research, since the native protein 
becomes denatured and misfolds during amyloid fibrillation events. The protein 
misfolding often affects the native structure, by inducing structural change to allow 
for the wider assembly of the protein into a supramolecular structure.  
1.3. What is amyloid? 
 Amyloid is commonly recognised for its pathological inherency, known as 
amyloidosis,3 which is a group of diseases such as; Alzheimer’s,4 Parkinson’s,5 and 
Type II diabetes.6 A general hallmark of these diseases are amyloid plaques,1,2 which 
are a build-up of amyloid fibrils. Amyloid fibrils are formed when soluble native 
proteins misfold, and through propagation, result in insoluble fibrillar structures.42,43 
This abridged description of fibrillation is not entirely correct since 
non-amyloidogenic proteins can also accumulate into aggregates,44,45 therefore what 
characterises a protein as ‘amyloidogenic’? 
 Proteins can only be described as amyloidogenic,1 if the resulting aggregates 
fulfil the following criteria; exhibition of cross-β structure45 and histological 
Congo-red (CR) staining, resulting in apple-green birefringence under cross polarised 
microscopy.46 Historically Geddes et al47 reported the amyloid structure was 
naturally present within the silk of a lacewing fly. 
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 Amyloid is investigated by the formation of cross-β structures, which are the 
result of amyloidogenic protein fibrillation. A cross-β structure (Figure 7) is a highly 
organised assembly of two or more β-sheets, which are orientated perpendicular to 
the fibril axis. There are two dyes, termed amyloid-specific molecules; 
Congo-red (CR) and thioflavin-T (ThT), which bind to the grooves and ridges of the 
cross-β structure.48–50 
 
Figure 7: Schematic of the amyloid cross-ß structure showing the ß-sheets composed of anti-parallel 
ß-strands, adapted from Biancalana et al.51 
The cross-β structure, shown in Figure 7, has been represented with β-sheets 
composed of anti-parallel β-strands but parallel β-strands are also possible.52 In 
either case, the β-sheets are assembled by the formation of a dehydrated β-sheet 
bilayer whereby the associated side chain groups are interdigitated, leading to both 
backbone and side chain hydrogen bonding, binding the sheets together in a 
steric zipper mechanism along the fibril axis.40,53,54 Ivanova et al55 previously 
reported an amyloidogenic sequence (LVEALYL) situated in HI chain B, which forms 
structurally similar amyloid-like fibrils in isolation to HI through the steric zipper 
mechanism (1.3.1. What is protein fibrillation?, page 40) and suggested that this 
segment is central to the fibrillation pathway. 
1.3.1. What is protein fibrillation? 
 Protein fibrillation is termed as the process for which proteins misfold from 
their native state into large linear aggregates.56 Investigation of the fibrillation 
pathway is important for amyloid studies since the large insoluble fibrillar assemblies 
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are hallmarks of amyloidosis. However questions were raised on how these fibrils 
incite toxicity within the proposed amyloid cascade hypothesis.4 Recent advances 
have re-evaluated the cascade perspective,57,58 and stipulated the pre-fibrillar mobile 
oligomeric species are the likely source of pathological toxicity.59,60 
The fibrillation process is a nucleated self-assembly reaction61 and can be 
generalised to a three-phase kinetic model, represented by a sigmoidal curve as 
shown in Figure 8, comprised of the; lag-, elongation- or growth- and finally 
saturation phase. Kinetically these phases correspond to; an increasing exponential 
growth rate (lag), linear maximum growth rate (elongation) and a decreasing 
asymptotic rate (saturation). Amyloid fibrillation kinetics are quantified using ThT 
fluorescence assays, which monitor the fibrillation pathway whereby fluorescence 
emission intensity is correlated to increasing fibrillation state, which will be discussed 
further in Chapter 4 (4.3.3. Measuring the amyloid-like fibrillation kinetics, 
page 144). 
 
Figure 8: The three-phase kinetic amyloid fibrillation pathway model, showing a 
(blue sigmoidal curve) fibrillation proceeding through the (yellow) lag-, (green) elongation- and 
(pink) saturation- phases as a function of time (x-axis) and aggregation (y-axis). 
The lag phase, shown as yellow background in Figure 8, consists of nuclei 
formation, which are stable states that allow growth and addition events to occur, 
and generate a critical concentration for detection within bulk assays.61 Formation of 
nuclei in the lag phase occurs by the misfolding of protein monomers either in the 
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bulk solution (homogeneous) or at a surface (heterogeneous), which is termed as 
primary (de novo) nucleation and is shown in Figure 9.62 
 
Figure 9: Schematic of the homogeneous primary nucleation mechanism, showing the soluble 
monomers as triangles with a (red) hydrophobic and (blue) hydrophilic domain and the 
(orange star) nucleation site. Adapted from Almeida et al.63 
The primary nucleation mechanism (Figure 9), shows the HI monomers 
existing in an equilibrium with the nuclei. In the case of HI, the monomers also exist 
in an equilibrium, which will be discussed further (1.4.1. Oligomer Equilibrium, 
page 47), therefore the primary nucleation equilibrium necessitates the dissociation 
of hexamer species through dimeric to monomeric first.64 Changes in the lag phase 
have been directly correlated to fibrillation kinetics, where decreased lag times have 
been associated with increased fibrillation.65–67 For HI, Nielsen et al68 have reported 
that increasing HI concentration or fibrillation in acidic conditions leads to a 
decreased lag time and accelerated fibrillation.  
The elongation phase, also termed growth phase, is the linear propagation of 
aggregates formed by the addition of monomers to the nucleation sites at the fibril 
ends,69,70 eventually resulting in a fibrillar structure as shown in Figure 10.3 In 
Figure 10a, this is shown by the addition of soluble monomers (triangles) to the 
preformed fibrillar species (black trapezoid). In addition to the elongation 
mechanism, this phase also consists of two secondary nucleation pathways; 
fragmentation and surface-catalysed, shown in Figure 10b and c. Fibril 
fragmentation (Figure 10b) generates an increased number of nucleation sites 
through which elongation can proceed, therefore accelerating fibrillation rate within 
the system.71 Surface-catalysed nucleation (Figure 10c) occurs on the surface of 
preformed fibrils, whereby transient adsorption of monomers results in templated 
fibrillation.72,73 
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Figure 10: Schematic showing the elongation phase which consists of the (blue border) growth and 
(orange border) nucleation states. The associated fibrillation mechanisms; (a) Elongation, 
(b) Fragmentation and (c) Surface-catalysed mechanisms. The soluble monomers are represented as 
triangles with a (red) hydrophobic and (blue) hydrophilic domain. Adapted from Almeida et al.63 
 The surface-catalysed mechanism shown in Figure 10, can disrupt an 
amyloidogenic fibrillation pathway, because fibrillation can occur at nucleation sites 
on preformed aggregate surfaces therefore resulting in statistically variable reaction 
rates.74 The nucleation arising from aggregate surfaces is termed seeded-growth, 
which has been shown to significantly affect the fibrillation pathway,69,75 and 
accelerated kinetics for HI have been reported.55,76 This mechanism is described here 
for nucleation on protein species, but it can also occur at physical surfaces, which will 
be discussed further (1.5.1. Protein interaction at the liquid-solid interface, page 52). 
Khurana et al77 describe fibrillation as a hierarchal assembly model, whereby 
the nucleated polymerisation firstly results in a linear aggregate structure termed a 
protofilament. A protofilament is formed, by two β-sheets (green and pink) 
interlocking together in a steric zipper mechanism, as shown in Figure 11a, forming 
a dehydrated β-sheet bilayer which runs along the fibril axis, shown in Figure 11b. In 
the case of HI, association of two protofilaments (pink / green and purple / orange) 
through intertwined or associated side-by-side processes results in the formation of 
a protofibril (green / purple), shown in Figure 11c.78,79 Finally, two protofibrils 
interweave resulting in a mature insulin fibril (green / purple and grey / orange) 
shown in Figure 11d.80 A recent investigation by Dolui et al81 has shown the 
increasing diameter size and morphological changes of HI as fibrillation proceeds by 
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atomic force microscopy (AFM), from 3 – 4 nm for protofilaments82 to 5 – 8 nm for 
protofibrils81 through to 10 nm for fibrils.78 
 
Figure 11: A schematic showing the hierarchal assembly of a fibril, (a) steric zipper mechanism 
between two ß-sheets, (b) protofilament between the two zippers along a fibril axis, (c) Protofibril with 
inset showing the association of two protofilaments along the axis and (d) a fibril formed by two 
protofilaments. The coloured borders are indicative of the three-phase kinetic model, 
(orange) nucleation, (blue) lag and (red) saturation. Adapted from Khuruna et al.77 
 The elongation phase (Figure 8) has received significant interest recently 
because current research reports amyloid toxicity is derived from the pre-fibrillar 
species as opposed to the mature fibrils, which are categorised as hallmarks of 
amyloidosis diseases due to their aggregation into plaques.24 The saturation 
phase (Figure 8), which is the association of fibrillar species into mature fibrils, is 
dependent upon the arrangement of protofibrils, which twist around each other, 
giving rise to differing fibril morphologies. The fibrillation process is affected by 
factors such as; temperature,83 agitation,84 pH,85 concentrations64 and denaturation 
additives86 as a function of time, which construct fibrils of differing morphologies. In 
the case of HI, fibrils formed in neutral conditions are significantly shorter than those 
in acidic conditions as shown in Figure 12.87 The chirality and morphology are also 
affected by slight variations in acidic conditions, where left-handed intertwined 
fibrils (~8 nm) are observed at pH 2.4 – 3.2 but become shorter (~2 nm) and 
aggregated right-handed fibrils at increased acidity (pH 1.1 – 2.1).79 
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Figure 12: Transmission Electron Microscopy (TEM) images of human insulin (HI) fibrillation showing 
fibril morphology differences with respect to fibrillation in (pH 7.0, a) neutral and (pH 1.8, b) acidic 
conditions. Adapted from Iannuzzi et al.87 
1.4. Human insulin: The model protein for amyloid research 
 The primary protein of interest within this thesis is human insulin (HI), which 
is a metabolic hormone physiologically important for the regulation of blood sugar. 
Insulin is a model protein for amyloid-fibrillation events, for two main reasons; its 
significance as a therapeutic for managing both Type I and II diabetes, and the high 
propensity to form amyloid-like fibrils in vitro.88 Globally, it is estimated 415 million 
people live with diabetes, which is set to rise to 642 million by 2040.89 
In both diabetic types, the condition can be managed by insulin treatments 
administered by transdermal injections.90 However, both diseases differ significantly 
in the onset of disease. Type I diabetes is an autoimmune disease, whereby the 
patient’s body is attacking and destroying insulin synthesising cells, β-cells, which are 
located within the pancreas. Conversely, Type II diabetes is insulin resistance, where 
the β-cells are becoming resistant to insulin therefore causing the pancreas to 
increase insulin production.91 Unfortunately, the excessive demand upon the 
pancreas to increase insulin production, damages the β-cells thus reduces production 
which leads to a diminished physiological insulin response over time as the cell 
damage increases. In both types the ability to regulate and maintain blood sugar 
levels effectively is reduced, therefore both conditions are treated by introduction of 
physiologically-active insulin.92,93 It is therefore of paramount importance to 
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understand the insulin fibrillation pathway in order to increase efficiency of the drug 
delivery systems, whilst reducing the risk of induced amyloidosis at the injection site. 
 The key focus for why this thesis focuses on HI rather than other 
amyloidogenic proteins, in addition to clinical importance, is the in vitro capability, 
specifically the ability to investigate HI fibrillation under laboratory conditions within 
a measurable timeframe. This thesis investigates how hydrophobic variability at the 
interface affects HI fibrillation, with the attention on surfaces which come into 
contact with insulin outside of the human body but are still important, such as; 
downstream processing, drug delivery systems and pharmaceutical storage. HI is 
globular protein, a class of proteins defined by their spherical architecture and 
sensitivity to changes in the local environment such as; temperature or pH, which 
allows for various conditions to be studied. 
Chemically, HI is a 51 amino-acid residue polypeptide consisting of two 
chains (A and B) containing 21 and 30 amino acids respectively. There are three 
disulfide bonds present within the molecule which provide structural support for 
both chains; one intra-chain (A6:A11) and two inter-chain (A7:B7 and A20:B19), which 
are illustrated as orange bonds in Figure 13.  
The three-dimensional representation of an NMR resolved HI monomer31 in 
Figure 13, was rendered from the protein data bank (PDB) file using the Visual 
Molecular Dynamics (VMD) software.33 HI consists of three α-helical secondary 
structure elements, two α-helices in chain A (green) and one in chain B (blue). The 
cyan and red colouration (Figure 13) denotes the C-termini at chains A and B 
respectively. The termini locations are also utilised for the single-point mutations 
observed for insulin analogues (as shown in 1.4.2. Mutations of insulin, page 48). 
Formation of an anti-parallel β-sheet, to stabilise the HI dimer, occurs at the B-chain 
C-termini from residues B24.94 
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Figure 13: Visual Molecular Dynamics (VMD)33 representation of human insulin (HI, PDB: 2JV1),31 
illustrating; (green) chain A, (blue) chain B, (orange) disulfide bonding, point mutation (cyan) A21 and 
mutation region for point mutations (red) B31 and B32. 
1.4.1. Oligomer Equilibrium 
Insulin can exist in various oligomeric states (Figure 14); monomer, dimer and 
hexamer, dependent upon the environmental conditions present.95,96 This 
equilibrium is important and has been exploited in the pharmaceutical industry. As 
the hormone is active in its monomeric state, but its stability is inversely proportional 
to the oligomeric state as fibrillation occurs more rapidly,97 therefore the hexameric 
state is preferential for logistical purposes as the hexamer reduces chemical 
degradation and toxic aggregation from occurring during storage.98 The physiological 
dissociation of hexamer to monomer state, upon injection, gives rise to the various 
pharmacodynamic analogues,99,100 which will be discussed further (1.4.2. Mutations 
of insulin, page 48). 
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Figure 14: Human insulin (HI) oligomeric states represented (left to right); monomer, dimer and 
hexamer. The colour denotes the (red) hydrophobic and (blue) hydrophilic domains. 
 The oligomeric states exist in an equilibrium, which is mediated by pH and HI 
concentration. In general, low pH (acidic) promotes monomeric state, whilst 
increasing the insulin concentration leads to a greater preference for higher order 
oligomeric species. Attaining the hexameric state requires zinc ion stabilisation, 
whereby the dimeric species co-ordinate to the zinc ion. In pH 2 conditions, acetic 
acid (20%) and reduced HI concentration, the monomeric state is preferred.68,101 
Ideally, amyloid-like fibrillation investigations should aim to study and contrast both 
oligomeric-dominant extreme conditions.96,101,102 The manipulation of oligomeric 
equilibrium is critical in this thesis, as both monomeric (pH 2, 20% acetic acid) and 
predominantly higher order oligomeric species (pH 7, phosphate-buffered saline, 
PBS) are studied to observe the differences posed at the hydrophobic interfaces. 
 The monomeric state is both pharmaceutically active and has also been 
reported to most readily adsorb to hydrophobic surfaces.21,68,88,103 This activity is 
derived from the monomeric structure, since it has an exposed hydrophobic region, 
which drives the surface adsorption to minimise exposure to the hydrophilic solution. 
Meanwhile, the oligomeric states are formed by two monomeric hydrophobic 
regions joining together (dimerising), thus burying this interface and reducing 
preference for surface adsorption through the hydrophobic interactions. If an insulin 
monomer adsorbs to the hydrophobic surface, this involves structural 
rearrangement leading to disordering and thus misfolding events at the bulk 
interface allowing for amyloid-like fibrillation to occur.104 
1.4.2. Mutations of insulin 
 The importance of insulin as a model protein for amyloid research has led to 
a lot of literature for the insulin fibrillation pathway, however the main concern 
attributed to this is the lack of clarity or consistency surrounding the insulin variant 
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studied. Historically, the management of diabetic conditions was with animal derived 
insulin, specifically bovine (cow) or porcine (pig). It was not until the 1980s that a 
human insulin variant was commercially available.105 HI was an issue for patients due 
to the associated pharmacokinetic and pharmacodynamic drug profiles, therefore 
pharmaceutical analogues were developed. These new pharmaceutical analogues, 
with significantly improved biostatistics, such as potency and drug lifetime, have 
resulted in five categorisations of medicinal-grade insulin, which are classified by 
drug activity lifetime; rapid-, short-, intermediate-, long- and ultra-long-acting. HI is 
categorised as a short-term drug, whereas a synthetic variant, insulin glargine, is a 
long-term drug due to its longer activity period, up to 24 hours.106,107 
 Insulin derivatives and analogues exist by means of amino acid mutations 
within the primary peptide sequence, where a single-point mutation can result in 
vastly different pharmacodynamics. A brief comparison of the single-point mutations 
present in the pharmaceutical insulin analogue glargine, and historic derived bovine 
and porcine, compared to HI is shown Table 1.  
Table 1: Analogues of insulin showing the mutated amino acid residue sites for each analogue; 
Human (HI), Glargine, Bovine, and Porcine. Only the mutated sites are displayed, and those which differ 
from HI are shown in bold. Glargine is the most mutated sequence for these analogues consisting of 
three residues across both chains at sites A21, B31 and B32, with the latter two residues additional to the 
HI sequence. Bovine also consists of three mutation sites across both chains, but with no additional 
residues, situated at A8, A10 and B30. Porcine is the least mutated analogue shown here, with only one 
mutation situated within the B-chain at B30. 
Insulin 
variant 
Amino acid mutation (chain, residue number) 
A8 A10 A21 B30 B31 B32 
Human Threonine Isoleucine Asparagine Threonine - - 
Glargine Threonine Isoleucine Glycine Threonine Arginine Arginine 
Bovine Alanine Valine Asparagine Alanine - - 
Porcine Threonine Isoleucine Asparagine Alanine - - 
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Table 1 highlights that overall there are six possible single-point mutation 
sites, three in each chain, including two additional residue sites at chain B, which 
result in differing pharmacodynamics apparent for; glargine, bovine, or porcine 
insulin. The pharmaceutically designed analogue, insulin glargine, consists of three 
mutations; one at the A-chain carbon terminus (A21) and the addition of two residues 
at the B-chain carbon terminus (B31, B32). In terms of historic insulin analogues, 
similarly to glargine, bovine consists of three mutations; two within the 
A-chain (A8, 10), and one at the B-chain carbon terminus (B30), whereas porcine has 
the least mutations with only one which is situated at the B-chain carbon 
terminus (B30),99,108 neither historic analogue contains any additional residues. 
It is important to consider the effect of single-point mutations on the HI 
sequence, as mutations result in vastly different protein properties either 
intentionally or otherwise, which are pharmaceutically beneficial because the 
associated pharmacopeia / kinetic / efficacy properties can be adapted as required. 
For example, insulin glargine was designed with the inclusion of the two additional 
arginine residues, which are both positively charged, at the B-chain termini and leads 
to a larger structural effect; isoelectric precipitation.109 This effect shifts the 
isoelectric point of insulin to neutral pH, which is critical from a pharmaceutical 
perspective. Injection of glargine into the human body, at physiological pH, leads to 
precipitation of the drug, which is a desired process as this prolongs the adsorption 
of glargine into the bloodstream resulting in a controlled long-term release.110 
 Overall, the effect of mutations in the wider context of amyloid research, 
leads to questioning the validity of utilising protein analogues, since the biophysical 
properties of the peptide differ and thus may aggregate and fibrillate differently. A 
slight modification of the primary sequence can have major ramifications regarding 
the protein output as observed with single-point mutations and the resulting 
analogues. A mutation at a hydrophobic region, or the inclusion of hydrophobicity 
could affect the oligomeric equilibrium of insulin and thus enhance or inhibit the 
aggregation propensity thereof. 
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1.4.3. Fibrillation pathway 
The previous section, (1.3.1. What is protein fibrillation?, page 40), has 
already presented the amyloid fibrillation pathway using HI as the exemplar protein 
to discuss the three-phase fibrillation kinetic model. A prerequisite for insulin to 
undergo the fibrillation process, is the dissociation of insulin oligomers within the 
oligomeric equilibrium (Figure 14) into the active fibrillation component, monomeric 
state. It has been reported that the fibrillation pathway is triggered at the monomeric 
state by a structural change resulting in partial unfolding and exposure of the 
hydrophobic domain to the environment.55,97,111 The unfolding event occurs at the 
A-chain N-termini, which exposes a hydrophobic domain,97 this unfolding is 
important for both surface adsorption and fibrillation to occur because of the 
hydrophobic interactions.112 These interactions result in a β-sheet formation, 
whereby disulfide bonds are retained,78,113 which gives rise to a protofilament 
through the steric zipper mechanism.114 
In this thesis both acidic and neutral pH conditions are studied to manipulate 
the oligomeric equilibrium. Acidic conditions are used to study amyloid-like 
fibrillation within a reasonable timeframe for measurements, whereby neutral pH is 
used for comparison to physiological conditions. 
1.5. Why are surfaces important? 
A surface or interface is defined as a boundary between two phases, whereby 
there is an abrupt change in properties with distance.115,116 Molecularly, surface 
atoms located at the outermost layer, have different chemical and physical 
properties to those in the bulk material because of a lack of neighbouring atoms.117 
Interfaces are often used in surface science studies to facilitate chemical or biological 
processes, such as electrochemical or heterogeneous catalytic reactions.118 The 
presence of a surface can influence a biological system; therefore, it is important to 
consider the effect of a substrate surface on a liquid suspension for various reasons 
ranging from storage to logistics or processing events, whereby the suspension is in 
contact with a high surface area. 
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1.5.1. Protein interaction at the liquid-solid interface 
Research targeting the interaction of proteins at surfaces is of increasing 
importance, to understand the implications on processes such as; clinical, medicinal 
and industrial. These processes could range from biomaterials for implants, to drug 
delivery, through to downstream processing in industrial environments. This thesis is 
principally interested in the implications which arise from the formation of fibrillar 
structures by amyloidogenic proteins, specifically the impact of surfaces on HI in 
respect to the long-term storage and logistical issues for the drug delivery system.  
Protein adsorption to the surface is a spontaneous process which occurs 
through chemisorption or physisorption processes.17,119 The protein’s structural state 
is dependent upon its classification, Norde et al120 classified proteins according to 
their structural stability. Low internal stability termed “soft” and thus likely to 
undergo structural rearrangement upon adsorption at the surface, whereas high 
internal stability termed “rigid” where limited structural rearrangement occurs.120 HI 
is a structurally labile globular protein and thus has been defined as ‘soft’ using the 
Norde classification,121 which infers structural rearrangement occurs upon 
adsorption to the surface. Adsorption to a surface is a complex phenomenon and can 
occur through various mechanisms, dependent upon the properties of both the 
surface and protein. There are many possible mechanisms for protein adsorption to 
a surface, as shown in Figure 15. However these are simplified adsorption models 
based on generalised assumptions of both the surface and protein.122  
The nine protein adsorption models shown in Figure 15, have been grouped 
into; specific site adsorption (Figure 15a, b, c), clustering adsorption (Figure 15d, e) 
and change in adsorbed protein state (Figure 15f, g, h, i). In the specific site 
adsorption models the protein (purple circle) initially adsorbs (shaded lilac) to an 
available site (green dashed line) on the surface (shaded grey). In the Langmuir 
model (Figure 15a) the protein adsorbs at discrete sites, whilst in the Random 
Sequential Adsorption model (RSA, Figure 15b) arbitrary adsorption to any site 
occurs and finally for the Tracking model (Figure 15c) the adsorption is facilitated by 
the pre-adsorbed protein. Pre-adsorbed species are also key in the clustering 
processes (Figure 15d and e); in the exchange model (Figure 15d) a monomer initially 
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adsorbs to the surface, but can then be replaced through dimer association from the 
bulk solution. Whilst in the surface clustering model (Figure 15e) adlayer adsorption 
or diffusion can occur. Adsorption of a soluble protein monomer to a pre-adsorbed 
species can occur either in a multi-layer form directly above or adjacent to the 
gathered species, which can result in diffusion of the species across the surface 
leading to surface clustering. The final models result in a protein state change upon 
adsorption to the surface, which are the; (f) rollover, (g) two-states, (h) three-states 
and (i) multi-state models. In regards to HI, all the models are valid but are dependent 
on the HI oligomeric state, suspension and surface properties.124 
 
Figure 15: Schematic showing the various possible (purple circles) protein adsorption events, with the 
(lilac) initial adsorption state onto a (grey) generalised surface mechanisms. (green borders) Specific 
site adsorption model are; (a) Langmuir, (b) Random Sequential Adsorption and (c) Tracking, with 
(dashed) possible adsorption sites shown as either (green) available or (red) unavailable. 
(blue borders) The clustering models are; (d) Monomer / Dimer exchange and (e) Surface clusters. 
(orange borders) A change in adsorbed protein state results in the following models; (f) Rollover, 
(g) Two-states, (h) Three-states and (i) multiple states, as shown by the shape change from circular to 
diamond or pentagon. Adapted from Rabe et al.123 
Arnebrant et al125 have reported that soluble HI monomers adopt a close 
packed layer on adsorption126 to metal surfaces. In the presence of gold, insulin 
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monomers have been reported to adsorb through chemisorption processes via the 
insulin disulfide bridges, as shown in Figure 16, which result in degradation of the 
insulin structure to accommodate formation of gold-sulfur bonds (Au-S).127 
Welinder et al127 proposed the structurally labile insulin monomer (or dimer) species 
becomes increasingly unfolded on adsorption to the gold surface due to sequential 
Au-S bonding. 
 
Figure 16: Schematic of an insulin monomer adsorption process to a (yellow) gold surface illustrating 
the effect of adsorption through the (orange) internal cysteine residues by various disulfide bonds. 
(a) adsorption to one disulfide bond, (b) distortion for two disulfide bonds and (c) unfolding resulting 
in three disulfide bonds to gold. Adapted from Welinder et al.127 
 Initially insulin adsorbs to a bare gold surface by chemisorption with 
formation of two Au-S bonds through one of insulin’s intra-disulfide bonds shown in 
Figure 16a. Insulin is structurally labile therefore distortion processes lead to 
adsorption through two intra-disulfide bonds resulting in four Au-S bonds formed 
shown in Figure 16b. The insulin monomer then becomes increasingly distorted, 
which results in unfolding processes, as all disulfide bonds adsorb to the surface thus 
formation of six Au-S bonds (Figure 16c). The formation of the strong Au-S bond 
occurs because gold has a high affinity for sulfur and is the driving force for the 
establishment of self-assembled monolayers (SAMs) through thiol and disulfide 
chemistry.128 After adsorption to the gold surface (Figure 16a), as HI is structurally 
labile, it undergoes a conformational change leading to the autocatalytic effect. 
 The autocatalytic effect, as described by Hammarstrom et al,129,130 occurs 
when the adsorbed insulin layer undergoes a conformational change which results in 
self-replication as adsorption to the layer proceeds, through the secondary 
nucleation surface-catalysed mechanism (Figure 10c).19 Firstly, the soluble insulin 
monomers adsorb to the surface substrate, resulting in a conformational change at 
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the adsorbed insulin layer. Continued adsorption initiates the nucleation phase 
thereby generating nucleation sites for which fibrillation can proceed. At a critical 
point, the nucleated insulin molecules dissociate from the adsorbed layer, thereby 
resulting in fibril seeds which propagate within the media through a seeded-growth 
approach. The loss of the insulin fibril seeds results in regeneration of the adsorbed 
layer, therefore allowing for further insulin adsorption at this layer and continuation 
of the autocatalytic cycle. Fibrillation of HI through the autocatalytic effect is further 
compounded by its classification as a “soft” protein as it is structurally labile on 
adsorption to hydrophobic and hydrophilic surfaces. 
1.5.2. Why is hydrophobicity key? 
A surface can be described by its wetting ability, which is the amount of contact a 
water droplet has at a surface interface defined as hydrophobic or hydrophilic 
character. This terminology is derived from Latin meaning; ‘hydro-’ (water), 
‘-phobic’ (repel) and ‘-philic’ (attract). Hydrophobicity has been observed in nature, 
the noteworthy example of a lotus leaf, which utilises hydrophobic character as a 
self-cleaning mechanism, whereby the water droplet rolls off the leaf removing dirt 
particulates from the leaf’s surface.131 The hydrophobicity of a material is 
determined by the contact angle of a water droplet at the surface, as shown in 
Figure 17. A surface is described as hydrophobic if the contact angle is greater than 
or equal to 90°. Conversely, a surface is classified as hydrophilic if it possesses a 
contact angle less than 90°, thus the surface is wetting. Recent scientific interests 
include superhydrophobicity (contact angle greater than 150°) and 
superhydrophilicity (contact angle equal to 0°), which are proposed for separation 
sciences.132  
 Hydrophobicity is not a specific phenomenon attributed to surfaces but is 
attributed to the overall charge of a molecule. A molecule with no regions of charge 
is non-polar, thus does not dissolve in water and is termed hydrophobic, whilst a 
molecule with partial positive or negative charges is hydrophilic. Molecules which 
consist of both hydrophobic and hydrophilic regions are termed amphiphilic, an 
example of such is a surfactant with a hydrophobic tail and hydrophilic head. In 
aqueous colloidal conditions and above a certain concentration, the individual 
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surfactants aggregate together, with the hydrophobic tails creating a hydrophobic 
core and the head groups interacting with the suspension, which forms a 
three-dimensional supramolecular assembly termed micelle. Aggregation is driven 
here by entropic factors, the loss of solvation shells surrounding the surfactants 
hydrophobic tail groups is greater than the loss of entropy as a result of the micelle’s 
hydrophobic core.133 
 
Figure 17: Characterising surface hydrophobicity, shown by changes in the (, orange) contact angle 
between the (blue) water droplet and (grey / black) surface. The increasing () contact angle 
corresponds to increasing hydrophobicity, surface dewetting and reduction in surface adhesion and 
surface free energy. 
 Proteins are complex amphiphilic constructs comprised of various 
hydrophobic and hydrophilic amino acid residue side groups. The amphiphilic 
character is an integral feature for many structural features, such as α-helices with 
hydrophobic groups orientated towards the centre and hydrophilic on the outside 
forming a hydrophobic core. Proteins adsorb to hydrophobic surfaces because of this 
entropic effect, by increasing entropy resulting from loss of a solvation shell around 
each protein molecule.134 A soft protein such as HI, adsorbs strongly to hydrophobic 
and hydrophilic surfaces because of the entropy gained from structural 
rearrangement, which overcomes electrostatic concerns. 
 Adsorption at a hydrophobic surface presents an additional concern for 
amyloidogenic proteins, as proteins adsorb to a hydrophobic surface as a cluster, 
which can then spread across the surface because of their innate high surface 
mobility.123 The generalised protein (green shaded circles) adsorption pathway for 
hydrophobic (red border) and hydrophilic (blue border) surfaces are shown in 
Figure 18. In the hydrophobic pathway (Figure 18a, b, c) the protein cluster firstly 
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adsorbs onto the surface by anchoring to the surface substrate, diffusing the 
pre-adsorbed species, thus allowing the protein cluster to disperse across the 
surface. In contrast, for the hydrophilic pathway (Figure 18 d, e, f), the protein 
cluster fails to adsorb, resulting in no anchoring mechanisms, thus detaches from the 
hydrophilic surface. 
 
Figure 18: Schematic of a (green) generalised protein cluster adsorption mechanism to a 
(red) hydrophobic or (blue) hydrophilic surface. Adapted from Rabe et al.123 
 Previous studies have reported that hydrophobicity affects the HI fibrillation 
pathway, in the presence of hydrophobic Teflon particles (~0.2 µm) the fibrillation 
kinetics are increased.96 It has been shown that the HI monomers undergo 
conformational changes on adsorption to thiol-functionalised gold surfaces which 
allow further HI binding.135 HI monomers have been shown to adsorb to hydrophobic 
surfaces preferentially, with one of the monomers hydrophobic interfaces orientated 
towards the surface.125,136 Nayak et al137 proposed it is the confinement of protein 
molecules on hydrophobic surfaces, which increased localised protein 
concentrations, that attributed to the enhanced fibrillation kinetics for insulin.  
 There are benefits to hydrophobic materials, for example their increasing 
usage in clinical applications because of the advantages such as; anti-corrosion, 
anti-fouling and self-cleaning.138 An emerging clinical application for 
superhydrophobic materials are medical implants, as the hydrophobicity can reduce 
biofilm formation, an accumulation of bacterial communities, which are attributed 
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to bacterial infections within the patient.139 Pharmaceutically, hydrophobic materials 
may present advances in drug delivery systems from utilising nanostructures,140 to 
polymer drug conjugates,141 through to 3D superhydrophobic cages,142 or for syringe 
needle coatings to reduce patient discomfort during transdermal injections.143 
1.5.3. Changing surface properties by functionalisation techniques  
 The primary aim of this thesis is to investigate how varying surface 
hydrophobicity affects HI fibrillation, for comparability purposes it is therefore 
advantageous to maintain the same bulk substrate and only change the surface 
functionality. This thesis investigates two bulk substrates, silicon and gold, because 
they are both used in medicinal applications, are of spectroscopic interest, but most 
importantly can be hydrophobically functionalised using standard methodology.  
Silicon is increasingly used from diagnostics144 to biomedical 
applications,145,146 through to amyloid research as a spectroscopic substrate.130 This 
thesis utilises silicon for the latter, as a substrate for which hydrophobic 
functionalisation can occur, its use as a substrate is ideal due to its spectroscopic 
potential. Surface-sensitive spectroscopic studies require a highly reflective surface, 
for which silicon when polished can attain, whilst the material itself has isolated 
Raman vibrational band characteristics (520 cm-1).147 Silicon can be easily modified 
through silane chemistry, which functionalises the interface with the desired 
modification as shown in Figure 19.  
The silanisation process resulting in SAMs, shown in Figure 19, firstly requires 
a clean hydroxylated silicon surface, this surface undergoes hydrolysis in the 
presence of a silane resulting in the loss of an alcohol group. The silanisation process 
can propagate further with silane molecules hydrolysing at the surface or 
polymerising with other silane groups. The silanisation process is ineffective and on 
termination results in residual hydroxyl sites, also known as silanol groups, which 
could lead to unintended chemical reactions or degradation of the silicon substrate. 
In applications such as chromatography, it is vital to limit the silanol availability as 
the functionalised interface dictates specific binding to the analyte.149 A process 
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termed end-capping shown in Figure 19d, is often used which functionalises the 
remaining silanol sites with a smaller silane functional group. 
 
Figure 19: Schematic for the formation of self-assembled monolayers (SAMs) using silane chemistry on 
a (grey) hydroxylated silicon surface. (blue border) The silanisation process commences with 
(a) hydrolysis of a silane molecule and hydroxyl group resulting in loss of methanol, (b) additional 
silane molecules can hydrolysis with both the surface and adsorbed silane methoxy group resulting in 
loss of methanol molecules. (gold border) The end-capping process (c) introduces a smaller functional 
silane to the remaining silanol groups and through hydrolysis results in loss of methanol molecule, 
providing (d) an end-capped silane functionalised silicon surface. Adapted from Ratner et al.148 
Gold, an inert metal, is a widely utilised material due in large parts to its 
biological compatibility and historical usage, with applications ranging from medical 
devices to anti-inflammatory and anti-microbial purposes.150 A bare gold substrate is 
also spectroscopically advantageous as it is reflective and thus can be utilised in 
surface-sensitive techniques. Similarly to silicon, a gold surface can be functionalised 
using SAMs with chemistry analogous to silanisation, utilising thiol and disulfide 
chemistry.151–156 It is important to note that while gold is spectroscopically an ideal 
material, as previously shown in Figure 16, the bare gold surface can associate to HI 
through the formation of Au-S bonds, which are detrimental to the structural stability 
of HI. The use of gold nanoparticles has been shown to inhibit bovine insulin 
fibrillation and affect its fibrillar morphology.157 Functionalised gold surfaces have 
previously been used in amyloidogenic studies from autocatalytic fibrillation of 
amyloid-β (Aβ),158 to seeded-fibrillation growth studies of bovine insulin by quartz 
crystal microbalance (QCM).159 
The work in this thesis designated an interface as the boundary between a 
hydrophobically functionalised solid substrate and a protein suspension, which is 
titled The Physical and Chemical Origins of Amyloid at Interfaces. The specific 
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objective of this work was to study the effect of hydrophobic functionalised 
interfaces, silicon and gold, on HI fibrillation under measurable conditions using an 
ensemble of spectroscopic techniques, to gain an insight into structural and kinetic 
properties particularly the pre-fibrillar state. 
1.6. Outline of thesis 
1.6.1. Chapter 2: Directed Human Insulin Fibrillation on Hydrophobic Silane 
Functionalised Silicon Surfaces 
 Reflection anisotropy spectroscopy is used to determine how adsorbed HI 
and its pharmaceutical analogue aligned with the underlying architecture of the Si 
surfaces. The initial promise of this methodology showing differing alignment for 
these proteins was abandoned when irreproducibility issues prevailed, and this goal 
was unfortunately not achieved. 
1.6.2. Chapter 3: The Importance of Protein Pre-Treatment 
 This chapter develops a new methodology for the preparation and storage of 
the HI suspensions to ensure the reproducibility of the results in subsequent work. 
1.6.3. Chapter 4: The Co-incubation Effect of Functionalised Mesoporous Silica 
Microparticles with Human Insulin, on Amyloid-like Fibrillation 
 Silica mesoporous microparticles are used in this study to investigate the 
effect of hydrophobic functionalised mobile surfaces on HI fibrillation using 
adsorption, kinetics and morphology techniques. The results showed that HI 
incubation with particles at pH 2 inhibited whilst at pH 7 enhancement of the typical 
sigmoidal curve occurred and these results were correlated to the transmission 
electron microscopy (TEM) images of the fibrils. 
1.6.4. Chapter 5: Hydrophobic Functionalisation of Gold Surfaces on Human 
Insulin Fibrillation 
 The effect of the surface hydrophobic functionalisation on the thickness of an 
adsorbed HI monolayer is investigated and correlated to pH and degree of 
hydrophobicity. These monolayers were probed with Raman spectroscopy to 
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determine the structural composition of the HI adlayer, specifically as structural 
rearrangement of HI had occurred upon adsorption to the hydrophobic surface. 
1.6.5. Chapter 6: Interrogating Human Insulin Adsorption on Hydrophobically 
Functionalised Gold Interfaces with Infrared-Scanning Near-field Optical 
Microscopy (IR-SNOM) 
 This chapter uses the novel technique of scanning infrared near-field optical 
microscopy (IR-SNOM) in a preliminary investigation to determine the effect of 
hydrophobic functionalised gold surfaces on the secondary structure of HI. The 
results presented are the first results obtained from an IR-SNOM in reflection mode 
(with the quantum cascade laser as the mid-IR source), of adsorbed protein at a 
hydrophobic interface. These results showed that the IR-SNOM is able to determine 
variations in the HI secondary structure contributions within the Amide I band. 
1.6.6. Chapter 7: Utilising Intrinsic Fluorescence to Probe a Potential Amyloid-
like Signature 
 Deep-blue autofluorescence, is a fluorescence phenomenon that has recently 
been associated as an amyloidogenic property. In this chapter fluorescence 
excitation – emission matrices are used to probe the origin of this phenomenon using 
 I, α-synuclein and other peptides. The results did not determine the origin, however 
did provide further information into the applicability of this technique for 
amyloid-like fibrillation. 
1.6.7. Chapter 8: Future Work 
 This chapter summarises the work of the thesis and provides ideas for future 
work for instrument development and experiments to elucidate more information 
on HI fibrillation. 
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Chapter 2: Directed Human Insulin Fibrillation on Hydrophobic Silane 
Functionalised Silicon Surfaces  
2.1. Introduction 
 This aim of this chapter is to investigate the amyloid-like fibrillation of two 
insulin variants, human insulin (HI) and insulin glargine, on a hydrophobically 
functionalised stepped silicon (Si) surface by reflection anisotropy 
spectroscopy (RAS). A stepped Si surface was used in this work to explore whether 
surface architecture induces the fibrillation pathway, which was measured using RAS 
to probe the electronic states of the aromatic amino acids within insulin to obtain 
orientation information associated with the fibrillation state at the interface. 
Chapter 1 introduced insulin glargine as a pharmaceutical analogue of HI with 
improved drug profiles (1.4.2. Mutations of insulin, page 48) therefore this chapter 
aims to examine whether there are any differences in the surface-catalysed 
fibrillation pathway attributed to the single-point mutations. 
 One method of surface-catalysed fibrillation is through the 
two-dimensional (2D) diffusion of surface-confined proteins at the surface interface, 
which has been shown to promote amyloid-like fibrillation for amyloid-β 
peptide (Aβ), α-synuclein (αS),1 and insulin.2 The 2D-diffusion process occurs when 
the monomeric species diffuses across the hydrophobic interface along with 
increased localised protein concentration at a confined region, which results in 
aggregation effects.3 This diffusion process is affected by surface topography, where 
increased roughness has been reported to inhibit fibrillation events for Aβ4 and 
insulin,5 whilst surface chirality also induces insulin fibrillar changes.6 It is already 
known that various surface properties affect self-assembly at the interface,7 which is 
important as amyloid pathology has been reported to be intrinsically linked to fibril 
morphology, specifically toxicity and severity of the disease.8,9 Additionally 
investigating whether surface architecture directs orientated amyloid-like fibrillation 
has a wide range of potential applications such as; catalysis10 and biomaterials.11 
 Measuring the directed surface-confined fibrillation process at an interface is 
challenging, since non-destructive techniques such as vibrational spectroscopy only 
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probe the out-of-plane protein orientations, whereas for fibrillation the in-plane 
orientations are significant. The in-plane directionality of the protein, as resolved by 
its side chain or backbone components, is of interest for fibrillar pre-alignment 
investigations.12 One analytical technique that can reveal in-plane orientation is  
atomic force microscopy (AFM), which has previously been used to show fibril 
alignment for collagen on mica13 and for F-actin on silicon surfaces.14 However AFM 
is time consuming and potentially destructive. An alternative approach is to use a 
non-destructive rapid surface-sensitive linear dichroism (LD) technique. 
2.1.1. Obtaining orientation information of a molecule 
 Linear dichroism is a spectroscopic technique which measures the difference 
in light absorption (Abs) that has been linearly polarised parallel and perpendicular 
to the orientation axis, as shown in equation (2.1).15  
𝐿𝐷 = 𝐴𝑏𝑠𝑝𝑎𝑟𝑎𝑙𝑙𝑒𝑙 − 𝐴𝑏𝑠𝑝𝑒𝑟𝑝𝑒𝑛𝑑𝑖𝑐𝑢𝑙𝑎𝑟 (2.1) 
This technique can provide orientation information on the fibrillation pathway, as the 
fibrils provide an overall net electronic transition which is measurable. An issue with 
this methodology is that the sample must first be orientated along a principal axis to 
be measured, therefore in solution a Couette cell must be used. This technique is 
analogous to circular dichroism (CD) which measures the difference in light 
absorption between left and right circularly polarised light and is widely used to study 
the secondary structure of proteins.16 In this research programme neither LD nor CD 
were applicable since neither technique will work on hydrophobic surfaces for 
amyloid-like fibrillation, where the substrate is not transparent to the light source. 
Modification of the optics used in LD provides a surface-sensitive technique, RAS, 
which was used to study the fibrillation pathway at the surface. 
2.1.1.1. Reflection Anisotropy Spectroscopy (RAS) 
 Reflection anisotropy spectroscopy (RAS), is a technique which can probe 
in-plane order at the surface. RAS measures the difference in reflectivity of normal 
incidence plane-polarised light between two perpendicular directions on the surface 
which is normalised to the mean reflectance, as shown in equation (2.2): 








where rx and ry are the complex reflection coefficients in the x and y direction of the 
surface, with the sum of these quantities given by r. RAS is often used with a 
substrate in which the bulk is isotropic as the bulk response is cancelled due to the 
geometrical symmetry, thus rendering this a surface specific technique for measuring 
anisotropy.17  
 A schematic of the RAS instrument is illustrated in Figure 20. The sample is 
illuminated by linearly polarised light which is directed via: a photoelastic 
modulator (PEM), a second polariser (usually called an analyser) and a 
monochromator onto a detector. The PEM consists of two elements; a birefringent 
optical element (shown in light grey) and a piezo transducer element (shown in dark 
grey). 
 
Figure 20: A schematic of the reflection anisotropy (RA) spectrometer, adapted from Weightman et 
al.17 
 The PEM is arranged so that when a voltage is applied to the piezo transducer, 
stress is induced in the optical element. When the optical element, which is a quartz 
crystal, is stressed it exhibits birefringence. The PEM is orientated so that the 
eigenvectors of the birefringence stress tensor act vertically and horizontally. These 
eigenvectors can also be referred to as the ‘fast’ and ‘slow’ axes. If the voltage applied 
to the piezo transducer alternates, then the changing stress in the optical element 
results in the ‘fast’ and ‘slow’ axes alternating between the horizontal and vertical 
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directions. Thus, light which has both vertical and horizontal components of 
polarisation will have that polarisation modulated by the PEM, as illustrated in 
Figure 20. Light which is entirely polarised in either the vertical or horizontal domain 
will not have its polarisation changed by the PEM. For example, an isotropic sample 
which reflects vertically polarised light will not be modulated by the PEM thus will 
remain vertically polarised and result in no RAS signal. 
 The reflected light for an anisotropic sample, which consists of both 
horizontal and vertically polarised components, will have its polarisation modulated 
by the PEM. This modulated polarised light will then enter the analyser and become 
polarised with amplitude modulation. At the detector the amplitude modulation 
gives rise to a varying alternating current (‘AC’) signal that will contain the rx – ry 
information. The direct current (‘DC’) or average detector output will be proportional 
to the mean reflectance, r. The RAS signal thus becomes proportional to the ratio of 
these ‘AC’ and ‘DC’ signals. 
 In the special case, where an anisotropic sample is orientated such that the 
eigenvectors of its optical anisotropy act vertically and horizontally, then the 
vertically polarised light hitting the sample will also reflect from it with vertical 
polarisation. The reflected vertically polarised light will pass through the PEM 
without modulation and generate a zero RAS signal. This aspect of RAS can be 
exploited to find the optical eigenvectors of a sample, which for crystalline samples 
generally occurs along the crystal’s principal axes, but which may be modified by 
absorbates. A detailed discussion of how RAS can be used to determine the 
absorbate orientation can be found in Paul  arrison’s thesis.18  
  AS was developed in the 1980’s by Aspnes19–21 to study semiconductor 
surfaces and an extensive literature review of the technique has been published.17 
The development of RAS from the ultra-high vacuum (UHV) environment studying 
semiconductors and molecular adsorption on metals in UHV through to studying the 
electrochemical interfaces is important as it is a non-destructive surface sensitive 
optical probe. 
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The Weightman group (collaborators on this work) have used RAS extensively to 
study various biological molecules at the solid / liquid interface including; nucleic 
acids,22–27 deoxyribonucleic acid (DNA),28–30 various amino acids,31,32 peptides33 and 
proteins,34–36 on a gold (110) surface.37 Other substrates have also been studied using 
RAS such as; DNA hybridisation on diamond,30 DNA deposition onto a vicinal Si 
surface38 and collagen secreted by fibroblast cells grown on 
polytetrafluoroethylene (PTFE) nanofibers.39 
 RAS studies have shown that orientational information can be obtained from 
the known orientations of the π-π* transitions in the nucleic acids with respect to the 
molecular structure22 together with a three-phase model40 that can be used to fit a 
RA spectrum. Another method that was developed to determine the orientation of 
the adsorbate was to rotate the sample.41 Rotation of a perfect anisotropic face 
centred cubic (fcc) surface such as the Au (110) follows a sin (2θ) rotation with 
maxima at 45° and a minimum at 135°, where the 0° and 90° correspond to the 
principal axes of the crystal. The adsorption of molecules onto the Au (110) surface 
have been found to align either perfectly or very slightly off the principal axis.29 This 
trend has also been found for collagen secreted from fibroblast cells which aligned 
with the nanofibers.39 Currently there are only a few known exceptions to this trend 
such as; the surface plasmon of Ag (110),42 DNA on diamond,43 stretching of 
polydimethylsiloxane (PDMS)44, the (11) reconstruction of Au (110)45 and in the 
study of thermotropic liquid crystals.46,47 
2.1.1.2. Electronic transitions of the aromatic amino acids 
 The three aromatic amino acids (tryptophan, tyrosine and phenylalanine) are 
used in intrinsic fluorescence (IF, 7.1.1. Introduction to Fluorescence Spectroscopy, 
page 222) techniques to obtain information on the protein state. In this chapter it is 
the two electronic transitions, which are termed La and Lb, of the aromatic amino acid 
residues within the protein structure which are measured by RAS. The electronic 
transitions arise from the indole or benzene-type chromophore within the respective 
aromatic amino acid; tryptophan, tyrosine and phenylalanine,48–51 which are shown 
in Figure 21. 
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Figure 21: The electronic transitions of La and Lb for; (red) tryptophan, (blue) tyrosine and 
(green) phenylalanine. Electronic transition values shown were taken from Zimmerman et al48 and 
Milan-Garces et al.51 
 The electronic transitions of La and Lb for the aromatic amino acids (Figure 21) 
vary in intensity. The strongest signals are observed from tryptophan because of 
stabilisation within the indole group and the intensity of the tyrosine signals are 
higher than those of phenylalanine. There are no tryptophan residues present in 
either insulin variant, therefore the RAS utilises the in-plane orientation with respect 
to the net tyrosine and phenylalanine transitions.  
2.1.2. The adaptability of Silicon 
 Silicon, the chemical element with an atomic number of 14, is the second 
most abundant element on Earth52 and is used in a wide variety of applications. In 
this thesis, Si is used because of its previous use in amyloid research,53,54 and its 
spectroscopic potential, chemical functionalisation capability and commercial 
availability. 
2.1.2.1. The application of reflection anisotropy on a silicon surface 
 A Si (110) substrate is used as a calibration standard for the RAS instrument 
because of the known positions of peaks in its RA spectrum and the ideal rotational 
behaviour of the surface crystallography as illustrated in Figure 22. Changes of 90° in 
the azimuth from 45° (red) to 90° (blue) to 135° (green) have a corresponding effect 
on the two anisotropic Si peaks (~290 and 356 nm), which have a maximum to 
minimum azimuthal dependence respectively. 
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Figure 22: Reflection anisotropy (RA) spectra of a cleaned Si (110) surface at three different azimuths; 
(red) 45°, (blue) 90° and (green) 135°. The (dashed) lines show the approximate wavelengths for the 
peaks at; 290 nm, 356 nm and 371 nm. 
 The cleaned Si (110) surface (Figure 22) is shown to change from maximum 
to minimum anisotropy signal at the 45° and 135° azimuths, which corresponds to 
the Si surface structure. The characteristic Si peaks (~290 and 356 nm) arise from 
electronic transitions in the dielectric constant of the material.55 A full 360° rotation 
of the sample, which is shown in Figure S1, demonstrates the ideal Si (110) surface 
architecture because of the symmetrical RA spectra and similarity at analogous 
azimuths. 
 The azimuthal dependence of the Si peaks (~290 and 356 nm) was tested by 
acquiring RA spectra for a full rotation (360°, 15° steps) of the sample. Figure 23 
shows three wavelengths from the RA spectra (Figure S1), which correlate to the two 
characteristic Si peaks (~290 and 356 nm, red and blue respectively) that exhibit high 
anisotropy and a smaller anisotropic peak (~371 nm, green).  
 The azimuth dependence for the Si peaks of the cleaned Si (110) 
surface (Figure 23) shows that the intensity of the peaks follows a sin (2θ) wave 
description. The full 360° rotation of the surface shows where the maximum and 
minimum anisotropic signals are and when the signal is zero (at 0°, 90°, 180° and 
270°) it is aligned to the crystal’s principal axis. As the location of the surface’s 
principal axes is known, then the adsorbed molecules orientation can be deduced in 
relation to the surface axes.  
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Figure 23: Azimuth dependence of the cleaned Si (110) surface for the three anisotropic peaks, at 
approximately; (red) 290 nm, (blue) 356 nm and (green) 371 nm.  
2.1.2.2. The importance of surface crystallography 
 Pre-requisites for the research described in this chapter were highly reflective 
surfaces for RAS, with differing surface architectures of the same substrate 
crystallography to investigate whether architecture directs fibrillation events and 
surface functionalisation capability. Si (111) wafers are available commercially as 
substrates with either atomically flat or stepped surface crystallography, as is shown 
in Figure 24. 
 
Figure 24: Schematic of the silicon (111) crystal structure for; (a) flat, (b) vicinal 6° offset in the [112] 
direction which results in the illustrated terraces. The colouration refers to the top three atomic layers 
at the surface; (blue) surface-, (pink) middle- and (green) lowest- atom. Adapted from Kim et al.56 
 A top-down overview of a Si (111) surface (Figure 24a) which is colour coded 
to highlight the hexagonal close-packed crystallography with the top three atomic 
layers; surface (blue), middle (pink) and lowest (green). The flat surface is a singularly 
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polished wafer of a Si (111) crystal, which is atomically flat with anticipated defects. 
Conversely a side-view schematic of the vicinal Si (111) surface (Figure 24b) shows 
that the 6° off-cut in the [112] direction results in 3 nm wide terraces with 
0.3 nm steps.  
2.1.2.2. Functionalisation of the interface using silane chemistry 
 Silane chemistry is a functionalisation methodology associated with 
organosilanes, which are silicon-based molecules consisting of at least one 
carbon-silicon bond.57 In this chapter a hydrophobic organosilane, 
trimethoxypropylsilane (TMPS), as shown in Figure 25, was used to functionalise the 
Si (111) surface. 
 
Figure 25: Chemical structure of trimethoxypropylsilane (TMPS).  
 TMPS, a trialkoxysilane with a propyl organofunctional group, has three 
hydrolysable methoxy groups which are hydrolysed at the surface to form alcohol 
groups thereby resulting in a propyl-terminated interface.58 A generalised 
self-assembled monolayer (SAM) schematic for functionalising a Si surface has been 
shown previously (Figure 19,1.5.3. Changing surface properties by functionalisation 
techniques, page 58). TMPS was used since the termination of the Si surface with the 
propyl group provides a hydrophobic interface, with limited degrees of freedom to 
reduce the potential for associated anisotropy. 
2.2. Materials and Methods 
2.2.1. Sample Preparation 
 All sample preparations were performed in designated fume hoods and the 
reagents used were of analytical grade or higher. All samples were manipulated with 
the same tweezers and handled at similar regions located at the edges of the Si 
substrate, where possible, to limit cross-contamination and induced physical effects. 
The samples were stored singularly in petri-dishes, and where possible were analysed 
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2.2.1.1. Surfaces 
 The silicon substrates, including all glassware and manual handling 
equipment, were cleaned with heated (~65°C) acidic Piranha solution (30% hydrogen 
peroxide and 70% sulfuric acid, 30 minutes). The cleaned items were rinsed at least 
three times with ultrapure (type I) water (Milli-Q, 18.2 MΩ cm-1), with the equipment 
oven-dried and the cleaned silicon substrates submerged in water (18.2 MΩ cm-1) 
prior to use. 
 The piranha cleaned Si substrates were dried under argon flow, then cleaned 
with UV-ozone (ProCleaner Plus, Bioforce Nanosciences) for 15 minutes on each side. 
A silane suspension, TMPS (0.5 mM) in toluene, was prepared and the ozone cleaned 
Si substrates were submerged in the sealed silane suspension, for 24 hours (~21°C). 
 After silanisation had been completed, a droplet of water onto the surface 
confirmed hydrophobicity as illustrated in Chapter 1 (1.5.2. Why is hydrophobicity 
key?, page 55). The surfaces were excessively rinsed with water (18.2 MΩ cm-1) to 
remove any multilayers and then dried under argon flow. 
2.2.1.2. Insulin suspensions 
 Human insulin (HI, 1 mg/mL, SAFC Biosciences) or insulin glargine (Lantus®, 
Sanofi, 1 mg/mL) were suspended in a pH 2.6 citrate-phosphate buffer (5.4 mL of 
0.2 M dibasic sodium phosphate and 44.6 mL of 0.1 M citric acid).59 Hydrophobically 
functionalised silicon substrates were immersed in a glass reaction vessel containing 
either HI or glargine for up to five days at ~75°C. Following the designated time 
period, the samples were briefly rinsed with water (18.2 MΩ cm-1) to remove any 
excess multilayer formation and stored in petri-dishes for analysis. 
2.2.2. Reflection Anisotropy Spectroscopy (RAS) experiments. 
 A Si substrate was mounted onto a rotational stage, with the region of 
interest situated directly in the centre of the stage.18 The tilt of the stage was 
optimised to ensure maximum signal reaches the detector, it was important that the 
area to be probed was illuminated and situated directly in the centre of rotation to 
probe the same area throughout.30 All the reflection anisotropy (RA) spectra were 
acquired between 1.5 and 5.5 eV (electron volt), converted into 
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wavelength (~827 – 225 nm) and then cropped (~225 – 500 nm) as the region above 
500 nm had minimal RA signal from the Si substrate. Data from the instrument was 
acquired using LabView (National Instruments) and then plotted using 
Origin (OriginLabs). 
2.3. Results and Discussion 
2.3.1. The effect of surface architecture on reflection anisotropy  
 The RA principles of Si (110), (2.1.2.1. The application of reflection anisotropy 
on a silicon surface, page 73) which determine the principal axes of the surface, were 
applied to two Si (111) surfaces; atomically flat and vicinal with a 6° off-cut. The Si 
surfaces have differing oxide layers as the flat and vicinal Si (111) surfaces were both 
piranha and ozone cleaned prior to functionalisation, which results in a reduced and 
more consistent oxide layer,17,60 whereas the Si (110) surface was utilised as a 
calibration standard and used ‘as is’. In Figure 26, RA spectra of the three 
azimuths (45°, 90° and 135°) acquired are shown. 
 
Figure 26: Reflection anisotropy (RA) spectra of a cleaned (red) flat or (blue) vicinal Si (111) surface at 
three different azimuths; (a) 45°, (b) 90° and (c) 135°. 
 The flat (red) and vicinal (blue) Si (111) RA spectra (Figure 26) for the three 
azimuths; (a) 45°, (b) 90° and (c) 135°, displayed significantly lower maximum 
anisotropic signals compared to the Si (110) surface. There are no characteristic Si 
peaks present in the flat RA spectra for all three azimuths, which is as expected since 
this is an isotropic surface with no difference in the x and y directions unlike in the 
crystallography of the Si (110) surface. In the vicinal spectra the characteristic Si 
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peaks, assigned to the Si (110) crystallography, are observed because the stepped 
surfaces give rise to a faceted Si (110) crystallography on the step edge.61 The 
measured anisotropy signal for the vicinal Si (111) surfaces is lower than that of the 
Si (110), which correlates with the vicinal Si (111) peaks arising from the faceted 
steps, as there are limited regions of measurable Si (110) crystallographic regions at 
the stepped interface. There appears to be a slight blueshift of 6 nm for the Si peaks 
between the Si (110) and Si (111) surfaces, which may be attributed to the 
differences in crystallography or variations in the silicon oxide layer.55 
 A full 360° rotation of both flat and vicinal Si (111) surfaces was acquired, as 
shown in Figure S2 and Figure S3. The 360° rotation of the flat Si (111) 
surface (Figure S2) does not show the characteristic Si peaks at any of the azimuths, 
as it is isotropic, therefore it is not possible to determine the location of the principal 
axes. Most of the molecules studied by RAS have been shown to adsorb in line with 
the principal axes of a substrate,23,24,29,35,36 therefore determining the location of the 
principal axes quickly is important to be able to determine adsorbed species 
orientation rapidly for both in situ studies and molecule screening purposes. 
 Similarly to the Si (110) surface, the azimuthal dependence of the Si 
peaks (~283 and 350 nm) for both vicinal and flat Si (111) surfaces was tested by 
acquiring RA spectra for a full rotation (360°, 15° steps) of the sample, which is shown 
in Figure 27. The three wavelengths studied correlate to the two Si peaks at their 
maxima (~283 and 350 nm, red and blue respectively) contrasted to the smaller 
anisotropic peak (~371 nm, green) measured previously for the Si (110) surface. 
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Figure 27: Azimuth dependence of the cleaned (a) vicinal and (b) flat Si (111) surfaces for the three 
anisotropic peaks, at approximately; (red) 283 nm, (blue) 350 nm and (green) 371 nm. 
 The azimuth dependence (Figure 27) shows that the vicinal 
surface (Figure 27a) follows the typical sin (2θ) variation in intensity arising from the 
anisotropy associated with the peaks in the Si RA spectrum. Conversely the flat 
surface (Figure 27b) exhibits no sin (2θ) dependence resulting in minimum signal 
across the azimuth. 
 It is possible to determine the location of the silicon substrate’s principal axes 
by its cleaving pattern; Si (100) breaks as a square, Si (110) as a parallelogram, and 
Si (111) in a triangular pattern. Physically cracking the substrate however is a very 
destructive technique which may occasionally not result in a break along the principal 
axes and therefore not ideal for some studies. The principal axes of a Si (111) surface 
are 60° apart, observed in the triangular break angles, therefore the 
maximum-minimum anisotropy for the RA spectra are at; 60°, 120° and 180°. 
However, for the vicinal surface, the aligned anisotropy (45°, 90° and 135°) arises 
from the principal axes (45° parallelogram) of the faceted Si (110) at the steps. Vicinal 
Si (111) is preferred because of the terraced architecture which allows for rapid 
determination of the location of the principal axes, which means fewer RA spectra 
for determination of molecular orientation. 
 The presence of the terraces on the vicinal Si (111) surface was important for 
this research programme, to determine the surface orientation by RA (Figure 26 and 
Figure 27), however the size of these terraces (3 nm wide x 0.3 nm high)62 was also 
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considered with regards to the HI monomer (2.5 x 2 x 3 nm).63 As the monomer is 
smaller than the terraces, diffusion perpendicular or parallel to the terraces was 
possible. To determine the orientation of HI diffusion it was important that the 
hydrophobic functionalisation did not obscure the RA signal attributed to the 
terraces. 
2.3.2. The effect of small molecule functionalisation on reflection anisotropy 
 The vicinal Si (111) surface was functionalised with TMPS and the RA spectra 
were collected at three azimuths (45°, 90° and 135°) as shown in Figure 28.  
 
Figure 28: Reflection anisotropy (RA) spectra of a vicinal Si (111) surface functionalised with 
trimethoxypropylsilane (TMPS) at three different azimuths; (red) 45°, (blue) 90° and (green) 135°. The 
(dashed) lines show the approximate wavelengths for the peaks at; 290 nm, 356 nm and 371 nm. 
 The TMPS functionalised Si (111) surface RA spectra (Figure 28) are very 
similar to the RA spectra of the piranha cleaned vicinal Si (111) surface, which implies 
that the TMPS is aligned with the Si principal axes since no changes were observed in 
the full rotation spectra either (Figure S4). Another possibility for the lack of 
observed differences is the point group symmetry of TMPS, which as shown in 
Figure 25 is symmetrical, therefore generating no measured anisotropic signal. The 
azimuthal dependence associated with the Si peaks (~283 and 350 nm) is shown in 
Figure 29. 
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Figure 29: Azimuth dependence of a vicinal Si (111) surface terminated with 
trimethoxypropylsilane (TMPS) for the three anisotropic peaks, at approximately; (red) 283 nm, 
(blue) 350 nm and (green) 371 nm. 
 The azimuthal dependence of the RA spectra (Figure 29) shows that the TMPS 
functionalised vicinal Si (111) surface follows the typical sin (2θ) variation, which was 
previously observed for the piranha cleaned vicinal Si (111) surface (Figure 27a). 
There is also a small increase in the intensity of the signal, therefore the TMPS 
layer (~0.4 nm)64 is aligned with the underlying crystallography. Increases in the 
intensity of the signal have also been observed for cytosine and adenine on Au (110), 
which are associated with interactions of the molecule with the electronic structure 
of the substrate.22–26 
 Similarly to the Si (110) surface, the orientation of the adsorbed molecules 
can be deduced in relation to the surface axes because the location of the surface’s 
principal axes are known from the maximum and minimum anisotropic signal, 
therefore the TMPS terminated surface can be used for the HI fibrillation studies 
because the functionalisation does not impact the RAS. 
2.3.3. Interfacial structural morphology inducing directed fibrillation 
 The TMPS-functionalised vicinal Si (111) surfaces were incubated in an 
acidic (pH 2.6, citrate-phosphate buffer) HI suspension (1 mg/mL) at elevated 
temperature (~75°C) over a one- or two- day period, with RA spectra acquired at the 
three azimuths (45°, 90° and 135°) as shown in Figure 30. 
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Figure 30: Reflection anisotropy (RA) spectra of a vicinal Si (111) surface functionalised with 
trimethoxypropylsilane (TMPS), incubated at ~75°C for (red) 1 day or (blue) 2 day, with human 
insulin (HI, 1 mg/mL) in citrate-phosphate buffer (pH 2.6) at the three different azimuths; (a) 45°, 
(b) 90° and (c) 135°. 
 Similarly as for the HI samples (Figure 30), RA spectra (45°, 90° and 135°) were 
acquired for the same incubation conditions (pH 2.6, citrate-phosphate buffer, 75°C 
for up to two days) of TMPS-functionalised vicinal Si (111) with insulin 
glargine (1 mg/mL), as shown in Figure 31. 
 
Figure 31: Reflection anisotropy (RA) spectra of a vicinal Si (111) surface functionalised with 
trimethoxypropylsilane (TMPS), incubated at ~75°C for (red) 1 day or (blue) 2 day, with insulin 
glargine (1 mg/mL) in citrate-phosphate buffer (pH 2.6) at the three different azimuths; (a) 45°, (b) 90° 
and (c) 135°. 
 The RA spectra (Figure 30) for the HI incubated TMPS-functionalised vicinal 
Si (111) surface shows similarity between the two incubation periods, specifically the 
observation of the characteristic Si peaks which indicates that the HI adsorption and 
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fibrillation events do not occur at the faceted Si (110) locations. In the case of 
cytosine adsorbed onto the Au (110) surface, the π-π* transition of the cytosine 
molecule was in the opposite direction to that of the signal arising from the Au (110) 
steps and resulted in the disappearance of the step signal.22 If the HI was adsorbing 
onto the steps of the vicinal Si (111) surface, then any loss or reduction in anisotropy 
signal for the characteristic Si peaks as fibrillation proceeds would be indicative of HI 
adsorption or fibrillation at the faceted Si (110) locations.65 There is however a small 
feature present at 225 nm for the two day incubated sample at 45° (Figure 30a), 
however the corresponding anisotropic peak is not observed for the 
135° (Figure 30c), which implies that either the HI fibrillation is orientated off the 
principal axes or the fibrils are aligned perpendicular to the surface similar to that 
observed with DNA hybridisation on diamond.43 This suggests that the HI is 
preferentially adsorbing onto the terraces of the vicinal Si (111) surface. At this point 
with this limited data set it is not possible to differentiate between adsorption on the 
terraces and the fibrils perpendicular to the surface, therefore a full 360˚ rotation of 
the sample was needed. 
The RA spectra for insulin glargine (Figure 31) are overall distinctly different 
from that of the HI (Figure 30), with no Si peaks observed for either incubation 
period, which implies that the insulin glargine is adsorbing and fibrillating at the 
faceted locations as opposed to HI because of the suppressed characteristic Si peaks. 
A lower wavelength peak (~225 nm) is also observed, similar to the HI RA 
spectra (Figure 30), which had previously been observed.64 It is possible that this 
peak is a marker for insulin fibrillation, associated with the net La electronic transition 
of the tyrosine residues (~225 nm).66 
 A full 360° rotation for both one- and two- day incubation periods of 
HI (Figure S5 and Figure S6) and insulin glargine (Figure S7 and Figure S8) are 
provided in the supplementary. For HI, the peak (~225 nm) is more pronounced for 
the longer incubation period (Figure S6), which implies association to the fibrillation 
state. A similar effect is observed for the insulin glargine, where the peak (~225 nm) 
for the two day incubation (Figure S8) results in increased anisotropy across a wider 
wavelength range. The 360° rotation shows that for HI the Si peaks are observed, 
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whereas there are no similar Si peaks shown in the incubated insulin glargine spectra. 
These results confirm that HI adsorbs on the terraces whilst glargine adsorbs at the 
step edges and in both cases, there is an increased concentration of fibrils as 
incubation time increases. 
 The results of the RAS for both HI and insulin glargine are overall encouraging 
as they show distinct differences for the variants; HI adsorbs along the terraces 
whereas insulin glargine on the step edges, as indicated by the differences in 
observed Si peaks. In both sample sets, the TMPS-functionalised vicinal Si surfaces 
were prepared similarly but with either HI or insulin glargine which gave rise to the 
distinctly different RA spectra. 
 The RA spectral differences arise from the orientation of the electronic 
transitions within the fibrillar insulin state. Discrimination of the electronic 
transitions to determine the specific fibrillar orientation is difficult as the tyrosine 
La (225 nm) is situated at the spectral edge with the respective phenylalanine 
La (210 nm) outside the scope of the measured region, and in both residues the 
Lb (280 and 260 nm respectively) transitions are located directly within the Si 
substrate feature. The β-sheets are orientated perpendicular to the fibril axis 
therefore the four tyrosine residues La and Lb electronic transitions are perpendicular 
and parallel to the fibril axis.67 Assuming that the four residues are situated within 
the β-sheet component, then it is possible with detailed analysis to determine where 
these residues are in relation to the principal axis and hence their alignment on the 
surface. Before embarking on a detailed analysis of this data using the three-phase 
model40 and the azimuthal dependence, to determine the orientation of the fibrils 
on the surface, it was necessary to show reproducibility of the obtained results as 
shown below (2.3.4. The impact of sample inhomogeneity, page 85). 
2.3.4. The impact of sample inhomogeneity 
 The RA spectra of HI and insulin glargine were distinctly different, (2.3.3. 
Interfacial structural morphology inducing directed fibrillation, page 82), however 
this was only data from one batch, therefore more samples were necessary to 
correlate these findings directly to the insulin variants. As described previously, fresh 
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TMPS-functionalised vicinal Si (111) surfaces were incubated in an acidic (pH 2.6, 
citrate-phosphate buffer) HI suspension (1 mg/mL) at elevated temperature (~75°C) 
for a one day period, with RA spectra acquired at the three azimuths (45°, 90° and 
135°) as shown in Figure 32. The RA spectra for HI incubated surfaces (Figure 32) 
were acquired for four sample batches (a – d), which were identically prepared. 
 
Figure 32: Reflection anisotropy (RA) spectra showing the differences between four sample sets (a – d) 
of a vicinal Si (111) surface functionalised with trimethoxypropylsilane (TMPS), incubated (~75°C, 
1 day), with human insulin (HI, 1 mg/mL) in citrate-phosphate buffer (pH 2.6) at the three different 
azimuths; (red) 45°, (blue) 90° and (green) 135°. 
 The RA spectra from the four identically prepared samples (Figure 32) shows 
that there is significant variability in the RA spectra. The only similarity in the results 
being the anisotropic peak at lower wavelengths (~230 nm). In only one 
batch (Figure 32a) are the characteristic Si peaks observed, which indicates that the 
HI fibrillates as previously (Figure 30) on the terraces, whereas the other three 
batches fibrillate similarly to insulin glargine (Figure 31) on the steps. 
 Three TMPS-functionalised vicinal Si (111) surfaces (i – iii) were incubated in 
an acidic (pH 2.6, citrate-phosphate buffer) insulin glargine suspension (1 mg/mL) at 
elevated temperature (~75°C) for; (a) one-, (b) two- and (c) three- day period, with 
the 45° azimuth RA spectra shown in Figure 33. 
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Figure 33: Reflection anisotropy (RA) spectra showing the spectral deviations at the same azimuth 
(45°) between three sample sets (teal, gold, and purple), which were labelled; i, ii, and iii. Each sample 
set is a vicinal Si (111) surface functionalised with trimethoxypropylsilane (TMPS), incubated (~75°C) 
with insulin glargine (1 mg/mL) in citrate-phosphate buffer (pH 2.6) for; (a) 1 day, (b) 2 day or 
(c) 3 day. 
 The three batches of insulin glargine incubated silicon surfaces (i – iii), show 
a similarity at one day incubation (Figure 33a) as previously observed for insulin 
glargine (Figure 31), with the presence of a lower wavelength anisotropic 
peak (~225 nm). This similarity across samples, is not present for either the 
two day (Figure 33b) or three day (Figure 33c) incubation periods, whereby the 
batches are spectrally dissimilar. At two day incubation (Figure 33b) neither i (teal) 
or ii (gold) batches display any anisotropic peaks, whereas the iii (purple) batch 
shows the characteristic Si peaks (~283 and 352 nm). The observed Si peaks for the 
iii (purple) batch continues into the third day incubation (Figure 33c), with the 
appearance of reduced anisotropy Si peaks for batch ii (gold), conversely for batch 
i (teal) the anisotropic peak (~230 nm) returns. 
 Overall the significant spectral dissimilarity between batches of identically 
prepared suspensions is concerning, which also correlated with the observation that 
surfaces were less optically reflective (by eye) with inconsistent coverage. The RAS 
technique is both reproducible and reliable, where the spectra of a stable sample 
over a period of time does not change, for example Si (110) provides a spectral 
fingerprint and is often used as a calibration standard for RAS instruments.68 Surface 
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differences observed by eye and the irreproducible RA spectra, suggests that these 
issues may arise from the insulin suspension preparation. 
 To check the insulin purity, mass spectroscopy (MS) was used because the 
molecular weight was known; HI (5808 Da) and insulin glargine (6063 Da). The results 
showed that for HI (Figure S9 and Figure S10) the correct mass was 
measured (~5808 Da) with minimal fragmentation. Conversely for insulin 
glargine (Figure S11 and Figure S12) an additional molecular weight (~4849 Da) of 
approximately 30% concentration (Figure S12) with a large fragmentation pattern 
and a noisy baseline (Figure S11) was observed. As the insulin glargine 
spectra (Figure S11 and Figure S12) showed that there were other components 
present, it was deemed unsuitable for use post the work presented within this 
chapter, because of the uncertainty surrounding the other components measured 
and whether they were attributed to contamination or proprietary commercial 
stabilisers. Consequentially only  I was used for the remainder of this thesis’ 
research programme, the challenges raised in this chapter surrounding the 
preparation of insulin suspensions for the synthesis of reproducible and reliable 
samples is further discussed in Chapter 3. 
2.4. Conclusion 
 The work reported in this chapter has shown that RAS is a highly sensitive 
surface-specific spectroscopic technique and can measure the orientation of 
adsorbed insulin species at a hydrophobically functionalised surface. These results 
show that vicinal Si (111) surfaces are desired to increase the speed at which analysis 
can be undertaken, by rapidly determining the principal axes of the surface as a result 
of the faceted Si (110) crystallography at the steps. The functionalisation of the 
surfaces by TMPS was shown to be appropriate as the acquired RA spectra were not 
affected by this functionalisation. 
 The irreproducibility in the RA spectra of insulin glargine was primarily 
associated with the contamination found in the mass spectra and therefore work on 
this variant was abandoned. The HI preparation methodology was also a challenge 
as illustrated by the inconsistency in the RA spectra, since the variable thickness of 
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the HI adsorbate led to irreproducible surfaces, which reduced the intensity of the 
reflected light signal at the detector. Significant further work is necessary in order to 
synthesise reproducible and reliable surfaces for studying the fibrillation process 
further, where the appropriate preparation of HI samples is critical and will be 
discussed in Chapter 3. 




Figure S1: A full 360° reflection anisotropy (RA) spectra for the cleaned Si (110) surface. 
 
Figure S2: A full 360° reflection anisotropy (RA) spectra for the cleaned flat Si (111) surface. 
 
Figure S3: A full 360° reflection anisotropy (RA) spectra for the cleaned vicinal Si (111) surface. 
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Figure S4: A full 360° reflection anisotropy (RA) spectra for the trimethoxypropylsilane (TMPS) 
functionalised vicinal Si (111) surface. 
 
Figure S5: A 0 - 90° reflection anisotropy (RA) spectra of the trimethoxypropylsilane (TMPS) 
functionalised vicinal Si (111) surface after incubation (~75°C, 1 day) with human insulin (HI, 1 mg/mL) 
in citrate-phosphate buffer (pH 2.6). 
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Figure S6: A full 360° reflection anisotropy (RA) spectra of the trimethoxypropylsilane (TMPS) 
functionalised vicinal Si (111) surface after incubation (~75°C, 5 day) with human insulin (HI, 1 mg/mL) 
in citrate-phosphate buffer (pH 2.6). 
 
Figure S7: A full 360° reflection anisotropy (RA) spectra of the trimethoxypropylsilane (TMPS) 
functionalised vicinal Si (111) surface after incubation (~75°C, 1 day) with insulin glargine (1 mg/mL) 
in citrate-phosphate buffer (pH 2.6). 
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Figure S8: A full 360° reflection anisotropy (RA) spectra of the trimethoxypropylsilane (TMPS) 
functionalised vicinal Si (111) surface after incubation (~75°C, 5 day) with insulin glargine (1 mg/mL) 
in citrate-phosphate buffer (pH 2.6). 
 
Figure S9: Mass spectra (m/z) of the human insulin (HI) used in this project, showing limited 
fragmentation pattern and minimal baseline noise level compared to the acquired spectra for insulin 
glargine. 
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Figure S10: Mass spectra (mass) of the human insulin (HI) used in this project, showing the expected 
mass of HI at 5808 Da, with limited fragmentation pattern and minimal baseline noise level compared 
to the acquired spectra for glargine. 
 
Figure S11: Mass spectra (m/z) of the insulin glargine used in this project, showing the prevalence of 
multiple species in the sample and an overall high baseline noise level. 
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Figure S12: Mass spectra (mass) of the insulin glargine used in this project, showing two significant 
mass peaks; the expected 6063 Da at 6062 Da but an additional peak at 4849 Da. 
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Chapter 3: The Importance of Protein Pre-Treatment 
3.1. Introduction 
 Chapter 2 showed that human insulin (HI) adsorption on the hydrophobic 
functionalised silicon (Si) surfaces, was inconsistent and irreproducible both within 
and across batches. This inconsistency manifested as a variable blue colouration on 
the surface as shown in Figure 34. 
 
Figure 34: Image of a trimethoxypropylsilane (TMPS) functionalised silicon wafer adsorbed with 
human insulin (HI) and mounted in an optical rotation stage. The reflective silicon surface shows 
inhomogeneous insulin adsorption with blue colouration on differing aspects of the surface. 
The blue coloured regions were of reduced reflectivity and with clearly 
defined transition between blue and non-coloured areas. This blue colouration was 
observed on multiple Si surfaces in various sample batches incubated with HI but was 
not consistent across the Si surface. The irreproducibility of the samples was 
therefore assumed to be linked with poor preparation of HI suspensions. This chapter 
aims to provide a standard methodology for handling HI to formulate reproducible 
and reliable HI adsorbed surfaces for investigating amyloid-like fibrillation. 
Overall, the scope of this thesis is to investigate the physical and chemical 
origins of amyloid at interfaces, with the hydrophobic interface modifications as the 
primary variable. The effect of surface functionalisation, specifically hydrophobicity, 
on the HI fibrillation has shown that differing surfaces affect the fibrillation pathway.1 
It is of paramount importance that the surfaces studied were controlled, specifically 
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reproducible, across batches for the same conditions studied. The introduction of 
additional inconsistency and irreproducibility associated with the surfaces, leads to 
difficulty in ascertaining the effects that hydrophobicity has on the interface. 
Furthermore, as this objective is to investigate the effect of oligomeric species on the 
HI fibrillation pathway at acidic and neutral pH, it is important that these HI 
suspensions are consistently reliable. 
3.2. Materials and Methods 
In this chapter, HI protein solutions (10 mg/mL) are prepared at pH 2, but the 
same preparation methodology was later applied to the pH 7 series. All experimental 
preparation was undertaken within designated fume hoods. 
3.2.1. Sample Preparation 
Investigating proteins requires lab workstations and glassware to be as clean 
as possible, to limit the potential for both biological and chemical contamination to 
occur. It should be noted that, where possible, lab stations were cleaned down with 
ethanol and multi-purpose cleaner daily and prior to sample preparation or analysis. 
3.2.1.1. Equipment Preparation 
All glassware was cleaned, at least overnight, in a Decon 90 bath and oven 
dried to remove any source of potential debris. Prior to usage, glassware, sample 
vials and any other glass / metal / plastic equipment was acidic Piranha cleaned 
(70% sulphuric acid: 30% hydrogen peroxide, ~65oC). Hydrogen peroxide (30 mL, 
30%) was added slowly to the sulphuric acid (70 mL). The piranha synthesis is a 
self-heating process, however, to ensure complete efficiency, the solution was left 
until effervescence had subsided before being added to the required glassware and 
further heated (~65oC, 30 minutes). After heating, the piranha solution was 
removed, carefully neutralised with sodium hydroxide and diluted before disposal, 
whilst the glassware was rinsed at least three times with ultrapure (type I) 
water (18.2 MΩ cm-1) before being oven-dried ready for use. 
3.2.1.2. Buffers 
The buffer solutions were prepared fresh, with enough volume; to suspend 
the protein at the required concentration, to use as a spectrometric blank, and 
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should any dilution be required. For the pH 2 buffer, sodium chloride (137.9 mM) and 
water (80 mL, 18.2 MΩ cm-1) were added to a conical flask (250 mL), with acetic 
acid (20 mL). For the pH 7 buffer, a phosphate-buffered saline (PBS) tablet (1 tablet) 
was dissolved in water (100 mL, 18.2 MΩ cm-1). Both solutions were 
sonicated (30 minutes) to ensure complete dissolution. 
The pH of the buffers was first checked by universal indicator paper, which 
was validated by pH meter (SevenEasy, Mettler Toledo). The buffer solutions were 
then syringe filtered (0.22 µm, polyethersulfone (PES) membrane, Merck) into 
laboratory bottles (Duran) using a large volume syringe (60 mL). Aliquots of the 
buffers were taken for; protein suspension, buffer blanks and dilution solutions. 
3.2.1.3. Suspension of human insulin 
 To allow comparability regarding the efficiency of the pre-treatment, the 
HI (10 mg/mL) was suspended in a pH 2 buffer (20% acetic acid and 139.7 mM 
sodium chloride) and then stored in a lo-bind Eppendorf tube (2 mL) prior to use. 
Untreated methodology 
 The HI (10 mg/mL) was suspended in the prepared pH 2 buffer (20% acetic 
acid and 139.7 mM sodium chloride) directly into a lo-bind Eppendorf tube, which 
was briefly vortexed (Vortex Mixer) to ensure complete dissolution.  
Treatment by hexafluoroisopropanol 
 The HI (10 mg/mL) was dissolved in hexafluoroisopropanol (HFIP, 20 mL), 
which was vortexed (Vortex Mixer) until complete dissolution. The HFIP was 
evaporated under nitrogen flow overnight. Buffer (pH 2, 20% acetic acid and 
139.7 mM sodium chloride) was added, and the suspended HI (10 mg/mL) was briefly 
vortexed before the solution was transferred into a lo-bind Eppendorf tube. 
Treatment by syringe filtration 
 The HI (10 mg/mL) was suspended in the prepared pH 2 buffer (20% acetic 
acid and 139.7 mM sodium chloride) directly into a lo-bind Eppendorf tube, which 
was briefly vortexed, and then immediately syringe-filtered (0.22 µm, PES). 
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3.2.2. Methods 
To reduce any potential sample variability resulting from sample handling, 
manual handling was limited. 
3.2.2.1. Dynamic Light Scattering (DLS) 
 To investigate the size distribution of the protein constituents, dynamic light 
scattering (DLS) was employed using a Zetasizer Nano ZSP (Malvern Panalytical Ltd, 
UK), which has a stated size range of 0.3 nm to 10 µm. Quartz cells (700 µL, 
fluorescence cells) with a parallel path length (1 cm) were used throughout. HI was 
suspended in an acidic buffer (pH 2, 20% acetic acid buffer), with instrumental 
parameters set; dispersant (water, 1.330 refractive index, 0.8872 mPa s-1 viscosity), 
temperature (25°C, 60 s equilibration time) and operating in back scatter (173°, 
10 scans, 50 s acquisition time). 
3.2.2.2. Infrared (IR) spectroscopy and microscopy 
 Infrared (IR) spectroscopy was performed on a Fourier transform 
infrared (FTIR) microscope (LUMOS, Bruker) in reflection mode. The instrumental 
parameters set were; spectral range (4000 cm-1 to 400 cm-1), resolution (2 cm-1), 
multiple scans to increase signal (100 scans for both background and sample), and 
atmospheric compensation. Although this investigation only utilised the 
Amide I (1700 - 1600 cm-1) and Amide II (1580 - 1510 cm-1) regions, the entire 
spectral range was acquired. 
3.2.2.3. Atomic Force Microscopy (AFM) 
 Atomic force microscopy (AFM) images were kindly provided by Dr Alan 
Massey, Surface Science Research Centre (University of Liverpool), using an Agilent 
5500 atomic force microscope.2 All measurements were carried out in air at room 
temperature. 
3.3. Results and Discussion 
3.3.1. Investigation of the blue coloured adsorbate 
 The blue coloured adsorbate, which varied in size and shape, randomly 
appeared on different samples despite maintaining the same experimental 
parameters was investigated, to determine the composition. This area was initially 
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analysed by IR microscopy, as shown in Figure 35, to probe the 
Amide I (1700 – 1600 cm-1) and Amide II (1580 – 1510 cm-1) regions. 
 
Figure 35: A bright-field optical microscope image (acquired at x5 visible zoom), attained on the 
LUMOS FTIR microscope, of the blue coloured adsorbed species on the 
trimethoxypropylsilane-functionalised vicinal Si (111) surface. The image shows inhomogeneous 
distribution of the blue adsorbed species, surrounded by regions of grey. The FTIR spectra was acquired 
at the centre of the image with a 50 µm diameter spot. 
 The bright-field optical microscopy image (Figure 35) shows the 
inhomogeneity of the blue adsorbed species, which is located at the centre of the 
image, as it is surrounded by grey regions of Si. There is a clear phase separation 
between the blue and light grey area, as observed at the lower left corner of the 
central blue region, where the curved boundary changes in colour from blue through 
dark grey to the light grey region. In both the upper and lower right quadrants of the 
image a diffuse blue colouring can be observed, which implies that the blue 
colouration is a component of the fibrillation process as opposed to a contaminant, 
since it is not an isolated event located in one region. The centre of the 
image (50 µm), which contained the blue adsorbed species only, was measured by IR 
with the resulting Amide I (1700 – 1600 cm-1) and Amide II (1580 – 1510 cm-1) 
regions shown in Figure 36. 
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Figure 36: A FTIR spectrum of the blue coloured adsorbed species region on the 
trimethoxypropylsilane (TMPS) functionalised vicinal Si (111) surface, acquired on the LUMOS FTIR 
microscope with a 50 µm diameter spot. 
 The FTIR spectrum obtained from the blue adsorbed species (Figure 36) 
shows the secondary structural features of a protein; a sharp β-sheet peak and a 
α-helix shoulder, located at ~1630 cm-1 and ~1660 cm-1 respectively.3 This data 
correlates with an investigation by Amenabar et al4 using infrared nanospectroscopy 
to probe insulin fibrils, which reported that the fibrils contain a β-sheet core 
surrounded by secondary structures of random orientation including α-helices. The 
Amide I and II bands observed in the measured IR spectra implies that the blue 
adsorbate consists of protein with the distinctly β-sheet and α-helical features 
therefore confirming that the blue regions are areas of adsorbed insulin. The higher 
proportion of β-sheet characteristic compared to α-helices, suggests that the 
adsorbed species is largely fibrillar.5 
 FTIR spectra and optical images were acquired of four other samples, which 
also exhibited regions of blue colouration but varied in size and colour intensity. The 
four samples were labelled A – D, of decreasing blue colouration with A (blue) 
highest and D (gold) the least, as shown in Figure 37. 
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Figure 37: FTIR spectra and optical microscopy images for four samples (A – D) of blue coloured 
adsorbed species on the trimethoxypropylsilane-functionalised vicinal Si (111) surface. The spectra for 
each sample; (blue) A, (green) B, (purple) C and (gold) D, are colour coded to the corresponding FTIR 
microscope image (acquired at x5 visible zoom). The FTIR spectra and optical images were recorded 
simultaneously with the spectra attained from the centre of each image with a 50 µm diameter spot. 
 The IR spectra of the four samples of various blue colouration (Figure 37), 
shows that all four samples contain a sharp β-sheet peak (~1630 cm-1) and a α-helix 
shoulder (~1660 cm-1). There is a perceived visual difference between the four 
samples in the amount of blue colouration present, this is correlated to the IR spectra 
which shows a higher absorbance for the blue sample A (blue) which decreases in 
relation to observed blue colouration until the light grey sample D (gold). This 
correlation between blue colouration and IR absorbance, implies that the blue colour 
is indicative of high insulin content. It is not clear by IR spectroscopy whether this 
content is due to fibrillar species or higher levels of HI adsorption, therefore AFM 
microscopy was used to investigate whether there is any structure at the surface and 
the resultant topography, as shown in Figure 38. 
 
‐
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Figure 38: Atomic force microscopy (AFM) image of the blue coloured adsorbed species on the 
trimethoxypropylsilane-functionalised vicinal Si (111) surface, showing inhomogeneous distribution 
with coverages up to ~68 nm thick. 
 The AFM image of the blue adsorbed species (Figure 38), shows that there is 
an overall inhomogeneous distribution of fibrillar structures, with very thick layers of 
HI present at various locations. The layer thickness is ~68 nm, however it is possible 
that the minimum regions which are situated inside the ‘valleys’ are of monolayer or 
multilayer HI coverage and not the Si substrate, therefore the HI thickness is at a 
minimum of ~68 nm. Assuming that the fibrils are lying flat on the surface, as 
observed in the AFM image, this would imply a seven-layer HI fibrillar coverage using 
the fibrillar size as 10 nm.6 
 The AFM results correlate with the IR spectra suggesting that the regions of 
blue colouration are areas of concentrated HI fibrils. It is therefore not surprising that 
the reflection anisotropy spectroscopy (RAS) was struggling to measure these regions 
because of the thickness of the adsorbed layer and consequent reduction in 
reflectivity. Inhomogeneous coverage is likely due to the auto-catalytic effect, as 
previously described by Hammarstrom,7,8 and for surface-sensitive techniques like 
RAS homogeneous and reflective surfaces are optimal, therefore a reproducible and 
reliable surface methodology is required. It is unknown as to why the high 
concentrations of fibrillar HI structures result in a visibly blue colouration, however 
there have been reports of a blue coloured fluorescence effect, which is further 
discussed and investigated in Chapter 7. 
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3.3.2. The impact of headspace 
 The blue colouration, which was determined to be insulin fibrils, appeared 
different for samples within the same batch, however the surfaces prior to 
incubation did not visually or spectrally vary. The potential root cause of the 
irreproducibility was due to the sample vessels, which were piranha cleaned glass 
jars, since it was not possible to control the size of the Si samples when cracking the 
wafers these jars were of varying sizes with differing headspace. The varying 
air:water interfaces for each jar, results in independent fibrillation kinetics despite 
similar treatment and incubation within the same environment.9,10 The differing 
fibrillation kinetics were experimentally observed as the incubated HI suspensions 
varied in appearance ranging from; clear and colourless, to cloudy with varying 
concentrations of white precipitate. The presence of the white precipitate was 
indicative of mature fibrils, which are insoluble and fall out of solution.11–13 
 Firstly, the incubation vessels were changed rather than individual glass jars 
the surfaces were placed together into a large glass crystallising dish which contained 
an entire sample set treated under the same conditions. The purpose for incubating 
all the samples together was to ensure the same air:water interface, thereby 
eliminating any deviations attributed to the incubation vessel. This did not solve the 
issue as despite being in the same incubation vessel some samples still displayed the 
same blue colouration, therefore the cause of irreproducibility was more 
complicated than the incubation vessel or the air:water interface. 
 Secondly the piranha-cleaned glass surfaces were also of concern as subtle 
differences in surface chemistry may arise due to variations in the piranha-cleaning 
process as a result of its synthesis, which may affect the availability of insulin to 
adsorb to the substrate and thus vary HI concentration in suspension. The Eppendorf 
lo-bind tubes (2 mL) were utilised for future work, as these satisfied the 
requirements; commercially available, chemically and temperature compatible, 
limited protein adsorption and all the same size. However, the low volumes meant 
that incubation with large substrates like silicon could no longer be incubated in situ. 
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3.3.3. Fibrillation conditions 
 The insulin preparations in Chapter 2, were designed in order that fibrillar 
structures were present on the functionalised silicon surface and therefore an 
extreme fibrillation methodology was utilised to ensure the sigmoidal curve attained 
saturation phase. To promote protein fibrillation a common methodology is to 
denature the protein, which is when proteins lose their secondary, tertiary and 
quaternary structure, through disruption of the intramolecular forces.14,15 
Denaturation has previously been exploited in amyloid research, as partial unfolding 
accelerates the amyloid-like fibrillation process, resulting in more favourable 
experimental conditions for which to measure fibrillation.16–20 As previously stated in 
Chapter 1 (1.3.1. What is protein fibrillation?, page 40), several experimental 
conditions have been used to denature proteins, such as; temperature,17 
agitation,21,22 pH,23,24 concentrations,25 and denaturation additives.18,26–28 
 The main issues associated with denaturation is that the extreme conditions 
no longer correlate to physiological and these variables are often difficult to control 
leading to increased deviations in fibrillation propensity. As this work investigates 
insulin adsorption and fibrillation at interfaces using an ensemble of spectroscopic 
techniques, it was therefore imperative that the process occurred on a convenient 
timeframe. A convenient timeframe is defined as one in which; samples remained 
stable between measurements, incubation time was minimised to allow for regular 
repeat batches, and any in situ analysis had to be captured within the convenient 
timeframe. A standardised protocol is needed for reproducible and reliable samples 
of HI, to control fibrillation so that the same conditions could be analysed in each 
spectroscopic technique. Consideration was given to minimise the impact associated 
with any time sensitive components, therefore; time, temperature, pH, protein 
concentration and preparation methodology is discussed here. Agitation of the HI 
suspensions was deemed unsuitable since it has been reported that the air-water 
interface can induce nucleation,29 through the incorporation of air bubbles into the 
suspension therefore leading to irreproducibility across samples.30,31 
 Temperature was interlinked with time, as a variable which affected the 
fibrillation kinetics, for example; increasing temperature resulted in a shortened 
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timeframe for fibrillation. The work in Chapter 2 used an elevated 
temperature (~75°C), which were far from physiological, to accelerate the surface 
kinetics; adsorption, diffusion and fibrillation.32 High temperatures have been shown 
to increase fibrillation through denaturation of the protein17,33, however it has been 
reported that temperatures above 50°C for HI results in irreversible denaturation 
attributed to the destruction of disulfide bridges.34–36 A minimum temperature to 
reduce any impact from seasonal fluctuations within the laboratory resulted in an 
effective room temperature (~21°C). This work designated two temperatures to be 
used to investigate the fibrillation pathway; effective room temperature (~21°C) and 
physiological (~37°C) which increases the fibrillation timescales however avoids the 
issues associated with temperature induced denaturation.22 
 The initial premise for this investigation was to investigate two pH conditions; 
physiological similar and one which promoted the HI fibrillation process. Neutral 
buffer conditions were made by dissolution of a PBS tablet, resulting in buffer 
similarities across batches. The acidic conditions, which promote fibrillation, were 
initially generated with citrate-phosphate buffer at pH 2 to inhibit the hexameric 
oligomerisation.37 The issue with this buffer is the potential variability in 
monomeric / dimeric distribution, other studies have shown that HI suspended in a 
20% acetic acid buffer generates a monomeric insulin preference.38–40 In all future 
work, HI was suspended in acidic (pH 2) buffer (20% acetic acid and 137.9 mM 
sodium chloride) as these conditions were shown to promote the HI monomeric 
state.41 
 In addition to the pH buffer conditions, Jorgensen et al42 showed that HI 
concentration was of importance as this was correlated with oligomeric state thus 
fibrillation kinetics. Low concentrations within 20% acetic acid buffer result in the 
preferred monomeric state but with reduced fibrillation kinetics, whereas too high 
concentrations increase fibrillation kinetics through the promotion of higher order 
species.43 This work utilised a concentration of ~10 mg/mL, as this typically achieved 
fibrillation within the measurable timeframe requirements and within the detection 
limits for the various spectroscopic instrumentation. 
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 The experimental variables; time, pH, temperature and HI concentration 
were all controlled in addition to the incubation vessels, to reduce the variability 
observed in Chapter 2. These controls were all designed to ensure that the HI 
achieves one oligomeric state so that the fibrillation process was reliable and 
reproducible, however this assumes that the HI is monomerised when suspended. 
3.3.4. Pre-treatment of proteins for an aggregate-free suspension 
 The HI fibrillation pathway (Figure 8) consists of nucleation events, termed 
primary or secondary as illustrated in Chapter 1 (1.3.1. What is protein fibrillation?, 
page 40), which are important for the fibrillation kinetics. Any aggregate in an insulin 
suspension has the potential to act as a secondary nucleation site, thereby affecting 
the fibrillation pathway through a seeded-growth mechanism.44–47 Sample 
irreproducibility arises from the variability in HI fibrillation pathway associated with 
the seeded-growth mechanisms,48–50 therefore an aggregate-free suspension is 
necessary to reduce fibrillation deviations across samples. The effects of variable 
fibrillation were evidenced in the RAS as shown in Chapter 2 and this correlated with 
the observation that vials of equally prepared but independently incubated HI 
suspensions, exhibited varying degrees of fibrillation associated with a lack of insulin 
pre-treatment. Proteins and peptides such as insulin51 and amyloid-β peptide (Aβ) 
readily aggregate,52 it is therefore important that a pre-treatment methodology is 
used so that the measured fibrillation pathways are not affected by aggregate 
attributed seeded-growth mechanisms. Pre-treatment of insulin by physical and 
chemical processes, such as; syringe-filtration have been reported to remove 
insulin’s seeding capability53 and reaction with HFIP has been shown to disaggregate 
Aβ.54 
 One method for removing aggregates present within insulin suspensions is by 
syringe-filtration, which physically removes aggregates larger than the pore size of 
the filter membrane. It was also important that the integrity of the suspensions was 
not affected, therefore a sterile system was utilised to avoid any possible 
introduction of unforeseen contaminants. The conditions studied in this work 
dictated the specific filter membrane necessary, as it had to be operable in both 
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acidic and neutral pH conditions.55 The best membrane available was 
polyethersulfone (PES) and the structure is shown in Figure 39. 
 
Figure 39: Chemical structure of polyethersulfone (PES). 
 Treatment of protein suspensions by syringe-filtration technique is a common 
practice in biochemistry and has been used previously in a variety of insulin 
studies.56,57 The disadvantage of this technique is the limited volumes that the system 
can process at any one time, therefore a disaggregation process for larger volumes 
at the same time is desirable. 
 Chemical treatment for the disaggregation of proteins can be performed in 
bulk using volatile chemicals such as HFIP and trifluoroacetic acid (TFA),58,59 where 
HFIP was used here with its structure shown in Figure 40. 
 
Figure 40: Chemical structure for hexafluoroisopropanol (HFIP). 
 HFIP was chosen for this work as it is a widely used biochemical technique to 
standardise solutions60 specifically in the treatment of α-synuclein (αS).61,62 These 
chemicals are used to monomerise the protein through removal of any aggregate 
states present63 with the mechanism believed to be that HFIP displaces the water 
molecules surrounding the protein, which reduces the preferential aggregation 
because of the diminished hydrophobic effect.64 This technique works in native 
proteins with predominantly α-helical secondary structures65 and has been shown to 
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been reports that the protofibrillar structure differs from native fibrillation 
pathways.67 
3.3.4.1. Protein pre-treatment for reduction of suspension aggregates 
 Particle size analysis as measured by DLS was used to investigate the 
effectiveness of HI pre-treatment for an aggregate-free suspension, with untreated 
or treated HI using physical or chemical techniques. HI was suspended in the pH 2 
buffer (20% acetic acid and 139.7 mM sodium chloride) as shown in Figure 41, where 
the untreated HI suspension (red) and treated HI using syringe-filtration (blue) or 
HFIP (green). 
 
Figure 41: Dynamic Light Scattering (DLS) traces for human insulin (HI, 10 mg/mL) suspended in a pH 2 
buffer (20% acetic acid and 139.7 mM sodium chloride) showing the effectiveness of pre-treatment in 
reducing protein aggregates; (red) untreated, (blue) syringe-filtered and (green) HFIP-treated. 
 The DLS results for the HI suspensions (Figure 41) show a distinct difference 
between the three treatment methods, with results ranging across four size 
distributions; ~0.7 – 10 nm, ~60 – 100 nm, ~100 – 700 nm and ~3000 – 6000 nm. 
There are three discrete size regions for the untreated HI suspension (red); 
~0.8 – 5 nm, ~75 – 700 nm and ~2500 – 6500 nm, which demonstrates that 
suspending HI without pre-treatment induces aggregation components. Treatment 
of the HI suspensions has varying results, with the syringe-filtered HI 
suspension (blue) reducing the measured size regions to one polydisperse peak, 
~0.6 – 10 nm centred at ~2.5 nm, whereas HFIP (green) resulted in three distinct size 
regions with a higher distribution towards the larger species; ~1.5 – 4 nm, 
~50 – 110 nm, and ~150 – 400 nm. 
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 In all three treatment methods the DLS shows a signal intensity between 
1 and 10 nm, which is consistent with an amalgamation of HI oligomeric states. The 
oligomeric states of HI range in size, from the small monomeric (2.5 x 2 x 3 nm)68 to 
the larger hexameric (3.5 x 5 nm).37 The untreated and syringe-filtered results have 
peak maxima at ~2.3 and ~2.5 nm respectively, which implies a majority of 
monomeric states whereas the HFIP-treated peak is skewed towards a higher size 
distribution. The polydispersity of the peaks is associated with the DLS methodology, 
which interpolates particle size through the assumption that particles are spherical69 
therefore a HI monomer species can range in size from 2 to 3 nm depending on its 
orientation in the media at the point of measurement. 
 Overall, the DLS results demonstrate that the HI suspensions must first be 
pre-treated to remove any aggregates, which have the potential to provide a 
seeding-like fibrillation process thus affecting reproducibility between HI samples. 
The significant size distributions between the untreated and HFIP-treated are of 
concern because the large size populations will increase the likelihood of differing 
aggregates, thus reducing the reproducibility of the insulin suspensions due to 
aggregate induced nucleation. The DLS results (Figure 41) show that for HFIP 
treatment there is a population of large species, which although HFIP is a standard 
technique monomerising Aβ peptides66 it does not work for HI. As shown by the DLS 
results (Figure 41) syringe filtration treatment was the most effective in providing an 
aggregate-free suspension, reducing the potential for cross-seeding events.70 As a 
consequence of the effectiveness of syringe filtration, all the buffers were also 
syringe-filtered to remove any potential aggregates or physical contaminants 
associated with the buffer components during preparation. 
3.3.5. Optimised human insulin protein suspension protocol 
 The results obtained within this chapter show the importance of handling HI 
suspensions correctly to avoid any sample irreproducibility issues. These issues were 
attributed to aggregate formation and general protein denaturation, therefore 
pre-treatment and reduced denaturation conditions were critical. 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 3 
Page 114 
3.3.5.1. Preparation standards 
 Throughout this work, all reagents were of analytical grade or higher, and all 
preparation was carried out in a designated fume hood which was cleaned with 
ethanol and anti-bacterial cleaner daily and prior to sample preparation or analysis. 
The reusable equipment and glassware to be used were first cleaned in either an 
acidic Piranha solution (30% hydrogen peroxide and 70% sulfuric acid, 30 minutes) to 
remove any hard deposits or in a basic 10% Decon 90 (overnight), rinsed with 
water (18.2 MΩ cm-1) and then dried in an oven. Any single-use equipment, such as; 
syringes, pipette tips or Eppendorf tubes, were first rinsed with the relevant buffer 
or reagent immediately prior to contact with the HI. All single-use equipment, where 
possible, was graded lo-bind to enable maximum recovery of HI. In general, there 
was an overall motivation to limit manual handing of HI for reduction of any potential 
influences upon the protein. 
3.3.5.2. Buffer preparation 
 The buffers for this work were optimised for the acidic and neutral pH 
conditions investigated, as previously discussed (3.3.3. Fibrillation conditions, 
page 108). All buffers were prepared fresh on the same day as the associated HI 
suspensions, where any excess volume was frozen for use as; spectroscopic blanks 
or for rinsing at a later date. 
 The acidic (pH 2) buffer, 20% acetic acid and sodium chloride (137.9 mM), 
was prepared by dissolution of the sodium chloride in acetic acid and sonicated for 
30 minutes. For the neutral (pH 7) buffer, a phosphate-buffer saline (PBS, 0.01 M) 
tablet was dissolved in water (100 mL, 18.2 MΩ cm-1) and sonicated for 30 minutes. 
 After sonication, the solutions were briefly vortexed to ensure complete 
suspension and homogeneity with the pH of each buffer checked. The buffers were 
then syringe filtered (0.22 µm, PES) into piranha cleaned Duran vessels, and aliquots 
taken for the; insulin suspensions, spectroscopic blanks and rinsing volumes. 
3.3.5.3. Human insulin suspensions 
 Following the confirmation by DLS (3.3.4.1. Protein pre-treatment for 
reduction of suspension aggregates, page 112), that pre-treatment of HI by syringe 
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filtration was essential to ensure an aggregate-free suspension. Prior to filtration of 
the HI suspensions, the clean syringe filters (0.22 µm, PES) were first wetted by 
rinsing with the relevant filtered pH solution. For pH 2 a small aliquot of 
buffer (20% acetic acid and sodium chloride 137.9 mM), whereas for pH 7 an aliquot 
of hydrochloric acid (0.1 M) was used. 
 For the acidic insulin suspension, HI (10 mg/mL) was suspended in the filtered 
pH 2 buffer (20% acetic acid and 137.9 mM sodium chloride) in a lo-bind Eppendorf 
tube (2 mL) which was briefly vortexed to ensure complete dissolution and then 
immediately syringe-filtered through the pre-wetted filter (0.22 µm PES). To 
maximise insulin recovery, the used filter was then flushed with the minimum volume 
of buffer, back into HI suspension. Conversely for the neutral insulin suspension, 
HI (10 mg/mL) was suspended in the minimum volume of hydrochloric acid (0.1 M), 
which was briefly vortexed, and immediately syringe-filtered through the pre-wetted 
filter (0.22 µm PES). Similarly, to the acidic suspension methodology, the filter was 
flushed through with dilute hydrochloric acid to ensure maximum insulin recovery. 
The suspension was back titrated to pH 7 by addition of filtered sodium 
hydroxide (0.1 M), then filtered pH 7 buffer (0.01 M PBS) added to attain the 
appropriate HI concentration (10 mg/mL). Aliquots of both suspensions were 
acquired, with the concentration checked by ultraviolet-visible (UV-Vis) spectroscopy 
at 280 nm. 
3.3.5.4. Incubation of the human insulin samples 
 The various samples of HI suspensions in lo-bind Eppendorf tubes (2 mL) were 
loaded into a tube rack and incubated in a designated incubator at either 
room (~21°C) or elevated (~37°C) temperature. This incubator only held the HI 
samples, therefore reducing any uncontrolled variability in temperature from the 
opening and closing of the doors. 
3.3.5.5. Generalised sampling methodology 
 Aliquots of the HI samples were acquired at specific time points as a function 
of incubation duration, the entire tube rack was removed from the incubator and 
each tube briefly vortexed to ensure homogeneity. A fresh lo-bind pipette 
tip (epT.I.P.S., Eppendorf) was used per sample with aliquots taken from the centre 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 3 
Page 116 
of the incubated microcentrifuge tube into a new tube, then the fibrillation tubes 
were rapidly returned to the incubator. The aliquoted samples were flash 
frozen (using liquid nitrogen) prior to storage in a -77°C freezer, for later analysis. 
This was to ensure the integrity of the samples were not subjected to multiple 
freeze-thaw cycles which are known to affect fibrillation events.71–75 
3.4. Conclusion 
 This work has shown that a standardised protocol for preparing HI 
suspensions is critical for reproducible and reliable samples. The distinct blue 
coloured regions that correlated with sample variability, contained high coverages of 
fibrillar HI as the AFM topography showed thick layers (~68 nm) of fibrillar structures 
with defined β-sheet and α-helical features in the Amide I (1700 – 1600 cm-1) region 
as ascertained by IR microscopy. 
 Pre-treatment of the HI suspensions was necessary, as the DLS results showed 
aggregates present within the untreated suspensions. The best pre-treatment 
method was syringe-filtration, as DLS showed no higher order species, therefore 
providing an aggregate-free suspension. The presence of aggregates increases the 
sample irreproducibility due to seeded-growth mechanisms. 
 The optimised procedure for handling HI fibrillation was designed to reduce 
sample variability, previously attributed to denaturation processes such as high 
temperature incubation. This optimised methodology is therefore utilised in all 
subsequent chapters.  
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Chapter 4: The Co-incubation Effect of Functionalised Mesoporous 
Silica Microparticles with Human Insulin, on Amyloid-like Fibrillation 
4.1. Introduction 
This aim of this chapter is to investigate fibrillation events in situ with 
modified (functionalised) hydrophobic silica microparticles, utilising conventional 
bulk solution spectroscopic techniques. The effect of varying hydrophobic 
functionalisation on the silica surfaces will be studied to observe if there are any 
kinetic or structural differences on the typical human insulin (HI) amyloid-like 
fibrillation pathway. 
 ydrophobic surfaces are considered to be ‘bad’ for a protein interface since 
they are known to cause the protein of interest to adsorb and aggregate on the 
surface, thus leading to fibrillation events.1,2 There has been limited research on how 
the extent of hydrophobicity affects and induces amyloid fibrillation, therefore a 
large variety of hydrophobic surfaces should ideally be studied to investigate the 
interactions between the protein and the surface type. There have already been 
studies of protein fibrillation at the solid-liquid interface, such as the work by 
Sluzky et al3which showed insulin aggregation in the presence of a hydrophobic 
surface, however the interfaces within these studies are often stationary with the 
surface inserted into the suspension or just the walls of the vessel itself. 
Characterisation of the hydrophobic interface effect is usually separated into the 
solution and surface studies, such as with Nayak et al2 who showed that HI fibrillation 
increases in the presence of hydrophobic surfaces by thioflavin-T (ThT) assay of 
aliquots from the incubated HI solution with the surfaces later analysed by atomic 
force microscopy (AFM). Conversely Ballet et al4 showed HI nucleation and 
fibrillation at pH 7 occurred on the hydrophobic surface by incubating within the 
96-well microplate, which was then measured by ThT assay. Whereas Moores et al5 
showed hydrophobic surfaces promoted the formation of spherical amorphous 
clusters of amyloid-β (Aβ) by AFM. These studies recognise the importance of 
surfaces, which can promote fibrillation through the autocatalytic effect into bulk 
suspension,6,7 however do not investigate the species simultaneously. The effect of 
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mobile hydrophobic surfaces in the solution on the HI fibrillation pathway will be 
investigated and provide information on HI adsorption and fibrillation. 
 Chapter 2 showed that HI fibrillation occurred on a hydrophobically 
functionalised silicon surface using Reflection Anisotropy Spectroscopy (RAS), which 
is a surface sensitive spectroscopic technique. The disadvantage of RAS and other 
surface sensitive spectroscopies is that they only probe the immediate surface. 
Protein adsorption and fibrillation can occur on the surface, however when an active 
fibril leaves the surface and goes into bulk solution then further nucleation or 
fibrillation can occur through seeded-growth mechanisms within the suspension, 
which these surface sensitive spectroscopies cannot probe. These surface techniques 
cannot quantify the changes occurring within the bulk suspension as a result of the 
functionalised surface interface, therefore a different methodology which utilises 
bulk suspension and functionalised surfaces is necessary. Silica microparticles which 
have a high surface area and the ability to be functionalised, can be suspended in the 
solution, enabling investigation of the bulk amyloid-like fibrillation pathway by 
solution-based spectroscopic techniques. 
To investigate the effect of hydrophobic microscopic particles on fibrillation, 
this chapter uses four types of mesoporous silica microparticles, which have various 
hydrophobic modifications ranging from bare silica through to large alkyl-chain 
functionalised surfaces. These functionalised interfaces are designed to disturb HI 
amyloid-like fibrillation by means of hydrophobic interactions, whilst the 
mesoporous nature of the particles is to allow for increased protein adsorption 
events. This chapter will study the effect of the hydrophobic functionalised 
microparticles on the HI amyloid-like fibrillation pathway by measuring and 
observing any differences in the fibrillation kinetics and the resultant fibrillar 
structures. 
4.1.1. What are silica microparticles? 
 The silica microparticles studied here (~5 µm diameter), have been kindly 
provided by Professor P. Myers, Department of Chemistry (University of Liverpool), 
and are typically used in High Performance Liquid Chromatography (HPLC) systems, 
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which separates compounds within an analyte by polarity. The nature of these 
microparticles are beneficial due to their increased surface area (220 m2/g, 
Spherisorb),8 which is ideal for protein adsorption,9 whilst the mesoporous design 
allows for small particles to pass through their “honeycomb-like” architecture.10 The 
mesoporous silica microparticles provided have a pore size of 8 nm, which is a similar 
size to that of a HI monomer (2.5 x 2 x 3 nm) and hexamer (3.5 x 5 nm),11–13 
therefore there is a likelihood that the HI can fit within the pore. Silica nanoparticles 
have previous been reported to efficiently adsorb protein,14–16 and functionalisation 
of such particles have been shown to inhibit α-synuclein fibrillation.17,18 Protein 
adsorption to mesoporous silicates have also been reported by Deere et al.19 
 The particles studied were functionalised with increasing hydrophobic alkyl 
chain length from bare silicon (Si), to six carbon (hexyl-functionalised, C6), through to 
eighteen (octadecyl functionalised, ODS1 and ODS2), as shown in Figure 42. The 
ODS2 particles were also end-capped with a trimethyl group, to render the surface 
non-acidic and non-polar, in addition to preventing degradation of the silicon 
surface.20 All four particles have the same 5 µm diameter and silica bulk substrate,8 
which allows for comparison of the effect of only varying the functionalised 
interface (as shown in Figure S13). 
 
Figure 42: Schematic showing the functionalised mesoporous silica microparticle; (a) non-bonded 
silica (Si, red), (b) hexyl-functionalised (C6, green), (c) octadecyl-functionalised (ODS1, blue) and 
(d) end-capped octadecyl-functionalised (ODS2, orange). The (grey) mesoporous silica substrate is 
shown with the (black) outermost interface. 
 As shown in Figure 42, the particles have the same core mesoporous silica 
substrate architecture which is an important factor for this work as these particles 
were considered analogous to the functionalised silicon substrate in Chapter 2. The 
objective for using particles was to be able to spectroscopically characterise the 
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effect of hydrophobic functionalised interfaces using solution-based methodologies, 
with the ability to separate the particles from the fibrillar species. It was the concept 
of particle separation that dictated the particle size; large particles such as 
polytetrafluoroethylene (PTFE) leads to sedimentation effects21 whereas small 
particles like nanoparticles can be incorporated into fibrillation inducing 
inhibition22,23 or acceleration.24 The purpose for the particles in this work are for only 
the hydrophobic functionalisation to give rise to HI amyloid-like fibrillation effects 
and not to be directly involved in the fibrillation process. Microparticles were 
therefore chosen for this work to avoid the fibrillation and instrumentation issues 
associated with nanoparticles,25 with systems in place to reduce the effect of 
sedimentation.26,27 
4.1.2. Probing the effect of functionalised microparticles on the amyloid-like 
fibrillation pathway 
To investigate how the microparticles influence the amyloid-like fibrillation 
pathway, requires; the amount of protein adsorbed to the particle, the particles 
effect on the kinetics and the resultant fibril morphology to be evaluated. Each of 
these factors are important to consider, in determining whether the fibrillation 
pathway has been altered. 
4.1.2.1. Determination of the amount of human insulin adsorbed to the particle  
To evaluate whether hydrophobicity induces HI fibrillation, this chapter will 
test both the amount of HI adsorbed to the particle and the corresponding secondary 
structure. Specifically, is the amount of HI adsorbed correlated to the various 
hydrophobic interfaces and therefore a factor in the propensity for HI adsorption. 
Determination of the amount of protein adsorbed to the various hydrophobic 
interfaces, will be both quantitatively and qualitatively assessed.  
CHN Elemental Microanalysis 
 Elemental Microanalysis (CHN) is a highly sensitive but destructive analytical 
technique that precisely quantifies the relative percentage of Carbon, Hydrogen and 
Nitrogen within a sample. The purpose for the CHN technique in this investigation is 
to be able to quantify the amount of protein which can adsorb to the hydrophobically 
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functionalised mesoporous silica microparticles. Elemental analysis has previously 
been used in determination of elemental content for nanoparticles,28 mesoporous 
silica29 and protein adsorption studies.30–32 The disadvantages of this technique is 
that the sample is entirely combusted, therefore preventing the same sample being 
utilised for further analysis and any moisture content will lead to miscalculations. 
Infrared spectroscopy 
 This chapter utilises infrared spectroscopy (IR), specifically the mid-IR 
range (4000 - 400 cm-1) to study protein adsorption to the particle, by probing the 
Amide I region (1700 - 1600 cm-1). IR is a vibrational spectroscopic technique which 
probes molecular vibrations, by the analyte absorbing an IR photon, however only 
certain vibrational modes are IR active. A vibration is IR active when it results in a 
dipole moment change, such as an asymmetric carbonyl. Furthermore, the greater 
the polarity, the larger the IR absorption. 
 IR is advantageous as it is non-destructive, can acquire functional group 
information rapidly, is able to probe both solids and liquids, and requires low sample 
quantities. For protein research it also allows marker-free analysis of the system and 
can resolve secondary structure by analysis of the Amide I (1700 - 1600 cm-1) 
region.33 IR does have disadvantages such as; lack of specificity attributed to 
overlapping absorption peaks, and atmospheric issues since both water and carbon 
dioxide molecules absorb IR strongly.34,35 Analysis of the adsorbed protein content 
by integration of the Amide I band in IR spectroscopy reduces the impact of 
non-protein contamination, therefore providing complementary information to the 
CHN analysis. 
4.1.2.2. Amyloid-like fibrillation kinetics 
 The kinetics of the fibrillation pathway can be manipulated using parameters 
such as; pH, protein concentration, addition of a denaturant, agitation and 
temperature (1.3.1. What is protein fibrillation?, page 40). Ideally the fibrillation 
kinetics for the HI suspensions will be similar across both pH conditions so that a 
complete sigmoidal curve is acquired. A sigmoidal curve is important for studying the 
fibrillation kinetics as it is used as a reference point for the fibrillation progression. 
This work studies the effect of pH on the fibrillation kinetics of HI suspensions, 
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therefore neither pH nor HI concentration can be varied whilst the addition of a 
denaturant or varying agitation will increase irreproducibility across batches. 
Temperature is the only variable which can be controlled and be consistent between 
the two pH conditions studied.  
 Producing a suitable sigmoidal curve (1.3.1. What is protein fibrillation?, 
page 40) is difficult as an appropriate number of data points are needed and is 
complicated as mature fibrils, which form as the fibrillation proceeds, are insoluble 
and fall out of solution.36,37 For example fluorescence assays are one method of 
studying fibrillation kinetics, where the measured fluorescence intensity increases as 
fibrillation proceeds. Prolonged measurement time after the saturation phase has 
been achieved can lead to a fluctuation in fluorescence intensity which is associated 
to the mature fibrils falling out of solution therefore skewing the fluorescence data.38 
Experimentally the issue is to ensure sufficient data points are obtained, so that 
fibrillation occurs in both pH conditions but that the experimental duration does not 
exceed the saturation phase for the fastest condition. This investigation uses an 
elevated temperature of 50°C in order to study both pH 2 and 7 in the same 
timeframe. 
Measuring fibrillation kinetics 
A standard methodology used in biochemistry to monitor the formation of 
amyloid-like fibrils as a function of time, is fluorescence spectroscopy which is further 
discussed in Chapter 7. Typically, in vitro studies utilise a chemical probe, which for 
amyloid research is an amyloid-specific dye molecule such as; Congo-Red (CR) or 
Thioflavin-T (ThT), to measure the amount of fibrils present within the sample. 
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Figure 43: The chemical structure of thioflavin-T (ThT); (red) benzothiazole ring, (black) central carbon 
bond and (blue) benzamine ring. 
The amyloid-specific dye molecule, ThT (Figure 43), is widely utilised to 
investigate fibrillation kinetics due to its fluorescent profile; upon binding to the 
amyloid fibril’s cross-β structure, a characteristic blue-shift of emission 
maxima (510 to 480 nm)38 and a corresponding intensity increase is observed. The 
observed fluorescence is believed to originate from the ThT binding into the cross-β 
morphology, specifically the grooves and ridges, which when bound restricts rotamer 
movement of the benzothiazole (red) and benzamine (blue) rings around the central 
carbon bond.39 Fluorescence intensity is considered an indication of fibril content due 
to the correlation between increasing intensity as fibrillation proceeds, resulting 
from additional fibrils or increasing fibrillar length.40 Quantification of the ThT 
kinetics results in a sigmoidal curve, as previously discussed in Chapter 1.41 
Fluorescence spectroscopy is highly advantageous because using a well-plate 
reader allows rapid acquisition of the fibrillation kinetics, therefore enabling studies 
of the pathway in situ. A 96-well plate allows for improved reproducibility, since 
triplicate wells can be run in parallel simultaneously with as many samples as 
logistically possible, albeit in smaller volumes. There are two methodologies which 
could be utilised to investigate the kinetics; continuous and end-point. In the 
continuous methodology, a plate is incubated within the reader, with the 
fluorescence of each well measured consecutively as fibrillation proceeds. In contrast 
the end-point methodology measures the fluorescence from sample aliquots which 
were taken at specific time intervals during the fibrillation process. Both 
methodologies are valid systems to monitor fibrillation events but due to the 
microparticles, which needed to be agitated to ensure dispersal, the end-point 
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4.1.2.3. Structural morphology of the amyloid-like fibril 
 This research programme proposes the use of hydrophobically functionalised 
mesoporous silica microparticles, as an analogous substrate to silicon wafers, for 
investigating the effect of surface hydrophobicity on the HI amyloid-like fibrillation 
pathway. In addition to the examination of the HI adsorption onto the particles and 
fibrillation kinetics, characterisation of the resultant fibrillar morphology is 
important. It is known that amyloid fibril morphology is critical because 
polymorphism potentially affects disease pathology.42 Amyloid fibrils are hallmarks 
of amyloidosis and although compositions vary between pathology; the critical cross-
β structure, which has discrete β-sheet strands perpendicular to the fibrils long-axis, 
are always present.43,44 
 The fibrillar morphology is obtained from images acquired by transmission 
electron microscopy (TEM), which can resolve nanometre structures (>0.2 nm), 
because it has a higher resolution than light microscopy due to the diffraction limit 
of the electrons.45 There are limitations to this technique; microscopic images may 
not be representative of the entire sample,46 and the prerequisite for analysis under 
vacuum thereby unable to image under ‘native’ solution conditions. TEM has 
previously been used to characterise HI fibrils in acidic and neutral pH conditions47,48 
and microparticles have also been studied,49 although neither have been investigated 
concurrently. 
4.2. Materials and Methods 
4.2.1. Sample Preparation 
 All the equipment and HI suspensions were prepared as described earlier, 
Chapter 3 (3.3.5. Optimised human insulin protein suspension protocol, page 113), 
but an abridged version is reproduced here. To reduce variability between studies, 
all the sample solutions were produced in bulk and used fresh or frozen (-77°C) for 
later use, a maximum of one thaw cycle was performed to reduce any potential 
freezing influences.50–54 Additionally, all reagents used throughout this thesis were 
of analytical grade or higher. 
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4.2.1.1. Buffers 
The buffer solutions (pH 2 and pH 7) were prepared fresh, with enough 
volume; to suspend the protein at the required concentration, to use as a 
spectrometric blank and for any required dilution. For the pH 2 buffer (20% acetic 
acid and 137.9 mM NaCl), sodium chloride (137.9 mM) and water (80 mL, 
18.2 MΩ cm-1) were added to a conical flask (250 mL), with acetic acid (20 mL). For 
the pH 7 buffer, a phosphate-buffered saline (PBS) tablet (1 tablet, 0.01 M) was 
dissolved in water (100 mL, 18.2 MΩ cm-1). Both solutions were sonicated for 
30 minutes and vortexed to ensure both had been suitably mixed. 
The pH of the buffers was first checked by universal indicator paper, which 
was validated by pH meter. Following acquisition of the correct pH, the buffer 
solutions were then polyethersulfone (PES) membrane syringe filtered (0.22 µm) 
into Durans’ using a large volume syringe (60 mL). Aliquots of the buffers were taken 
for; protein suspension, buffer blanks and dilution solutions. 
4.2.1.2. Human insulin suspensions 
 The HI (10 mg/mL) was suspended in a pH 2 buffer (20% acetic acid and 
139.7 mM sodium chloride) in a lo-bind Eppendorf tube (2 mL), briefly vortexed to 
ensure complete dissolution and then immediately syringe-filtered (0.22 µm PES). 
Preparation of HI in pH 7 buffer involved firstly suspending HI in the minimum volume 
of hydrochloric acid (0.1 M), briefly vortexed and then immediately syringe-filtered. 
The solution was titrated back to pH 7 by addition of sodium hydroxide (0.1 M) and 
PBS buffer added to dilute the suspension to the required concentration. 
4.2.1.3. Functionalised mesoporous silica microparticle suspension preparation 
 The hydrophobic functionalised mesoporous silica microparticles (Si, C6, 
ODS1 and ODS2, Spherisorb) are very light and dusty, thus when dry must be handled 
within a fume cupboard. To suspend these particles into solution, their hydrophobic 
nature has to be overcome firstly by creating a solvation shell, otherwise they remain 
at the air:water interface. 
 A suspension of acetonitrile (80%, HPLC grade) in ultrapure (type I) 
water (20%, 18.2 MΩ cm-1) was vortexed, before an aliquot was taken and added to 
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a glass sample vial (14 mL) containing the silica microparticles. The particles were 
wetted when they were no longer observed at the air:water interface. The buffers 
were titrated into the suspension, until the volume of acetonitrile mixture was 
displaced. Aliquots of the silica microparticles were then added into HI suspensions, 
which were prepared in lo-bind microcentrifuge tubes (2 mL), until the effective 
concentrations of HI (10 mg/mL) and silica particles (20 mg/mL) were attained. 
4.2.1.4. Incubation of the suspensions 
 The various microcentrifuge tubes, which contained the suspensions of both 
the controls (HI-only and silica microparticles-only) and the samples (HI and silica 
microparticles), were briefly vortexed to ensure homogeneity before incubation at 
room temperature (~21°C) or elevated temperature (~37°C). Aliquots of the 
suspensions were acquired at specific time points as a function of incubation 
duration. The final aliquots taken for the fibrillar state were visibly cloudy. At each 
time point, the tubes were briefly vortexed and then aliquoted into a new 
microcentrifuge tube, with the fibrillation tubes returned rapidly to the incubator 
and the aliquoted samples flash frozen for later analysis. The samples were stored 
frozen (-20°C short or -77°C for longer durations) until needed, then thawed back to 
laboratory temperature before being analysed. 
4.2.2. Characterisation of the particle’s influence upon amyloid-like fibrillation 
4.2.2.1. CHN Elemental Microanalysis 
 The CHN analysis was performed in-house, within the Department of 
Chemistry’s analytical services (University of Liverpool), with a minimum of eight 
results (n=8) acquired for each sample. The HI and microparticle 
suspensions (4.2.1.3. Functionalised mesoporous silica microparticle suspension 
preparation, Page 128) were studied by CHN to determine the amount of HI 
adsorbed for the initial adsorption before fibrillation occurs. The suspensions were 
briefly vortexed (30 seconds), allowed to rest (60 minutes), after which they were 
vortexed again (30 seconds) to ensure homogeneity. 
 An aliquot of this suspension was taken and set aside, labelled ‘adsorbed’, 
whilst the remaining suspension was rinsed three times with the specific buffer and 
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after rinsing, an aliquot was removed and labelled ‘adsorbed fraction after rinsing’. 
Both aliquots were dried under air-flow, with samples taken for IR analysis. The 
remaining material was dried in an incubator (~100oC) overnight to remove any 
residual moisture content.  
 To calculate the coverage of insulin on the particles, the following equation 
was used:  
𝑐𝑜𝑣𝑒𝑟𝑎𝑔𝑒 (𝜇 ∙ 𝑚𝑜𝑙 ∙ 𝑚−2) =
106 ∗ 𝑃𝑐
𝑆 ∗ [(1200 ∗ 𝑁𝑐) − 𝑃𝑐(𝑀𝑊 − 1)]
 
(4.3) 
where Pc = % carbon, Nc = number of carbons in HI, MW = molecular weight of HI, 
and S = silica particle surface area.55 
4.2.2.2. Infrared spectroscopy 
 The airdried aliquots were analysed by IR spectroscopy to determine the 
amount of HI present through quantification of the Amide I band (1600 – 1700 cm-1). 
IR spectroscopy was performed using a diamond mounted attenuated total 
reflection (ATR) IR instrument (Alpha, Bruker). The diamond window, stage and 
clamp were cleaned extensively with isopropanol prior to use and between samples. 
The instrumental parameters were; spectral range (4000 – 400 cm-1), 
resolution (2 cm-1), multiple scans to increase signal-to-noise (100 scans for both 
background and sample) and atmospheric compensation. The insulin coverage was 
calculated by integration of the Amide I band as described by Mauri et al.56  
4.2.2.3. End-point fluorescence kinetics 
 The aliquots acquired during the fibrillation incubation were first 
thawed (~21°C, 1 hour) in their microcentrifuge tubes (2 mL, lo-bind, Eppendorf). A 
non-treated optical bottom black well-plate (96-well, Nunc, ThermoFisher) was 
prepared with ThT (1 µL, 2 mM). The sample tubes were briefly vortexed 
(10 seconds) to ensure solution homogeneity and pipetted into the wells (100 µL) in 
triplicate, resulting in a final dye concentration of 20 µM. The plate 
reader (FlexStation III, Molecular Devices) was pre-heated (~25°C) and parameters 
set for a top-read emission scan (λEx 440 – 475 nm, λEm 480-600 nm, 10 nm intervals, 
low detector sensitivity and shake once prior to acquisition) of each well. The fibril 
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kinetic data (λEm 490 nm) was analysed using Origin Pro (2016 64-bit) and for the 
incubated silica microparticles fluorescence reads the controls (i.e. particle only) 
were subtracted from the data shown. The statistical analysis, by ANOVA one-way, 
for the kinetics resulted in the reported significant values of p ≤ 0.05. 
4.2.2.4. Transmission Electron Microscopy 
The prepared carbon electron microscopy (EM) grids and uranyl acetate (4%) 
were supplied by the Physiology department at the University of Liverpool. An aliquot 
of the end-point sample solution (10 µL) and uranyl acetate (10 µL) were pipetted 
onto opposite sides of a Parafilm section. A pair of tweezers were utilised to 
manipulate the EM grids, with the dull side applied onto the sample droplet for 
30 seconds, excess solution was removed by blotting onto filter paper. The EM grid 
was then added same side down onto the uranyl acetate droplet for 30 seconds, 
again excess solution was removed by blotting onto filter paper, and the EM grid left 
to air dry overnight (~16 hours) before analysis. Samples were imaged using an 
electron microscope, Tecnai G2 Spirit BioTwin (FEI) at 120 kV. 
4.2.2.5. Dynamic Light Scattering and Zeta Potential 
To investigate the size distribution and zeta potential of the functionalised 
silica microparticles, dynamic light scattering (DLS) was employed using a Zetasizer 
Nano ZSP (Malvern Panalytical Ltd, UK), which has a stated size range of 
0.3 nm to 10 µm (1.0x1004 nm). Quartz cells (700 µL, fluorescence cells) with a 
parallel path length (1 cm) were used. HI was suspended in an acidic buffer (pH 2, 
20% acetic acid buffer), with instrumental parameters set to; dispersant (water, 
1.330 refractive index, 0.8872 mPa s-1 viscosity), temperature (25°C, 60 s 
equilibration time), and operating in back scatter (173°, 10 scans, 50 s acquisition 
time). The zeta potentials were acquired (10 scans per sample) using folded capillary 
cells (Malvern Panalytical Ltd, UK). 
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4.3. Results and Discussion 
4.3.1. Characterisation of mesoporous silica particles 
The hydrophobically functionalised mesoporous silica microparticles were 
first characterised by DLS and zeta potential. The particle size, distribution and zeta 
potential results for all particle types within both pH conditions are shown in Table 2. 
Table 2: Characterisation of the functionalised mesoporous silica microparticles within pH 2 and pH 7 
conditions by dynamic light scattering (DLS) and zeta potential (ZP), resulting in particle size, 
polydispersity index (PDI) and zeta potential measurements. The standard deviation (SD) was attained 





/ µm ± SD 
Polydispersity index 
Zeta potential  
/ mV ± SD 
Si 2 5.61 ± 0.3 1.00 -5.74 ± 0.4 
Si 7 5.27 ± 0.3 1.00 -20.04 ± 1.4 
C6 2 5.86 ± 2.1 0.75 -4.83 ± 0.3 
C6 7 1.77 ± 0.0 0.90 -1.22 ± 0.2 
ODS1 2 3.09 ± 0.8 0.70 -7.59 ± 0.7 
ODS1 7 3.94 ± 3.2 0.71 -15.16 ± 0.9 
ODS2 2 8.52 ± 0.1 1.00 -12.37 ± 1.8 
ODS2 7 8.64 ± 0.0 1.00 -22.70 ± 1.3 
 
 The characterisation of the microparticles by DLS and zeta potential (Table 2) 
show that there is a large variation between the various particle types, particularly 
for the larger functionalised particles. Each particle type was commercially defined 
as having a mean particle size of 5 µm (± 2 µm), which all particles with respect to 
their standard deviation fulfil except for the ODS2 functionalised. The ODS2 
functionalisation resulted in a higher calculated size than expected, which is possibly 
attributed to its inherent fluorescence (4.3.3. Measuring the amyloid-like fibrillation 
kinetics, page 144) therefore affecting size acquisition by DLS. There does not appear 
to be any trend correlated with hydrophobic functionalisation or pH conditions, 
however there is variation between the particle types. The bare silica particle, Si, 
resulted in similar particle size for both pH conditions and correlated with the 
assumed 5 µm size. Conversely C6 for pH 2 conditions resulted in a similar 5 µm size 
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however this value was with a ± 2.1 µm SD, whereas at pH 7 the resultant size was 
far smaller at 1.77 µm. The ODS1 particles resulted in a smaller than anticipated size 
of 3.09 and 3.94 µm for pH 2 and 7 respectively, where the neutral pH result included 
± 3.2 µm SD, therefore not correlating with the effect of pH on C6. 
 The polydispersity index (PDI) is a statistic of how heterogeneous a sample is, 
which ranges from a value of 0 for a uniform (monodisperse) sample to 1 for a 
non-uniform (polydisperse sample) with varying particle size populations.57 In this 
project all particle types in both conditions studied resulted in a very broad size 
distribution, therefore are highly disperse as the values acquired ranged from 
0.7 to 1 PDI. The high PDI values for the samples mean that they are unsuitable for 
particle size characterisation by DLS since the instrumental algorithms are optimised 
for lower PDI samples. An advantage for with this instrument was the ability to 
acquire zeta potentials simultaneously. 
 Zeta potentials are a useful factor to investigate colloidal stability of a sample, 
which is ascertained from the particle’s surface charge, where high positive or 
negative values are indicative of high stability because of electrostatic repulsion.58 
Conversely low values are correlated to low stability as the particles can overcome 
the electrostatic interactions therefore leading to the particles aggregating.58 It is 
important to note that zeta potentials are only one factor used to predict colloidal 
stability, since other factors notably suspension chemistry and use of surfactants 
affect the physical stability.59 In all the particle types, except for C6, the change in pH 
from pH 2 to 7 results in a decrease in zeta potential therefore suggesting increased 
stability. In all samples the zeta potential values are not associated to the high values 
stated by others, less than -25 mV and higher than +25 mV,60 therefore the particles 
are likely to aggregate. The OSD2 particles in both pH conditions are shown to be 
more stable than the ODS1 particles as indicated by the increased negative values. 
The C6 particles show an inverse trend, where pH 7 increases in zeta potential which 
also correlates with the particle size that resulted in a decreased mean size. 
 The trend for hydrophobic functionalisation shows increasing 
functionalisation at pH 2 results in an increased assumed stability, whereas no trend 
is observed for pH 7. While these zeta potential values imply instability due to the 
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low values, others have reported that colloidal silica shows exceptional stability at 
low zeta potentials,61 furthermore these results were obtained on poly disperse 
samples, which are not considered ideal for zeta potential measurements.62 
 Overall, the microparticles are shown to be highly polydisperse, which 
correlates with the fluctuating particle size values attained demonstrating that the 
particles consist of a range of size distributions. This is an important factor to consider 
when calculating the amount of HI adsorbed to each particle as a result of variable 
surface areas. 
4.3.2. Determining amount of insulin adsorbed to the particle surface 
 The adsorption of HI to the functionalised mesoporous silica microparticles, 
which was quantified by CHN microanalysis and IR spectroscopy, was first 
considered. The amount of HI adsorbed in pH 2 conditions to the functionalised 
particles, which were; Si (red), C6 (green), ODS1 (blue) and ODS2 (orange), was 
quantified by CHN for the adsorbed (filled circles) and rinsed (open circles) as shown 
in Figure 44. The net carbon and nitrogen percentage results are plotted on the x- 
and y- axis respectively, where HI content is correlated to increases in both axes 
(Figure 44). 
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Figure 44: The net (control-subtracted) amount of carbon and nitrogen, at pH 2 (20% acetic acid and 
137.9 mM NaCl), for the microparticles (filled circles) adsorbed with human insulin (HI) after 
60 minutes and (open circles) rinsed with buffer solution. These are the mean values with error bars 
showing the standard deviation for all samples of the microparticles; (red) Si, (green) C6, (blue) ODS1 
and (orange) ODS2. 
 At pH 2, all adsorbed states are shown to have higher net carbon and nitrogen 
percentages compared to the rinsed states, therefore higher HI content for the 
adsorbed samples. The CHN results showed the largest difference in adsorbed and 
rinsed states for the bare silica particles, Si, with overall both the highest and lowest 
HI content for the adsorbed and rinsed states respectively. The smallest difference 
between adsorbed and rinsed states was shown for the ODS2 particles, whilst a high 
variation attributed to large error bars was observed for the C6 and ODS1 adsorbed 
and rinsed states. There is an overall reduction in the attributed error for the rinsed 
states as opposed to the adsorbed states, corresponding to loss of less tightly bound 
HI (physisorbed) layers. 
 The CHN analysis for the HI adsorbed and rinsed states of the silica particles 
in pH 2 (Figure 44), shows lower net carbon and nitrogen percentages for the rinsed 
compared to adsorbed states implying loss of HI from the particles, because the 
rinsing process removes excess (non-adsorbed) HI from the samples. If all the HI was 
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removed from the particles, then the rinsed states would result in zero for the net 
carbon and nitrogen as the data has been control (particle) subtracted, however 
Figure 44 shows this is not the case, therefore there is residual HI adsorbed to the 
particles. The CHN for the rinsed state of Si resulted in no net nitrogen but minimal 
carbon, which implies that HI has been entirely removed as there is no nitrogen 
content, therefore the residual carbon load is potentially due to instrumental error, 
organic contamination, or as a result of a drying artefact. 
 Functionalisation of the particles appear to reduce the overall capability for 
HI adsorption in acidic conditions, with Si the least hydrophobically functionalised 
adsorbing the most HI, and ODS2 the most functionalised adsorbing the least HI. A 
potential reason for the adsorption difference is due to the steric properties of the 
functionalised groups, which may block access into the particle’s pores, therefore 
reducing the accessible surface area for HI adsorption. ODS2 is both C18 
functionalised and endcapped, which further reduces the accessible HI adsorption 
area. The reduction of both carbon and nitrogen net percentages between the 
adsorbed and rinsed states is lowest for the functionalised particles (C6, ODS1, and 
ODS2) compared to Si, which implies that the adsorbed HI is strongly bound to the Si 
surface. 
 The work in this section aims to investigate whether there are any differences 
in  I adsorption which are specifically attributed to the microparticle’s hydrophobic 
functionalisation. It is known that surface adsorption is important to the amyloid-like 
fibrillation pathway, as described in Chapter 1. Importantly is the presence of the 
particles inducive to fibrillation or the hydrophobic functionalisation. Statistical 
significance was determined by ANOVA with Tukey post-hoc analysis (p < 0.05), 
which resulted in only eighteen sets of significantly difference for the net carbon and 
one for the net nitrogen. The net carbon showed; adsorption and rinsed states of the 
Si, C6 and ODS1, adsorbed Si to the adsorbed and rinsed states of C6, ODS1 and ODS2, 
rinsed Si to the adsorbed states of C6, ODS1 and ODS2, adsorbed C6 to rinsed ODS1, 
adsorbed C6 to both adsorbed and rinsed ODS2, rinsed C6 to adsorbed ODS1, and the 
adsorbed ODS1 to the adsorbed and rinsed states of ODS2. The net nitrogen showed 
significant difference between the adsorbed and rinsed state of Si. 
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 The amount of HI adsorbed in pH 7 conditions to the functionalised particles, 
which were; Si (red), C6 (green), ODS1 (blue) and ODS2 (orange), was quantified by 
CHN for the adsorbed (filled circles) and rinsed (open circles) states as shown in 
Figure 45. The overall adsorbed state HI content is similar to the pH 2 CHN 
results (Figure 44), however the pH 7 results (Figure 45) show considerable 
variability with regards to the rinsed states providing no clear trend. The Si and ODS1 
particles show reduction in the HI content for the rinsed state, however only Si 
exhibits difference between the two with ODS1 having overlapping error bars 
(Figure 45). The C6 particles, for both adsorbed and rinsed states, have very similar 
mean results but with substantial overlapping error bars. The ODS2 results exhibit a 
contrasting trend, with increased HI content for the rinsed state as opposed to 
adsorbed, which is compounded by a significant difference with no error bar overlap. 
 
Figure 45: The net (control-subtracted) amount of carbon and nitrogen, at pH 7 (0.01 M PBS), for the 
net (control-subtracted) amount of carbon and nitrogen, at pH 2 (20% acetic acid and 137.9 mM 
NaCl), for the microparticles (filled circles) adsorbed with human insulin (HI) after 60 minutes and 
(open circles) rinsed with buffer solution. These are the mean values with error bars showing the 
standard deviation for all samples of the microparticles; (red) Si, (green) C6, (blue) ODS1 and 
(orange) ODS2. 
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 The CHN analysis for the HI adsorbed and rinsed states of the silica particles 
in pH 7 (Figure 45) conditions shows a high variability between the net carbon and 
nitrogen percentages and thus the HI content. Each mean point consists of large error 
bars, which makes it difficult to ascertain whether the rinsed state HI content is less 
than the adsorbed state, with the exception to Si as this shows a clear reduction. This 
high variability was not observed to the same extent at pH 2, implying that the issue 
is attributed to the pH conditions as opposed to the analytical technique. It is known 
that at pH 7, the HI equilibrium is shifted towards higher order oligomeric species 
such as dimer or hexamer as opposed to the pH 2’s monomeric preference. The 
rinsing of the particles may lead to surface adsorbate reorganisation or additional 
oligomeric species adsorption resulting in oligomerisation, therefore increasing the 
variability across the samples.  
 The Si and ODS1 particles exhibit similar reduction in both net carbon and 
nitrogen percentages, with higher errors attributed to ODS1, which implies that the 
functionality plays a smaller role for neutral pH compared to acidic, however this 
trend is not observed for C6 and ODS2. The C6 particles result in very similar mean 
carbon and nitrogen percentages for both adsorbed and rinsed, with the latter having 
an increased mean, which implies higher HI content for the rinsed as opposed to the 
adsorbed state. Conflicting trends are observed for the ODS2 particles, where the net 
carbon and nitrogen percentages increase from the adsorbed to rinsed states, which 
implies that there is additional HI content for the rinsed state but these have very 
large error bars. Statistical significance was determined by ANOVA with Tukey 
post-hoc analysis (p < 0.05), which resulted in only three sets of significantly 
difference for the net carbon; rinsed state of Si and ODS2, rinsed state of ODS1 and 
ODS2, and adsorbed and rinsed state of ODS2. 
 Overall, the rinsed state percentages for the C6, ODS1, and ODS2 
functionalised particles have very high error bars, therefore caution is necessary 
regarding any perceived trends. Conversely the adsorbed state percentages for all 
the particles, are both similar to those obtained at pH 2 conditions suggesting the 
maximum HI adsorption obtainable. To investigate the maximum HI coverage for the 
particles in both pH conditions, a non-invasive spectroscopic technique and 
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comparison with literature is necessary. Additional sample aliquots, which had not 
been oven dried, were examined by IR spectroscopy to ascertain the HI content 
through integration of the Amide I region (1600 – 1700 cm-1), which was compared 
to the HI coverage as determined by CHN analysis. 
 The calculated HI coverage on the particles is shown in Figure 46, for 
pH 2 (Figure 46a – c) and pH 7 (Figure 46d – f) conditions as determined by; CHN 
carbon (Figure 46a, d), CHN nitrogen (Figure 46b, e) and integration of the IR 
Amide I region (Figure 46c, f). The pink shaded region is indicative of the theoretical 
HI adsorbed monolayer coverage, which others have determined to range between 
1.1 – 1.7 mg/m2 for the adsorption of insulin on solid surfaces.63–65 
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Figure 46: The human insulin (HI) coverage on each particle, after 60 minutes adsorption, for 
(a – c) pH 2 (20% acetic acid and 137.9 mM NaCl) and (d – f) pH 7 (0.01 M PBS) as determined by CHN 
elemental analysis; (a, d) net carbon, (b, e) net nitrogen and by (c, f) integration of the IR Amide I 
region. (shaded pink region) The theoretical monolayer coverage of HI, as determined by 
Arnebrant et al63 and Mollman et al.65 These are the mean values with error bars showing the standard 
deviation. 
 The HI coverage calculated from the CHN and IR results is shown in Figure 46, 
with the theoretical monolayer coverage shown as a purple bar, where no immediate 
trends related to functionalisation are observed. The CHN 
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results (Figure 46a, b, d and e) generally highlights that the monolayer coverage was 
not attained for any of the samples studied, with exception to the rinsed 
pH 7 C6 (% carbon and nitrogen) and pH 7 ODS2 (% nitrogen) samples which were 
within the error bars. Conversely the IR results (Figure 46c and f) show that for all 
functionalised microparticles the HI monolayer coverage was attained or exceeded. 
The CHN and IR results obtained do not appear to correlate, as CHN shows reduced 
HI coverage compared to IR. It is likely that this lack of correlation is attributed to the 
instrumental setups, as both sample sets were acquired from the same experiment 
with the observed deviation occurring from the CHN samples having been dried 
overnight to remove any residual moisture content.  
 The undercalculated HI monolayer coverage for the CHN samples is likely 
attributed to the drying process, where the samples were heated overnight in an 
incubator (~100°C). The high temperature will denature the HI but as CHN is an 
elemental analysis technique which probes the carbon and nitrogen content, the 
denaturation effect is of no concern since the probed elemental species will remain 
similar. However, a consequence of this denaturation is sample instability, which 
results in a lack of consistency within the sample therefore when aliquoting the very 
small amounts of sample for CHN analysis leads to large error bars, as shown. 
 Conversely it is possible that the IR analysis overcalculates the monolayer 
coverage because although the samples were not heated (no heat induced 
degradation),66 however there is potential for oversampling. This oversampling is 
observed for the adsorbed likely due to multilayer coverage, whereas this is removed 
for the rinsed state. Furthermore, the IR samples were air-dried when analysed 
therefore potential for non-adsorbed HI species to be included in the measurements. 
Additionally, there are instrumental considerations specifically the packing of the 
sample and lack of sensitivity of the ATR. Experimentally the IR is sampling from 
below and has a penetration depth of ~2 μm,67 which leads to a varying assessment 
of the HI species on the small portion of the microparticles surface studied giving rise 
to the variation in results. 
 A decreasing trend for the adsorbed HI content as microparticle 
functionalisation increases is generally observed for the CHN 
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results (Figure 46a, b, d and e), however this is largely dependent on the pH 
conditions. The pH 2 conditions clearly exhibit this decreasing trend in both adsorbed 
and rinsed sample sets, whereas this trend is inconclusive for pH 7 conditions 
because of the large variation in error bars. The HI content is higher for the pH 7 
adsorbed states compared to the pH 2, which is likely attributed to the HI oligomeric 
state within the two pH conditions. At pH 2, the HI species is likely monomeric 
therefore strongly bound to the hydrophobic microparticle because of the 
hydrophobic effect. A HI monomer preferentially adsorbs to a hydrophobic surface, 
which is entropically driven by the loss of water,68 to limit exposure of its hydrophobic 
domain. This drive to limit exposure is entropically driven therefore is a strong 
interaction to the hydrophobic functionalised interface. At the same time the higher 
order oligomeric species present in neutral pH conditions does not have the same 
hydrophobic effect to drive adsorption, since the hydrophobic domain is buried 
within the dimer structure. However, a HI oligomer species can adsorb to the particle 
by physisorption processes, with the same adsorption sites possible as for the 
monomer. Assuming a close-packed monolayer coverage,69 for every adsorption site 
a monomer (5.8 kDa), dimer (11.6 kDa) or hexamer (34.8 kDa) HI species can adsorb. 
The higher HI content observed for the neutral pH conditions is a result of higher 
order oligomeric HI species adsorbed to the available sites. 
 The HI oligomeric state does not account for the differences in rinsed states 
between the pH conditions, where pH 2 resulted in reduction of HI content and pH 7 
maintained similar content. Rinsing the particles after a short adsorption time 
removes the excess HI from the particle, which corresponds with the pH 2 results 
however is not observed for pH 7. The pH 7 rinsed states for the particles, except Si, 
result in a largely similar HI content. The HI content for the rinsed compared to 
adsorbed states, is possibly due to the particles undergoing hydrophobic collapse,70 
where the particles aggregate to reduce exposure to the rinse buffer thus trapping 
the HI oligomers. The acquired data for the rinsed particles have large error values, 
therefore it is difficult to ascertain the contribution from hydrophobic collapse. 
 The IR results (Figure 46c and f) show a higher error variability than the CHN 
data however there are possible trends to be considered here. Firstly, in both pH 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 4 
Page 143 
conditions, the non-functionalised Si particle exhibits the lowest HI content which is 
below the monolayer coverage. Conversely for all the functionalised particles, the 
monolayer coverage was attained, and the HI content decreased with a trend from 
C6 to OSD2 with the exception for pH 7 ODS2 which increased. Similarly, to the CHN 
results, the pH 7 samples by IR analysis shows a higher HI content compared to the 
pH 2 conditions. Conversely, the rinsed states for the IR samples are on average lower 
than the associated adsorbed states which does not correlate to the CHN results. 
However as initially stated the high error variability for the neutral pH conditions 
means that these results are difficult to distinguish.  
 A theoretical monolayer coverage of HI on the microparticles was calculated 
by first using the surface area of the silica microparticles (220 m2/g)8 as described by 
the manufacturer. In all samples, 20 mg/mL microparticles were suspended in 2 mL 
resulting in 40 mg of microparticles within the vial therefore providing a total silica 
microparticle surface area (8.8 m2). The amount of HI monolayer coverage varies 
depending on the packing of the system, however using the minimum (1.1 mg/m2)63 
and maximum (1.7 mg/m2)65 packing density results in 10 – 15 mg HI required for 
monolayer coverage, which is appropriate for this work. A possibility as to why 
variation in the HI monolayer coverage was observed is in relation to the stated 
surface area, which does not account for the accessible surface area.  The surface 
area was commercially obtained8 using Brunauer Emmett Teller (BET) methods, 
which determine surface area based on gas adsorption to a surface.71 The BET theory 
presents an issue with this surface area determination, where the HI species are far 
larger than gas molecules so are likely unable to access the same surface area sites 
within the mesoporous architecture, which reduces the microparticles available 
surface area for adsorption. 
 Overall the work to quantify the amount of HI adsorbed to the silicon particles 
has shown that; there is a greater amount of HI adsorbed at pH 7 conditions 
compared to pH 2, the functionalised particles results in increased HI adsorbed 
compared to bare Si particles however this trend reduces as alkyl length increases. 
The obtained CHN and IR results implies that the C6 alkyl hydrophobicity is the 
optimum functionalisation, within the samples studied, for HI adsorption in both 
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pH 2 and 7 conditions which implies that the increasing chain length affects 
adsorption sites. A general trend is observed between the adsorbed and rinsed 
particle states, where the rinsed state results in a reduction of the amount of HI 
adsorbed however a few exceptions to this trend are within the observed error 
margins. The initial aim for this section of work was to determine whether the 
amount of HI adsorbed provides information on the expected HI fibrillation pathway, 
by ascertaining multilayer growth which may implicate structural rearrangement 
events. This aim was not achieved since quantification of adsorbed HI on mesoporous 
Si microparticles by elemental microanalysis or IR spectroscopy was not ideal, as 
shown by the variation in results between samples and the lack of correlation 
between CHN and IR. In future other techniques, which address these shortcomings, 
should be utilised to give rise to a better methodology. 
4.3.3. Measuring the amyloid-like fibrillation kinetics 
 The results presented within this section utilise ThT kinetic assays to 
determine the effect of incubating HI with the functionalised mesoporous silica 
microparticles on the HI amyloid-like fibrillation pathway. The ODS2 particles are not 
presented here, as particle-only control experiments (see Figure S14) resulted in 
ODS2 exhibiting an inherent intrinsic fluorescence profile as incubation time 
proceeded, therefore could not be used in this experiment. In the next section where 
TEM was used to observe fibril structural morphology, images were obtained for all 
samples thus the effect of ODS2 functionalisation will be continued later (4.3.4. 
Observing structural morphology changes, page 149). 
4.3.3.1. The effect of pH on human insulin amyloid-like fibrillation kinetics 
 The effect of pH on the fibrillation of the control, HI-only, over a four-day 
incubation (37°C) period is shown in Figure 47. At pH 2 a sigmoidal curve is observed, 
which is indicative of complete fibrillation, however at day 4 a reduced fluorescence 
intensity was observed, which implies that the insoluble mature fibrils have fallen out 
of solution.36,37 Conversely in pH 7 conditions, only a partial sigmoidal curve is 
observed which does not attain the same fluorescence intensity as for pH 2 
conditions. 
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Figure 47: Thioflavin-T (ThT) end-point assay (n=3) showing human insulin (HI) amyloid-like fibrillation 
at 37°C incubation for (solid) pH 2 (20% acetic acid and 137.9 mM NaCl) and (dashed) pH 7 (0.01 M 
PBS) conditions. The ThT fluorescence is normalised to the pH 2 mean maxima, with error bars showing 
the standard deviation. 
 Figure 47 shows that the parameters used were suitable as both pHs 
exhibited fibrillation within a reasonable timeframe with enough datapoints to 
determine any influence of the silica microparticles on the HI fibrillation pathway. 
These results provide a good baseline for which the effect of silica microparticles can 
be observed. 
4.3.3.2. Presence of functionalised mesoporous silica microparticles upon the 
amyloid-like fibrillation kinetics of human insulin  
 The incubation of HI with the functionalised particles, which were; Si (red), 
C6 (green) and ODS1 (blue), in pH 2 conditions compared to the HI-only control (pink) 
is shown in Figure 48. A complete sigmoidal curve, achieving saturation phase, 
followed by a decreased fluorescence intensity at the day four incubation is observed 
for all samples. An overall reduction in the normalised fluorescence intensity for the 
incubated silica particles is observed, with a further reduced intensity shown for 
day 2 compared to the HI-only control. The fluorescence intensity for the particles is 
shown to be highest for Si, and lowest for ODS1. 
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Figure 48: Thioflavin-T (ThT) end-point assay (n=3) showing human insulin (HI) amyloid-like fibrillation 
at 37°C incubation for pH 2 (20% acetic acid and 137.9 mM NaCl) for the (pink) HI-only control 
compared to incubation with functionalised mesoporous silica microparticles; (red) Si, (green) C6 and 
(blue) ODS1. The ThT fluorescence shown has been control subtracted and normalised to the mean 
fluorescence maxima, day 2.5 HI-only control, with error bars showing the standard deviation. The 
(pink) HI-only control is the same data as shown in Figure 47. 
 The ThT end-point assay for pH 2 conditions, shows that the fibrillation 
pathway for all samples has completed since a saturation phase was 
observed (Figure 48). This is further reinforced by a decreased fluorescence observed 
at the day four incubation compared to the day three, which implies that the 
insoluble mature fibrils in all the samples are falling out of solution.36,37 The 
fibrillation kinetics data for pH 2 clearly shows that the presence of the functionalised 
silica microparticles, inhibits the typical HI amyloid-like fibrillation pathway. The 
different fibrillation kinetics observed for the various microparticles, with the highest 
intensity for Si and the lowest for ODS1 implies the possibility of divergent fibrillation 
pathways. An observed reduction in mean fluorescence intensity at day two is 
observed for C6, and possibly Si given the large error bars, implying that there are 
two differing fibrillation pathways as the same trend is not observed for ODS1. 
Statistical significance was determined by ANOVA with Tukey post-hoc 
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analysis (p < 0.05), which resulted in significant fluorescence data for all HI results 
compared to the particles; Si, C6 and ODS1, except for day 0. 
 The incubation of HI with the functionalised particles for pH 7 conditions 
compared to the HI-only control is shown in Figure 49. A partial sigmoidal curve is 
observed in all samples, with an overall increased fluorescence intensity for the 
incubated silica particles. 
 
Figure 49: Thioflavin-T (ThT) end-point assay (n=3) showing human insulin (HI) amyloid-like fibrillation 
at 37°C incubation for pH 7 (0.01 M PBS) for the (pink) HI-only control compared to incubation with 
functionalised mesoporous silica microparticles; (red) Si, (green) C6 and (blue) ODS1. The ThT 
fluorescence shown has been control subtracted and normalised to the mean fluorescence maxima, 
day 4 Si incubated with HI, with error bars showing the standard deviation. The (pink) HI-only control 
is the same data as shown in Figure 47. 
 The ThT end-point assay for pH 7 conditions shows that within the same 
parameters as for pH 2, only a partial fibrillation pathway for all samples has 
occurred, which is indicated by the observed elongation phase since the fluorescence 
intensity does not plateau by the day four incubation. A plateau region is observed 
for the functionalised particles between days one and two, followed by an 
exponential intensity rise which suggests that the particles provide distinctly 
different fibrillation pathways, since this trend is not observed in the control trace. 
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The diverging pathways of the functionalised particles, as previously shown in pH 2, 
are observed here where ODS1 has an overall typically higher fluorescence intensity 
at incubation days zero and four. The presence of particles in pH 7 conditions clearly 
shows an enhancement in the fibrillation kinetics of the HI amyloid-like pathway. 
Statistical significance was determined by ANOVA with Tukey post-hoc 
analysis (p < 0.05), which resulted in significant fluorescence data for day 4 incubated 
HI fluorescence compared to; Si, C6 and ODS1. 
 There appears to be a fluorescence signal at pH 7 for both Si and C6 particles 
at day zero, which would imply that ThT has bound to cross-β structure present here. 
A potential source and most likely factor for this fluorescence stems from sample 
preparation, the fluorescence data is acquired from end-point reads, whereby 
aliquots of the same solutions were taken, flash frozen and stored in a freezer (-77°C) 
until required. The first data point was taken about an hour after protein addition to 
ensure protein adsorption to the particles, therefore it is possible that a ThT-active 
species has been generated between first synthesis and freezing, or alternatively 
between thawing and analysis.50,52 
 Overall, the incubation of HI with functionalised mesoporous silica 
microparticles are clearly shown to inhibit for pH 2 and enhance for pH 7 the HI 
amyloid-like fibrillation kinetics. The general kinetics trends are correlated to the 
overall fluorescence intensity for the particles compared to controls, where reduced 
intensity is inhibition and increased is enhancement. In addition to the overall 
intensity changes, the particles exhibit specific fluorescence variations such as; 
reduction at day two for pH 2, and for pH 7 a plateau followed by exponential region 
is observed, which implies a fibrillation pathway change for the particles. 
 To investigate the mechanistic effect of particles on the HI fibrillation 
pathways further techniques such as fluorescence microscopy are necessary, 
because of the complications arising from the ThT measurements. The ThT 
molecules, which bind to the cross-β structure,72 are assumed to attach at active sites 
of the fibril however the complication arises from the various fibrillar locations. HI 
fibrillation can occur in solution through nucleation mechanisms, see Chapter 1 
(1.3.1. What is protein fibrillation?, page 40), however the addition of particles 
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provides an alternative pathway through protein adsorption events73 or an 
autocatalytic approach resulting in fibrillation by seeded growth.6,7 The overall ThT 
complexity makes fibrillation pathway determination using this technique difficult, 
however the results clearly show that the particles affect the HI amyloid-like 
fibrillation through inhibition or enhancement processes. 
4.3.4. Observing structural morphology changes 
 The TEM images shown in this section were acquired from the same samples 
previously studied in the kinetics measurements (4.3.3. Measuring the amyloid-like 
fibrillation kinetics, page 144), but from different aliquots. 
4.3.4.1. The effect of pH on human insulin amyloid-like fibril morphology 
 Variations of pH have previously been reported to affect the morphology of 
insulin fibrils,48,74–77 however there is no other study which have utilised the same 
experimental conditions as this investigation. The effect of pH on the HI-only control, 
post-incubation (37°C, four days) is shown in Figure 50, which shows fibrillar 
structures in the acidic conditions (Figure 50a and c), and only smaller pre-fibrillar 
aggregates for the neutral conditions (Figure 50b and d). 
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Figure 50: Transmission electron microscopy (TEM) images of the human insulin (HI) control in both 
(a, c) pH 2 (20% acetic acid and 137.9 mM NaCl) and (b, d) pH 7 (0.01 M PBS) fibrillation conditions. 
 The TEM images for the HI-only control (Figure 50) confirm the trends 
observed in the measured kinetics (Figure 47), because fibrillar and pre-fibrillar 
aggregates were observed by TEM for pH 2 and pH 7 respectively. The obtained 
end-state species are similar to those reported in literature where acidic pH produces 
long fibrils, whereas neutral pH has much smaller structures.48 The presence of 
fibrillar (Figure 50a and c) and pre-fibrillar species (Figure 50b and d) in the TEM 
images for the HI end-state species, confirms that the sigmoidal saturation and 
elongation phases were attained, respectively. An attempt was made using 
ImageSXM79 to quantify the fibrillar structures present, however due to the 
background noise levels, the analysis assumes an increased distribution for smaller 
objects.80 In addition to the overlapping fibrils this made quantification using image 
analysis difficult. The overall higher population distribution of pre-fibrillar 
species (0 – 50 nm) in the pH 7 conditions, contrasts with the small population of 
larger assemblies observed in the pH 2 conditions. The pH 2 fibrils, which were 
acquired from the non-aggregated species, were on average longer (0.407 – 1.54 µm) 
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compared to the pH 7 pre-fibrillar species (0.02 – 0.33 µm). Morphologically for the 
pH 2 fibrillar species a feathering effect was observed, which is attributed to surface 
catalysed fibrillation events or fibrillar aggregation, whilst the pH 7 pre-fibrillar 
species were difficult to distinguish from the grid. 
4.3.4.2. Presence of functionalised mesoporous silica microparticles on amyloid-like 
fibril morphology 
 The morphology of the fibrillar HI-only control has been observed to be 
affected by acidic and neutral pH conditions, and also the presence of the 
mesoporous silica microparticles were shown to affect the HI amyloid-like fibrillation 
kinetics (4.3.3.2. Presence of functionalised mesoporous silica microparticles upon 
the amyloid-like fibrillation kinetics of human insulin, page 145) therefore TEM will 
be used to investigate the effect of particles on the HI fibrillar morphology. The 
purpose for the TEM imaging in this study is to investigate whether there is a 
difference in the resultant fibrillar species upon incubation with the particles which 
is associated to a variation in the fibrillation pathway. 
 The TEM images for the HI amyloid-like fibrillation in pH 2 conditions, are 
shown in Figure 51, for the incubation with the hydrophobically functionalised 
mesoporous silica microparticles; Si (Figure 51a), C6 (Figure 51b), ODS1 (Figure 51c) 
and ODS2 (Figure 51d), compared to the HI-only control (Figure 51e). All TEM images 
show fibrillar structures for the pH 2 conditions, therefore supporting the kinetic data 
that the saturation phase of the sigmoidal curve was attained because of the 
presence of mature fibrils. The functionalised particles give rise to fibrils which are 
thinner and less straight (‘wispy’) in morphology compared to the HI-only control. 
The Si incubated fibrils are morphologically similar to HI but on average 
shorter (~0.5 µm) and thinner compared to the HI (~1 µm), whereas the C6, ODS1, 
and ODS2 incubated fibrils are much longer and exhibit twisted morphology. 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 4 
Page 152 
 
Figure 51: Transmission electron microscopy (TEM) images showing the human insulin (HI) fibril 
morphology at pH 2 (20% acetic acid and 137.9 mM NaCl) conditions, (e) for HI-only and in the 
presence of mesoporous silica microparticles; (a) Si, (b) C6, (c) ODS1 and (d) ODS2. 
 The TEM images for the HI amyloid-like fibrillation at pH 2 
conditions (20% acetic acid and 137.9 mM NaCl) shows that presence of the 
microparticles have greatly affected the observed fibrillar structures (Figure 51), with 
the fibrils aggregated into large clusters. In TEM images for the incubation with C6, 
ODS1, and ODS2 particles (Figure 51b – d) the fibrils are longer than the 
HI-only control, which implies an increased elongation phase with limited 
fragmentation events. All the incubated particles exhibited an overall reduced 
fluorescence intensity kinetics (Figure 48), implying a reduced saturation phase 
corresponding to the maximum number of ThT-binding sites, however there appears 
to be more fibrils produced. The formation of fibrils with less available ThT-binding 
sites implies morphologically dissimilar fibrils from the control, which is shown 
in Figure 51. 
  The TEM images for the HI amyloid-like fibrillation in pH 7 conditions, are 
shown in Figure 52, for the incubation with the hydrophobically functionalised 
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mesoporous silica microparticles; Si (Figure 52a), C6 (Figure 52b), ODS1 (Figure 52c) 
and ODS2 (Figure 52d), compared to the HI-only control (Figure 52e). The TEM 
images show a variation of pre-fibrillar structures, which is consistent with the kinetic 
data that the sigmoidal curve was not completed, as the saturation phase was not 
attained, therefore pre-fibrillar aggregates of various dimensions are observed. The 
incubated particle images exhibit fibrillar structures, with variable morphology, 
however only aggregates are observed in the HI-only control (Figure 52e). The TEM 
images for the incubated particles (Figure 52a – d) showed; small (~0.5 µm) fibrillar 
species with one large aggregate for Si, long (~0.5 – 1.0 µm) wispy fibrils for C6, 
short (~0.25 – 0.75 µm) pre-fibrillar structured aggregates for ODS1, and pre-fibrillar 
aggregates for ODS2 with very similar morphology to the HI-control. 
 
Figure 52: Transmission electron microscopy (TEM) images showing the human insulin (HI) fibril 
morphology at pH 7 (0.01 M PBS) conditions, (e) HI-only and in the presence of mesoporous silica 
microparticles; (a) Si, (b) C6, (c) ODS1 and (d) ODS2. 
 The TEM images for the HI amyloid-like fibrillation at pH 7 
conditions (0.01 M PBS) supports the ThT kinetics data (Figure 49) which showed 
that the particles enhance fibrillation, since more fibril-like aggregates are observed 
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by TEM (Figure 52). There are distinct morphology differences for the aggregate 
species in the presence of particles; smaller fibrillar structures for Si and 
C6 (Figure 52a and b), for ODS1 (Figure 52c) pre-fibrillar aggregates, whilst 
ODS2 (Figure 52d) appears very similar to the HI-only control with limited pre-fibrillar 
aggregates observed. These images correspond to the ThT data, where incubation 
with the particles enhances fibrillation for the three particle types measured; Si, C6 
and ODS1. 
 The TEM images for the HI amyloid-like fibrillation in pH 2 (Figure 51) and 
pH 7 (Figure 52) conditions were acquired in regions free from particles, in an 
attempt to alleviate fibril masking.81 The effect of HI amyloid-like fibrillation in the 
vicinity of the hydrophobic functionalised silica microparticles for both pH conditions 
are shown in Figure 53 (a – h), to observe the association of particles and fibrils. At 
pH 2 (Figure 53a – d) the fibrils and particles are dispersed within the imaged area, 
whereas in neutral pH conditions (Figure 53e – h) particles aggregate together and 
the fibrils aggregate. 
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Figure 53: Transmission electron microscopy (TEM) images showing the human insulin (HI) fibril 
morphology for both (a-d) pH 2 (20% acetic acid and 137.9 mM NaCl), and (e-h) pH 7 (0.01 M PBS) 
conditions in the presence of mesoporous silica microparticles; (a, e) Si, (b, f) C6, (c, g) ODS1 and 
(d, h) ODS2. 
 The TEM images for HI amyloid-like fibrillation at both pH conditions in the 
vicinity of the microparticles (Figure 53) shows that there are fewer fibrillar 
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structures at pH 7 (Figure 53e – h) compared to pH 2 conditions. At pH 7 there 
appears to be high aggregate density in the vicinity of the particles, in addition to an 
overall clustering of particles (specifically the particles along the grid lines) implying 
a hydrophobic aggregation effect. This clustering effect is not observed in pH 2, as 
the particles appear dispersed within the imaged area (Figure 53a – d). These TEM 
images show that the commercially available hydrophobically functionalised 
mesoporous silica microparticles, which are listed as 5 µm diameter with a 
polydispersity of 40%, are variable in both morphology and size8 correlating to the 
DLS results (Table 2). The observed geometric distortions can occur from unstable 
particles, defined in the images by large protrusions, or adsorbed protein layers 
which are shown by a fuzzy appearance around the particle edge. These variations 
do not affect this investigation since the aim of this work was to investigate whether 
the hydrophobic functionalised particles affect the HI amyloid-like fibrillation in both 
pH 2 and 7 conditions.  
 The kinetics investigation using ThT has shown the particles affect the HI 
amyloid-like fibrillation pathway at both pH 2 and pH 7 conditions, through observed 
inhibition (Figure 48) and enhancement (Figure 49) respectively. In the presence of 
particles, a modified sigmoidal curve is measured implying altered fibrillation 
pathways, which is apparent at neutral pH with a plateau region followed by an 
exponential fluorescence increase. These results were supported by the TEM imaging 
which showed that the structural morphology of the HI amyloid-like fibrils differed in 
the presence of hydrophobically functionalised mesoporous silica microparticles, 
from the controls, in both pH conditions. The TEM images for the inhibited fibrillation 
kinetics at pH 2 (Figure 51 and Figure 53a – d), showed elongated and twisted 
fibrillar morphology for the resultant fibrils incubated with particles (C6, OSD1 and 
ODS2), but shorter and thinner fibrils in the presence of Si particles. Conversely the 
TEM images for the enhanced fibrillation kinetics at pH 7 (Figure 52 and 
Figure 53e – h), showed a higher variation with the incubated particles; small fibrillar 
species with wispy morphology for the Si and C6 particles, pre-fibrillar aggregates for 
ODS1 and ODS2. The variable structural morphology for the TEM imaged fibrils 
confirms that the particles induce a modified fibrillation pathway for HI.  
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4.3.5. The effect of mesoporous silica microparticles on the human insulin 
amyloid-like fibrillation pathway 
 The mesoporous silica microparticles were chosen to be studied because they 
were comprised of identical core substrate architecture but with differing 
hydrophobically functionalised surfaces, which enabled a controlled study for the 
effect of variable hydrophobic interfaces. These particles have a large surface area 
and exhibit dynamic behaviour within solution when suspended, therefore leading 
to increased interactions between the HI and particles. 
 Each functionalised particle varied in the degree of hydrophobicity by 
modification of the surface alkyl chain. Importantly the hydrophobicity arises from 
the alkyl chain length as opposed to other functionalisation groups. The 
functionalisation is comparable to studying other substrates through chemical 
methodologies like; silane, thiol or disulphide-based chemistry. Notably the 
constituent functional groups are commercially widely available, which allowed for 
further work by modification of other surfaces. 
 A hydrophobic surface is known to accelerate amyloid-like fibrillation events 
for hydrophobic proteins,1,73,82,83 because the protein is more likely to adsorb 
therefore inducing misfolding events. Hydrophobicity is a key driving force because 
the exposed hydrophobic domain of the HI monomer preferentially adsorbs to the 
hydrophobic surface to reduce interaction with water molecules, which is 
entropically favourable with the release of bound water molecules. Furthermore, 
strong adsorption to the surface can provide a misfolding potential for HI, which 
unfolds to minimise exposure to water, therefore providing fibrillation through 
propagation of the misfolded adsorbed species. 
 The work in this chapter shows no clear correlation between increasing the 
functionalised particles’ alkyl chain length and  I adsorption or amyloid-like 
fibrillation. Adsorption results characterised by microanalysis and IR, were 
inconclusive with large standard deviations suppressing any potential trends. Kinetics 
analysis shows that the amyloid-like fibrillation in the presence of particles does 
deviate from the HI-only controls, however there is no definitive trend with regards 
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to functionalisation. The inability to assess the kinetics of ODS2, due to its inherent 
fluorescence, further complicated the kinetics analysis. Fibrillar morphology also 
failed to provide any trend consistent with the functionalisation, however the 
acquired images appear to show an increased quantity of fibrils for the fibrillation 
with particles compared to the controls. 
 In addition to the influence of the particles’ hydrophobicity, the  I state was 
also considered within this work. At acidic conditions, particularly with the buffer 
used in this investigation, HI existed in a predominantly monomeric state whereas at 
neutral pH an amalgamation of oligomeric states was possible. These states were 
predominantly dimer and higher order oligomeric states, hexameric species were 
also likely since this work used HI suspensions containing zinc.84 The HI oligomeric 
state is critical for particle adsorption and amyloid-like fibrillation, the hydrophobic 
effect drives HI monomers to adsorb to the hydrophobic interface, however at 
neutral pH this exposed hydrophobic domain is inaccessible. Higher order oligomeric 
states, such as dimers and hexamer species, are complexes whereby the hydrophobic 
domain is buried between the dimeric interfaces, therefore negating the 
hydrophobic attraction and by extension the entropic gain is no longer a driving 
factor for adsorption. 
 This chapter has shown that the pH conditions do affect the amount of HI 
adsorbed to the particles by microanalysis and IR techniques. At pH 2 there is a 
substantial difference between the adsorbed and desorbed HI content, whereas at 
pH 7 there is minimal observed difference due to the significant errors attained. This 
difference in adsorbed HI implies that for acidic conditions the HI is strongly bound 
to the particles surface potentially through chemisorption. Conversely for neutral 
conditions the amount of HI adsorbed fluctuates, which implies that physisorption 
occurs corresponding to variations of bound oligomeric state HI. It is already known 
that pH affects the amyloid-like fibrillation kinetics and fibrillar morphology,48,85 
therefore it is not surprising that differences in ThT assays and TEM images were 
observed. In both conditions, the particles appear to accelerate fibrillation. In the 
presence of particles the lag time decreases, however in acidic pH the fluorescence 
intensity associated with the saturation phase reduced compared to the control, 
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whereas for neutral pH the intensity is greater but saturation phase has not been 
attained. Fibrillar morphology in the presence of the particles is also affected, where 
a trend is difficult to determine for pH 2, whilst at pH 7 the particles clearly favour 
pre-fibrillar aggregates. 
 The results of this work also show that the presence of the particles likely 
induces amyloid-like fibrillation through a different pathway as opposed to the 
controls. This is particularly evident in the pH 7 kinetics data where the particles 
appear to reach a plateau between days 1 and 2.5, which implies that the ThT dye 
has bound to cross-β structure with a secondary stage fibrillation occurring after 
2.5 days. A plateau was not observed for the pH 2 however the decreased lag phase 
and saturation phase suggests that a different fibrillation pathway than the control 
was used. These results are supported by the differences observed in the TEM images 
with respect to amyloid-like fibrillation in the presence of particles. Further work is 
necessary in order to characterise the fibrillation pathways in the presence of 
hydrophobic particles; however the results clearly show differences between the 
HI-only controls and the incubation with particles supporting the implication that the 
particles affect the fibrillation pathway. It is likely that acidic conditions, which 
promote HI monomer adsorption, leads to an increased amyloid-like fibrillation 
through surface-catalysed interactions such as; seeded-growth mechanisms. 
Conversely for neutral pH conditions, where HI exists as a multi-oligomeric species 
with physisorption adsorption events, results in chaperone-type fibrillation 
processes by bringing the HI species together. 
4.4. Conclusion 
 This investigation has shown that the presence of hydrophobically 
functionalised mesoporous silica microparticles affect the HI amyloid-like fibrillation 
pathway in both acidic and neutral pH conditions. The fibrillation kinetics, as 
measured by ThT assay, demonstrate that the particles affect the distinctive 
sigmoidal curve through inhibition at pH 2 and enhancement at pH 7. The associated 
differences between the two pH conditions implies a divergence of the amyloid-like 
fibrillation pathway. Enhancement at neutral pH is likely attributed to a different 
fibrillation pathway undertaken, since a plateau phase was observed. Conversely at 
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acidic pH the lag phase kinetics were decreased but demonstrated a reduced 
fluorescence intensity for the saturation phase. This variation was statistically 
significant between the control HI samples and the particles in both pH conditions, 
in contrast the variation between the functionalised particles themselves was 
insignificant, which corresponds to the effect of particles as opposed to the change 
in pH conditions. These results were correlated by TEM microscopy with the resultant 
fibrillar morphology, which showed marked differences between pH and the 
functionalisation types, whereby the morphological dissimilarities imply the 
hydrophobic functionalisation acts a scaffold resulting in various fibrillation 
pathways. 
 All hydrophobic surfaces are not equivalent, as shown by the fibril 
morphology for the four hydrophobically functionalised mesoporous silica 
microparticles. Importantly the pronounced difference in morphology suggests that 
a structural rearrangement is induced by the interface. The limited differences in 
protein adsorption and fibrillation kinetics, would imply a templated-type process 
occurs during prolonged adsorption which induces structural rearrangement, whilst 
maintaining a cross-β structure. 
 The results generated within this work were far from ideal because of 
challenges surrounding the; constituent components and analytical techniques. 
Firstly, although the microparticles used were commercially available, there were 
large variations of size and shape that were not initially accounted for. Secondly the 
ODS2 particles were inherently fluorescent, which resulted in failure to analyse the 
amyloid-like fibrillation kinetics along with the other particles studied. Thirdly the 
analytical techniques used for studying the adsorbed HI content on the particles, 
which were by microanalysis and IR techniques, were greatly affected by variations 
in sample preparation therefore leading to significant error values. 
  









/ µm (1) 
Particle size 
dist. / µm (2) 
Surface Area 
/ m2g-1 (3) 
Pore diameter 
(range, 4) / nm 
% Carbon 
Load 
S5 Silica - 5 ± 2 220 8 (5.4 – 11.0) - 
S5 C6 Silica Hexyl 5 ± 2 220 8 (5.4 – 11.0) 4.7 
S5 ODS1 Silica Octadecyl 5 ± 2 220 8 (5.4 – 11.0) 6.2 
S5 ODS2 Silica Octadecyl 5 ± 2 220 8 (5.4 – 11.0) 11.5 
(1) Mean particle size, µm 
(2) 90% of distribution, µm. 
(3) Specific surface area m2g-1, Brunauer-Emmett-Teller (BET) adsorption isotherm. 
(4) 5-95% of total (nm). Measured by nitrogen adsorption. 
Figure S13: Data Table specifications of the mesoporous silica microparticles utilised in this chapter; 
Si, C6, ODS1 and ODS2, reproduced from Spherisorb.8 
 
Figure S14: Thioflavin-T (ThT) end-point assay (n=3) showing the fluorescence exhibited by ThT binding 
onto the functionalised silica microparticles; (red) Si, (green) C6, (blue) ODS1 and (orange) ODS2, over 
90 minutes in pH 7. Note the detector saturates at 8000 a.u. therefore rendering ODS2 unfeasible in 
the kinetics investigation. The error bars show the standard deviation. 
  
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 4 
Page 162 
Bibliography 
1. Sluzky, V., Tamada, J. A., Klibanov, A. M. & Langer, R. Kinetics of insulin aggregation in aqueous solutions upon 
agitation in the presence of hydrophobic surfaces. Proc. Natl. Acad. Sci. U. S. A. 88, 9377–9381 (1991). 
2. Nayak, A., Dutta, A. K. & Belfort, G. Surface-enhanced nucleation of insulin amyloid fibrillation. Biochem. Biophys. Res. 
Commun. 369, 303–307 (2008). 
3. Sluzky, V., Klibanov, A. M. & Langer, R. Mechanism of insulin aggregation and stabilization in agitated aqueous 
solutions. Biotechnol. Bioeng. 40, 895–903 (1992). 
4. Ballet, T. et al. DnaK Prevents Human Insulin Amyloid Fiber Formation on Hydrophobic Surfaces. Biochemistry 51, 
2172–2180 (2012). 
5. Moores, B., Drolle, E., Attwood, S. J., Simons, J. & Leonenko, Z. Effect of Surfaces on Amyloid Fibril Formation. PLoS 
One 6, e25954 (2011). 
6. Hammarström, P. et al. A catalytic surface for amyloid fibril formation. J. Phys. Conf. Ser. 100, 052039 (2008). 
7. Hammarström, P. et al. An Auto-Catalytic Surface for Conformational Replication of Amyloid Fibrils—Genesis of an 
Amyloid World? Orig. Life Evol. Biosph. 41, 373–383 (2011). 
8. PhaseSeparations. Spherisorb Packing Materials and Columns for HPLCS. 16 (1985). 
9. Shezad, K. et al. Surface Roughness Modulates Diffusion and Fibrillation of Amyloid-β Peptide. Langmuir 32, 8238–
8244 (2016). 
10. Engelhardt, H. & Müller, H. Chromatographic characterization of silica surfaces. J. Chromatogr. A 218, 395–407 (1981). 
11. Gualandi-Signorini, A. M. & Giorgi, G. Insulin formulations--a review. Eur. Rev. Med. Pharmacol. Sci. 5, 73–83 (2001). 
12. Hua, Q. & Weiss, M. A. Mechanism of Insulin Fibrillation. J. Biol. Chem. 279, 21449–21460 (2004). 
13. Pohl, R. et al. Ultra-rapid absorption of recombinant human insulin induced by zinc chelation and surface charge 
masking. J. Diabetes Sci. Technol. 6, 755–763 (2012). 
14. Lundqvist, M., Sethson, I. & Jonsson, B. H. Protein adsorption onto silica nanoparticles: Conformational changes 
depend on the particles’ curvature and the protein stability. Langmuir 20, 10639–10647 (2004). 
15. He, Q. et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and 
cellular responses. Biomaterials 31, 1085–1092 (2010). 
16. Chen, L. et al. Novel mesoporous silica spheres with ultra-large pore sizes and their application in protein separation. 
J. Mater. Chem. 19, 2013–2017 (2009). 
17. Taebnia, N. et al. The effect of mesoporous silica nanoparticle surface chemistry and concentration on the α-synuclein 
fibrillation. RSC Adv. 5, 60966–60974 (2015). 
18. Taebnia, N. et al. Curcumin-Loaded Amine-Functionalized Mesoporous Silica  anoparticles Inhibit α-Synuclein 
Fibrillation and Reduce Its Cytotoxicity-Associated Effects. Langmuir 32, 13394–13402 (2016). 
19. Deere, J., Magner, E., Wall, J. G. & Hodnett, B. K. Mechanistic and structural features of protein adsorption onto 
mesoporous silicates. J. Phys. Chem. B 106, 7340–7347 (2002). 
20. SiliCycle. What is endcapping? (2018). 
21. Shah, V., Bharatiya, B., Shah, D. O. & Mukherjee, T. Correlation of Dynamic Surface Tension with Sedimentation of 
PTFE Particles and Water Penetration in Powders. Langmuir 31, 13725–13733 (2015). 
22. Hsieh, S., Chang, C. & Chou, H. Gold nanoparticles as amyloid-like fibrillogenesis inhibitors. Colloids Surfaces B 
Biointerfaces 112, 525–529 (2013). 
23. Sukhanova, A. et al. Nanoparticles With a Specific Size and Surface Charge Promote Disruption of the Secondary 
Structure and Amyloid-Like Fibrillation of Human Insulin Under Physiological Conditions. Front. Chem. 7, (2019). 
24. Colvin, V. L. & Kulinowski, K. M. Nanoparticles as catalysts for protein fibrillation. Proc. Natl. Acad. Sci. 104, 8679–
8680 (2007). 
25. Maiti, N., Chadha, R., Das, A. & Kapoor, S. Adsorption and sub-nanomolar sensing of thioflavin T on colloidal gold 
nanoparticles, silver nanoparticles and silver-coated films studied using surface-enhanced Raman scattering. 
Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 149, 949–956 (2015). 
26. Ganguly, S. & Chakraborty, S. Sedimentation of nanoparticles in nanoscale colloidal suspensions. Phys. Lett. A 375, 
2394–2399 (2011). 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 4 
Page 163 
27. Yazdimamaghani, M., Barber, Z. B., Hadipour Moghaddam, S. P. & Ghandehari, H. Influence of Silica Nanoparticle 
Density and Flow Conditions on Sedimentation, Cell Uptake, and Cytotoxicity. Mol. Pharm. 15, 2372–2383 (2018). 
28. Akgöl, S., Öztürk, N. & Denizli, A. New generation polymeric nanospheres for catalase immobilization. J. Appl. Polym. 
Sci. 114, 962–970 (2009). 
29. Li, Z. et al. Mesoporous nitrogen-rich carbons derived from protein for ultra-high capacity battery anodes and 
supercapacitors. Energy Environ. Sci. 6, 871–878 (2013). 
30. Liu, X. et al. Monodispersed MCM-41 large particles by modified pseudomorphic transformation: Direct diamine 
functionalization and application in protein bioseparation. Microporous Mesoporous Mater. 122, 114–120 (2009). 
31. Nagase, K. et al. Thermoresponsive anionic copolymer brushes containing strong acid moieties for effective 
separation of basic biomolecules and proteins. Biomacromolecules 15, 3846–3858 (2014). 
32. Niu, Y. et al. Formation of cyclodextrin monolayer through a host–guest interaction with tailor-made 
phenyltriethoxysilane self-assembled monolayer. Colloids Surfaces A Physicochem. Eng. Asp. 470, 224–229 (2015). 
33. Schultz, K. C. et al. A Genetically Encoded Infrared Probe. J. Am. Chem. Soc. 128, 13984–13985 (2006). 
34. Barth, A. Infrared spectroscopy of proteins. Biochim. Biophys. Acta - Bioenerg. 1767, 1073–1101 (2007). 
35. Haris, P. I. Can infrared spectroscopy provide information on protein-protein interactions? Biochem. Soc. Trans. 38, 
940–946 (2010). 
36. L. Lyubchenko, Y. Amyloid misfolding, aggregation, and the early onset of protein deposition diseases: insights from 
AFM experiments and computational analyses. AIMS Mol. Sci. 2, 190–210 (2015). 
37. Chuang, E., Hori, A. M., Hesketh, C. D. & Shorter, J. Amyloid assembly and disassembly. J. Cell Sci. 131, jcs189928 
(2018). 
38. Gade Malmos, K. et al. ThT 101: a primer on the use of thioflavin T to investigate amyloid formation. Amyloid 24, 1–
16 (2017). 
39. Groenning, M. Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils-current 
status. J. Chem. Biol. 3, 1–18 (2010). 
40. Manno, M., Craparo, E. F., Martorana, V., Bulone, D. & San Biagio, P. L. Kinetics of Insulin Aggregation: 
Disentanglement of Amyloid Fibrillation from Large-Size Cluster Formation. Biophys. J. 90, 4585–4591 (2006). 
41. Kuznetsova, I. M., Sulatskaya, A. I., Uversky, V. N. & Turoverov, K. K. Analyzing Thioflavin T Binding to Amyloid Fibrils 
by an Equilibrium Microdialysis-Based Technique. PLoS One 7, e30724 (2012). 
42. Tycko, R. Amyloid Polymorphism: Structural Basis and Neurobiological Relevance. Neuron 86, 632–645 (2015). 
43. Nelson, R. et al. Structure of the cross-β spine of amyloid-like fibrils. Nature 435, 773–778 (2005). 
44. Jahn, T. R. et al. The Common Architecture of Cross-β Amyloid. J. Mol. Biol. (2010). doi:10.1016/j.jmb.2009.09.039 
45. Rosenauer, A., Krause, F. F., Müller, K., Schowalter, M. & Mehrtens, T. Conventional Transmission Electron Microscopy 
Imaging beyond the Diffraction and Information Limits. Phys. Rev. Lett. 113, 096101 (2014). 
46. Morris, R. E. The use of nonparametric statistics in quantitative electron microscopy. J. Electron Microsc. (Tokyo). 49, 
545–549 (2000). 
47. Ivanova, M. I., Sievers, S. A., Sawaya, M. R., Wall, J. S. & Eisenberg, D. Molecular basis for insulin fibril assembly. Proc. 
Natl. Acad. Sci. 106, 18990–18995 (2009). 
48. Iannuzzi, C., Borriello, M., Portaccio, M., Irace, G. & Sirangelo, I. Insights into Insulin Fibril Assembly at Physiological 
and Acidic pH and Related Amyloid Intrinsic Fluorescence. Int. J. Mol. Sci. 18, 2551 (2017). 
49. Maciel, V., Yoshida, C., Pereira, S., Goycoolea, F. & Franco, T. Electrostatic Self-Assembled Chitosan-Pectin Nano- and 
Microparticles for Insulin Delivery. Molecules 22, 1707 (2017). 
50. Schoonenboom, N. S. M. et al. Effects of Processing and Storage Conditions on Amyloid β (1–42) and Tau 
Concentrations in Cerebrospinal Fluid: Implications for Use in Clinical Practice. Clin. Chem. 51, 189–195 (2005). 
51. Sigurdsson, E. M., Calero, M. & Gasset, M. Amyloid proteins. methods and protocols. (Humana Press, 2012). 
52. Domigan, L. J., Healy, J. P., Meade, S. J., Blaikie, R. J. & Gerrard, J. A. Controlling the dimensions of amyloid fibrils: 
Toward homogenous components for bionanotechnology. Biopolymers 97, 123–133 (2012). 
53. Castillo-León, J. & Svendsen, W. E. Micro and Nanofabrication Using Self-Assembled Biological Nanostructures. 
(William Andrew Publishing, 2015). 
54. Liu, H.-C., Chiu, M.-J., Lin, C.-H. & Yang, S.-Y. Stability of Plasma Amyloid-β 1–40, Amyloid-β 1–42, and Total Tau Protein 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 4 
Page 164 
over Repeated Freeze/Thaw Cycles. Dement. Geriatr. Cogn. Dis. Extra 10, 46–55 (2020). 
55. Myers, P. private communication. 
56. Mauri, S., Volk, M., Byard, S., Berchtold, H. & Arnolds, H. Stabilization of Insulin by Adsorption on a Hydrophobic Silane 
Self-Assembled Monolayer. Langmuir 31, 8892–8900 (2015). 
57. Danaei, M. et al. Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier 
Systems. Pharmaceutics 10, 57 (2018). 
58. Gaikwad, V. L., Choudhari, P. B., Bhatia, N. M. & Bhatia, M. S. Characterization of pharmaceutical nanocarriers: in vitro 
and in vivo studies. in Nanomaterials for Drug Delivery and Therapy (ed. Grumezescu, A. M. B. T.-N. for D. D. and T.) 
33–58 (Elsevier, 2019). doi:10.1016/B978-0-12-816505-8.00016-3 
59. Chi, E. Y., Krishnan, S., Randolph, T. W. & Carpenter, J. F. Physical stability of proteins in aqueous solution: mechanism 
and driving forces in nonnative protein aggregation. Pharm. Res. 20, 1325–36 (2003). 
60. Shnoudeh, A. J. et al. Synthesis, Characterization, and Applications of Metal Nanoparticles. in Biomaterials and 
Bionanotechnology (ed. Tekade, R. K. B. T.-B. and B.) 527–612 (Elsevier, 2019). doi:10.1016/B978-0-12-814427-
5.00015-9 
61. Bhattacharjee, S. DLS and zeta potential – What they are and what they are not? J. Control. Release 235, 337–351 
(2016). 
62. Roebben, G. et al. Interlaboratory comparison of size and surface charge measurements on nanoparticles prior to 
biological impact assessment. J. Nanoparticle Res. 13, 2675–2687 (2011). 
63. Arnebrant, T. & Nylander, T. Adsorption of insulin on metal surfaces in relation to association behavior. J. Colloid 
Interface Sci. 122, 557–566 (1988). 
64. Mollmann, S. H., Bukrinsky, J. T., Frokjaer, S. & Elofsson, U. Adsorption of human insulin and AspB28 insulin on a PTFE-
like surface. J. Colloid Interface Sci. 286, 28–35 (2005). 
65. Mollmann, S. H. et al. Interfacial adsorption of insulin: Conformational changes and reversibility of adsorption. Eur. J. 
Pharm. Sci. 27, 194–204 (2006). 
66. Phillips, N. B., Whittaker, J., Ismail-Beigi, F. & Weiss, M. A. Insulin Fibrillation and Protein Design: Topological 
Resistance of Single-Chain Analogs to Thermal Degradation with Application to a Pump Reservoir. J. Diabetes Sci. 
Technol. 6, 277–288 (2012). 
67. Bruker. Application Note AN 74, Attenuated Total Reflection (ATR) – a versatile tool for FT-IR spectroscopy. (2011). 
68. Nilsson, P., Nylander, T. & Havelund, S. Adsorption of insulin on solid surfaces in relation to the surface properties of 
the monomeric and oligomeric forms. J. Colloid Interface Sci. 144, 145–152 (1991). 
69. Mollmann, S. H. et al. Interfacial adsorption of insulin: Conformational changes and reversibility of adsorption. Eur. J. 
Pharm. Sci. 27, 194–204 (2006). 
70. Przybyciel, M. & Majors, R. E. Phase Collapse in Reversed-Phase LC. LC GC Eur. (2002). 
71. Liu, P. S. & Chen, G. F. Characterization Methods. Porous Materials (Elsevier, 2014). doi:10.1016/B978-0-12-407788-
1.00009-5 
72. Biancalana, M. & Koide, S. Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta - 
Proteins Proteomics 1804, 1405–1412 (2010). 
73. Jorgensen, L. et al. Adsorption of insulin with varying self-association profiles to a solid Teflon surface—Influence on 
protein structure, fibrillation tendency and thermal stability. Eur. J. Pharm. Sci. 42, 509–516 (2011). 
74. Shammas, S. L. et al. Perturbation of the stability of amyloid fibrils through alteration of electrostatic interactions. 
Biophys. J. 100, 2783–2791 (2011). 
75. Khurana, R. et al. A General Model for Amyloid Fibril Assembly Based on Morphological Studies Using Atomic Force 
Microscopy. Biophys. J. 85, 1135–1144 (2003). 
76. Kurouski, D., Dukor, R. K., Lu, X., Nafie, L. A. & Lednev, I. K. Normal and reversed supramolecular chirality of insulin 
fibrils probed by vibrational circular dichroism at the protofilament level of fibril structure. Biophys. J. 103, 522–531 
(2012). 
77. Kurouski, D. et al. Disulfide bridges remain intact while native insulin converts into amyloid fibrils. PLoS One 7, 1–9 
(2012). 
78. Rueden, C. T. et al. ImageJ2: ImageJ for the next generation of scientific image data. BMC Bioinformatics 18, 529 
(2017). 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 4 
Page 165 
79. Barrett, S. ImageSXM. (2015). Available at: http://www.imagesxm.org.uk.  
80. Barrett, S. private communication. 
81. Williams, D. B. & Carter, C. B. Transmission Electron Microscopy. Transmission Electron Microscopy: A Textbook for 
Materials Science (Springer US, 2009). doi:10.1007/978-0-387-76501-3 
82. Sharp, J. S., Forrest, J. a. & Jones, R. a L. Surface denaturation and amyloid fibril formation of insulin at model lipid-
water interfaces. Biochemistry 41, 15810–15819 (2002). 
83. Giacomelli, C. E. & Norde, W. Influence of hydrophobic teflon particles on the structure of amyloid β-peptide. 
Biomacromolecules 4, 1719–1726 (2003). 
84. Nettleton, E. J. et al. Characterization of the Oligomeric States of Insulin in Self-Assembly and Amyloid Fibril Formation 
by Mass Spectrometry. Biophys. J. 79, 1053–1065 (2000). 
85. Sneideris, T. et al. pH-Driven Polymorphism of Insulin Amyloid-Like Fibrils. PLoS One 10, e0136602 (2015). 
 
  
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 5 
Page 166 
Chapter 5: Hydrophobic Functionalisation of Gold Surfaces on 
Human Insulin Fibrillation 
5.1. Introduction 
 This chapter will investigate how hydrophobic functionalisation affects the 
human insulin (HI) amyloid-like fibrillation pathway, by means of mass and structural 
changes on a hydrophobic functionalised gold substrate. Chapter 4 showed how the 
presence of hydrophobic functionalised mesoporous silica microparticles affected 
the amount of HI adsorbed and the fibrillation kinetics, which resulted in 
modification of the HI pathway as shown in the different fibril morphologies. The 
implication of the results from Chapter 4, suggested that it was the hydrophobic 
functionalisation which affected the typical amyloid-like fibrillation pathway, 
therefore this chapter will investigate the effect of surface hydrophobic variability, 
specifically the adsorption and structural features of the adsorbed HI monolayer. 
 The hydrophobicity of the silica microparticles were shown to result in 
different fibril morphologies, indicating that key fibrillation pathway differences are 
a consequence of HI restructuring at the interface, most likely due to the 
autocatalytic mechanism (1.5.1. Protein interaction at the liquid-solid interface, 
page 52).1,2 The objective of this chapter is to investigate the effect that hydrophobic 
variability has on HI adsorption in both acidic and neutral pH as a function of time, in 
order to probe if the divergence of the fibrillation pathway can be observed by 
associated changes in mass and structural character. To investigate the difference in 
mass and structural features at an interface in situ, requires a new set of analytical 
techniques to be utilised; Quartz-Crystal Microbalance with Dissipation (QCM-D) and 
Raman spectroscopy. QCM-D is necessary to measure the mass changes associated 
with HI adsorbing in a flow system over time, and Raman spectroscopy to probe the 
structural features of the adsorbed HI to determine whether structural 
rearrangement has occurred. The typical operating mode of the QCM-D is with gold 
sensors and so in this chapter an analogous silane functionalisation is adopted for 
these gold sensors. 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 5 
Page 167 
5.1.1. Hydrophobic functionalisation of gold surfaces 
 A bare gold substrate is spectroscopically advantageous as it is reflective and 
thus can be utilised in surface-sensitive techniques, and typically functionalised using 
self-assembled monolayers (SAMs) such as thiol and disulfide chemistry.3–6 The 
conventional SAM scheme, Figure 54, for these methods is a four step approach; 
physisorption, surface rearrangement, chemisorption through nucleation at the 
sulfur head group, and reorganisation into a perpendicular orientation.5 The ability 
to functionalise the gold surface is important for investigating the effect of various 
hydrophobic interfaces on the HI amyloid-like fibrillation pathway. 
 
Figure 54: Schematic for the (red) disulfide functionalisation of (yellow) gold, showing; (a) free 
disulfide in solution, (b) physisorption, (c) surface rearrangement, (d) chemisorption and 
(e) perpendicular reorganisation processes. Adapted from Vericat et al.5 
 This chapter utilises disulfide chemistry in order to functionalise the surface, 
because of the safety concerns associated with thiols, however both result in the 
desired functionality.4 For this chapter to provide complementary data to Chapter 4, 
similar hydrophobic interfaces were needed, which required analogous disulfide 
components. Firstly, the non-bonded silica surface (Si) could not be replicated, as the 
analogous substrate is bare gold which is hydroxylated and hydrophilic after cleaning, 
thereby will not provide similar fibrillation routes with possible insulin distortion.7 
Secondly the octadecyl endcapped (ODS2) surface was composed of octadecyl alkyl 
groups and end-capped with trimethoxysilane, which could not be replicated with 
disulfide chemistry on a gold substrate. The remaining functionalisation 
modifications hexyl (C6) and octadecyl (ODS1, C18) were both available commercially 
in disulfide form. The functionalisation of gold with dihexyl disulfide or 
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dioctadecyl disulfide, results in a hydrophobic variation associated with increasing 
alkyl chain length.8 
5.1.2. Obtaining layer thickness of an adsorbate  
Quartz-crystal microbalance with dissipation (QCM-D) is a sensitive technique 
to calculate the amount of substance adsorbed to a sensor, which is determined from 
the measured differences in frequency and dissipation of the oscillating quartz crystal 
after excitation.9 A QCM-D instrument utilises a piezoelectric sensor to determine 
mass changes, this works by measuring the change in frequency of the sensor’s 
oscillation, and the dampening of the dissipation, which refers to the wave decay 
time after power to the sensor is removed. Generally adsorbed species on the sensor 
result in a decrease in the measured frequency and a corresponding increase in the 
decay time. QCM-D with or without dissipation has previously been used to 
investigate; blood coagulation on spin-coated titanium sputtered gold sensors,10 
fibrillation of human islet amyloid polypeptide (hIAPP),11 and the adsorption of; 
thiols,12 cell tissue,13 mucin14 and fibronectin on the gold sensors.15 The ability to 
measure both frequency and dissipation simultaneously can provide information on 
the species mass and the rigidity of the adsorbed layer, for example a globular 
protein like bovine serum albumin (BSA) results in moderate frequency reduction 
and a low dissipation value,16 a typical QCM-D trace is shown in Figure 55. 
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Figure 55: A typical representative quartz-crystal microbalance with dissipation (QCM-D) trace, with 
(black) change in frequency on the primary and (red) change in dissipation on the secondary y-axis and 
increasing time on the x-axis, for (a) human insulin (HI) adsorption and (b) desorption from the sensor 
as (magenta dashed lines) solution is changed. 
 The typical QCM-D trace (Figure 55) shows change in frequency (Hz, black) on 
the primary and change in dissipation (red) on the secondary y-axis, with respect to 
increasing time on the x-axis. In Figure 55, the addition of HI is shown at the first 
dashed line (a) and a buffer rinse is shown at the second dashed line (b). The addition 
of HI causes a change in the frequency and dissipation traces, with frequency 
decreasing and the dissipation increasing, which is associated to an increased mass 
and a change in the adsorbed layer viscosity.9 The buffer rinse removes the excess 
HI, as shown by the increase in the frequency and decrease in the dissipation. In this 
QCM-D trace example (Figure 55), the frequency and dissipation do not return to the 
baseline prior to protein adsorption therefore this implies that not all the HI has been 
desorbed from the surface. This representative trace is only one of the harmonics 
acquired from the sensor, each sensor is capable of acquiring multiple harmonics 
which will be discussed further (5.1.2.1. Which harmonic?, page 169). 
5.1.2.1. Which harmonic? 
 The QCM-D used in this research programme is a multi-harmonic instrument, 
where it can excite the gold sensor at different frequencies. Each gold sensor can 
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resonate at different harmonics (n≥1), where the first frequency (5 MHz) is termed 
the fundamental (n=1) with the following termed overtones (n>1). The overtones 
provide differing gold sensor frequencies, for example the next overtone (n=3) 
corresponds to a frequency of 25 MHz. In each harmonic, the frequency and 
corresponding dissipation are acquired simultaneously therefore allowing for 
information on the adsorbed layer mass and viscosity, the principals of which are 
shown in Figure 56. 
 
Figure 56: Typical differences observed in the measured (a) frequency and (b) dissipation profiles for 
(red) soft and (blue) rigid layers adsorbed to a quartz crystal microbalance with dissipation (QCM-D) 
sensor. The decreasing rigidity of an adsorbed layer leading to a soft or viscoelastic type results in a 
wave frequency reduction and rapid loss of dissipation intensity. Adapted from Biolin Scientific.9 
 As described earlier, a QCM-D sensor measures the change in frequency of 
the sensor’s oscillation (Figure 56). Adsorption of a species to the sensor results in a 
change in the frequency (Figure 56a), which can be used to determine the adsorbed 
mass (5.1.2.2. Quantifying adsorbed layer thickness, page 171). However, acquiring 
the dissipation value provides further information on the adsorbed species, 
particularly if the adsorbed species is soft or viscoelastic therefore is not a rigid, 
evenly distributed thin film. The viscoelasticity of the adsorbed layer is considered by 
dissipation measurement (Figure 56b), which refers to the wave decay time and 
whether the sensor is dampened by a rigid of soft adsorbed layer.9 Acquiring both 
the frequency and dissipation, allows for quantification of the adsorbed layer by a 
modelling system (5.1.2.2. Quantifying adsorbed layer thickness, page 171) such as; 
the Sauerbrey equation or Voigt model to calculate the adsorbed layer thickness. 
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5.1.2.2. Quantifying adsorbed layer thickness 
 Quantification of the adsorbed protein layer thickness is calculated by using 
one of two models; Sauerbrey or Voigt. The Sauerbrey equation relates frequency 
with mass,17 as shown in equation (5.4): 




where 𝑚 is mass, 𝐶 is a constant for quartz, ∆𝑓 is change in frequency and 𝑛 is the 
harmonic used in the analysis. The Sauerbrey equation only uses the acquired 
frequency to determine the adsorbed layer mass, as it assumes the layer is rigid and 
thin, and has previously been used in amyloid-like fibrillation studies of insulin.18 
Conversely Voigt is a viscoelastic model, which considers dissipation and uses all the 
acquired sensor harmonics,12,19 as shown in equation (5.5): 
𝐺∗ = 𝐺′ + 𝑖𝐺′′ = 𝜇1 + 𝑖2𝜋𝑓𝑛1 (5.5) 
where G* is the complex shear modulus, G´ is the storage modulus, G´´ is the loss 
modulus, 𝜇 is the elasticity coefficient, 𝑓 is the frequency coefficient and 𝑛 is the 
shear viscosity coefficient.12 The Voigt model has previously been used to investigate 
amyloid-like fibrillation of glucagon resulting in multi-layer growth.20 
 Generally, both models provide adsorbed layer thickness information, 
however the Sauerbrey model characterises a rigid species and only utilises the 
frequency harmonic, whereas the Voigt viscoelasticity model can determine softer 
species as a result of considering the dissipation. In this research programme, QCM-D 
is used to quantify the amount of HI adsorbed to the functionalised gold sensor, with 
respect to the pH conditions and the hydrophobic functionalisation of the surface. 
The data will be modelled using both models to determine which model is more 
suitable for insulin adsorption. 
5.1.3. Obtaining structural information of the adsorbed insulin 
 Investigation of the adsorbed HI layer requires a non-destructive 
surface-sensitive technique, which can provide structural information of the 
adsorbed layer. Raman spectroscopy (Raman) is a vibrational spectroscopic 
technique similar to infrared (IR) spectroscopy, in that it interrogates the vibrational 
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modes of a molecule however the approach is different; IR absorbs a photon to excite 
the molecule to a higher vibration level whereas Raman probes the scattering effect. 
There are three possible scattering effects; Rayleigh, Stokes, and Anti-Stokes, which 
are either inelastic or elastic, and are shown in Figure 57. Rayleigh is elastic as there 
is no change in energy, whereas both Stokes and Anti-Stokes are inelastic with an 
energy change. This can be expressed as the laser energy (E0) can be scattered by a 
species (Es) resulting in; Rayleigh (Es = E0), Anti-Stokes (Es < E0), and Stokes (Es > E0). 
The selectivity rules for Raman are different from IR. IR activity requires a change in 
dipole, however for Raman a change in polarizability is necessary. 
 
Figure 57: Energy level diagram comparing the probed energetic states of a sample by spectroscopy 
with the three scattering effects of (orange, purple and pink) Raman (Rayleigh, Stokes and Anti-Stokes) 
compared to (red) infrared and (blue) fluorescence spectroscopy. The (green) energetic relaxation is 
also shown for fluorescence spectroscopy. Adapted from Marcelli et al.21 
 A major benefit for the use of Raman spectroscopy within this work is that it 
is not affected by either water or carbon dioxide, unlike IR, therefore the presence 
of any encapsulated water within the adsorbed HI layer will not be of concern. 
Assuming an appropriate instrumental setup is already established, there are very 
few disadvantages to Raman spectroscopy. The inherent weakness of Raman is that 
scattering results in an extremely low signal, which is often overcome instrumentally 
by increasing the signal integration time or the laser power. The issue with this 
solution is that the effect of increasing the beam time or laser power, may result in 
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sample degradation, due to localised sample heating. A further disadvantage, albeit 
sample-specific, is undesired fluorescence overwhelming the Raman signal and thus 
the spectra, which occurs when the laser excitation wavelength is near to the 
electronic transition energy state of the sample. 
 Resolving the undesired fluorescence effects is relatively simple, assuming 
accessibility to other lasers, the excitation wavelength can be switched to a different 
wavelength further away from the transition energy state. Addressing the low Raman 
signal issue is more complicated, however recent spectroscopic developments have 
resulted in two innovative spectroscopic techniques which improve the signal by 
chemical and electromagnetic enhancement effects. Manipulation of metallic 
properties is key for both techniques, which are termed Surface Enhanced Raman 
Scattering (SERS) and Tip Enhanced Raman Scattering (TERS). 
5.1.3.1. Surface Enhanced Raman Spectroscopy (SERS) 
 SERS improves the Raman spectroscopy signal by the presence of either a 
roughened surface or by the addition of metallic nanoparticles, because of two signal 
enhancement mechanisms; electromagnetic (EM) or chemical enhancement (CE). 
The EM is a plasmonic enhancement, which arises from the nano-systems free 
electrons oscillating in respect to the electromagnetic field.22–24. The CE, also termed 
Charge-Transfer, arises by the promotion of an electron from the highest occupied 
molecular orbital (HOMO) to the lowest unoccupied molecular orbital (LUMO) of the 
adsorbed species as a result of the metallic nanoparticles electronic fermi level.25,26 
Importantly, gold nanoparticle addition can enhance the Raman signal 
through SERS, which is desirable however it has been reported the presence of 
particles can affect fibrillation.27 The aim of this chapter is to probe the effect that 
hydrophobic interfaces have on the human insulin amyloid-like fibrillation pathway, 
it is therefore crucial no other variables are introduced. 
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5.2. Materials and Methods 
5.2.1. Sample preparation 
 All the equipment and HI suspensions were prepared as described earlier, 
Chapter 3, and all reagents used throughout this thesis were of analytical grade or 
higher. 
5.2.1.1. Cleaning Gold Surfaces 
 The gold sensors (QSX 301, Biolin Scientific) and tweezers (Erem by Weller, 
 S) were cleaned following the manufacturer’s instructions. This involved  two 
UV-ozone cleans (10 minutes, Bioforce Nanosciences) on either side followed by 
immersion in an alkaline piranha solution (ultrapure (type I) water (18.2 MΩ cm-1), 
30% hydrogen peroxide, 25% ammonia) and heated to ~75°C for 15 minutes, which 
were then rinsed excessively and dried under argon flow. A final UV-ozone 
clean (10 minutes) was performed on either side to oxidise the surface. The sensors 
were briefly stored on lint-free medical wipes in petri-dishes until surface 
functionalisation could occur. 
Disulfide functionalisation 
 In two glass vials (14 mL), dihexyl disulfide (0.1 M) and dioctadecyl 
disulfide (0.1 M) solutions were suspended in toluene (14 mL). The freshly cleaned, 
dried, gold sensors were submerged within the solutions (60 minutes), removed, 
dried under argon flow and mounted into the QCM-D modules. The sensors were 
always handled carefully using the same tweezers to prevent any potential 
cross-contamination. Successful hydrophobic functionalisation with limited exposed 
hydroxylated gold, was determined by contact angle measurements using ImageJ.28 
5.2.1.2. Synthesis of Gold Nanoparticles (50 nm core) 
 The synthesis of spherical gold nanoparticles was adapted from Huhn et al,29 
with author Mahmoud Soliman kindly providing assistance.30 The procedure itself 
was a modification on Bastus et al31 using a step-wise approach to form the larger 
cores. Firstly, all glassware utilised was thoroughly cleaned to remove any potential 
contaminants, which would disrupt the synthesis, and rinsed multiple times with 
water (18.2 MΩ cm-1). A three-necked round-bottom flask was fitted with a stirrer 
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bar (10 mm, PTFE), a large Liebig condenser on the central neck and septa inserted 
into the other two necks to permit injections into the reaction vessel. This setup was 
installed onto a hotplate (IKA RCT Basic), equipped with a temperature-controlled 
probe (IKA ETS-D5) and a heating block (Radley). 
 Firstly, small gold nanoparticle seeds (18 nm diameter) were synthesised by 
heating (~75°C) the sodium citrate solution (150 mL, 1.32 mM) on a vigorous 
boil (~100°C) for ~10 minutes. Tetrachloroauric acid (1.5 mL, 25 mM) was injected 
into the solution, which resulted in a colour change after 5 minutes from 
straw-yellow to blue and finally a crimson red coloured solution. This solution was 
maintained at a vigorous boil (~100°C) for ~10 minutes, before the temperature was 
reduced (~90°C) and an aliquot taken (labelled g0). 
 An additional volume of tetrachloroauric acid (1 mL, 25 mM) was injected 
into this seeded suspension at a reduced temperature (~90°C) with vigorous stirring 
for ~30 minutes, before two further doses (1 mL, 25 mM) were injected, each with a 
rest period in between (~30 minutes). The solution was then diluted, 90 minutes 
after first gold injection, by removal of nanoparticle suspension (55 mL, labelled g1), 
with water (53 mL, 18.2 MΩ cm-1, Milli-Q) and sodium citrate (2 mL, 60 mM) added 
into the heated solution (~30 minutes). 
 This process of three tetrachloroauric additions (1 mL, 25 mM) followed by 
dilution, occurred four more times which resulted in six aliquots (labelled g1 to g6). 
At each aliquot, the resultant nanoparticle suspension was analysed by 
Ultraviolet-visible (UV-Vis) spectroscopy to determine the gold nanoparticle size by 
their surface plasmon resonance (SPR),32 as shown in Figure S16. After synthesis, all 
particle solutions were refrigerated (~4°C) until use. 
5.2.2. Analytical Methodologies 
5.2.2.1. QCM-D 
 The QCM-D instrument (E4 Q-Sense, Biolin Scientific) utilised throughout this 
chapter was a four-channel setup enabling simultaneous data acquisition across all 
four sensors. Prior to running experiments and before removing crystals, the system 
was cleaned as per the protocols provided by Biolin Scientific. 
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Cleaning 
 A two-step cleaning approach was consistently applied to the QCM-D 
instrument, a daily clean was carried out both before and after experiments, whilst 
a thorough clean was performed when necessary. A daily clean involved installing a 
‘cleaning crystal’, a previously used sensor crystal now deemed unfit for purpose, 
into the flow module. The system was heated to ~35oC, then firstly 
water (18.2 MΩ cm-1) was flowed through at 50 μL min-1 for 60 minutes, followed by 
a 2% sodium dodecyl sulfate (SDS) solution at 50 µL min-1 for 60 minutes, and then 
finally a final water rinse at 100 µL min-1 for 120 minutes. The system was left to air 
dry, before the sample crystals could be installed. A thorough instrument clean 
involved opening the flow modules to clean the seals of the flow modules. The parts 
were submerged in ethanol and sonicated for 5 minutes, dried under argon flow and 
reinstalled into the instrument. This process was performed when necessary, 
monthly or if there were any deviations in performance observed. 
Data acquisition 
 The experimental procedure first required the clean sample crystals to be 
installed into the flow modules, the system was heated to ~21°C and water flowed 
at 50 µL min-1 for 120 minutes to equilibrate the system. Equilibrium was achieved 
when a flat baseline was attained across all the relevant sensor 
harmonics (5s averaging) using the acquisition program (QSoft 401, Biolin Scientific). 
The typical experiment used the flow rate of 50 µL min-1 with the following 
arrangement; water flow (18.2 MΩ cm-1, 20 minutes), buffer rinse (60 minutes), 
HI (60 minutes), buffer rinse (20 minutes), water flow (18.2 MΩ cm-1, 20 minutes), 
and finally the daily cleaning process. 
 The data was processed using QTools (Biolin Scientific), firstly the data was 
cropped to remove the water and cleaning cycles, which were not necessary for 
modelling parameters. Cropped data was then offset to the origin and fitted using 
Sauerbrey and Voigt models. 
5.2.2.2. Raman Spectroscopy 
Raman analysis of the protein adsorbed sensors was carried out using a 
portable probe-based instrument (MiniRam, BWTek), equipped with a red 
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laser (785 nm), all experiments were performed using reduced laser power (75%). 
The sample region was aligned below the laser (785 nm), which was 
optimised (1 s integration time, 1 scan) using the software (BWRam 10). Once the 
conditions and beam position were optimised, ten spectra were co-added at the 
same location, each spectrum consisted of an average of three spectra acquired at 
60 s integration time, this process was repeated at several locations across the 
surface. The acquired spectral data were then processed using Origin (2016). 
Baseline correction was achieved by fitting a 3rd degree polynomial. 
Surface Enhanced Raman Spectroscopy (SERS) 
 The HI adsorbed QCM-D sensors were dried under argon flow, and then 
100 µL concentrated centrifuged gold nanoparticle solution was pipetted onto the 
surface and left for 60 minutes with the excess nanoparticle solution removed by 
filter paper blotting. The sample region was aligned below the laser (785 nm), which 
was optimised (1 s integration time, 1 scan) using the software (BWRam 10). Once 
the conditions and beam position were optimised, ten spectra were co-added at the 
same location, each spectrum consisted of an average of three spectra acquired at 
60s integration time, this process was repeated at several locations across the 
surface. The acquired spectral data was exported (csv) to Origin and processed. 
5.2.2.3. Contact Angle Measurements 
 A droplet (50 µL) of water (18.2 MΩ cm-1) was added to the surface, which 
was then captured using a webcam. The images were then processed by ImageJ,28 
with the contact angle calculated. Representative images of the contact angle 
measurement are shown in Figure S15, which resulted in contact angles of; 47° for 
the piranha cleaned gold, 105° for the C6 functionalised and 109° for the C18 
functionalised surfaces. The results showed that the piranha cleaned gold was 
hydrophilic with contact angle less than 90°, whilst both functionalised surfaces were 
hydrophobic with contact angles greater than 90°. 
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5.3. Results and Discussion 
5.3.1. The effect of pH and surface hydrophobicity on human insulin 
adsorption  
 The adsorption of HI at both pH 2 and pH 7 conditions on C6 and C18 
functionalised gold surfaces was monitored by QCM-D, with representative traces 
(where N>8) as shown in Figure 58. 
 
Figure 58: Representative (N>8) quartz crystal microbalance with dissipation (QCM-D) for human 
insulin (HI) adsorption on (a and b) hexyl (C6) and (c and d) dioctadecyl (C18) functionalised gold 
surfaces at (a and c) pH 2 (20% acetic acid and 137.9 mM NaCl) and (b and d) pH 7 (0.01 M PBS) 
conditions. Solution changes are indicated with (magenta) dashed lines for (i) buffer to HI and (ii) HI to 
buffer. 
 There are significant variations in the QCM-D traces (Figure 58) for the pH 
conditions and the functionalised surfaces studied, with observed differences in both 
adsorbed mass (black) and viscosity (red) traces. 
 The HI adsorbed C6 functionalised surface at pH 2 (Figure 58a) is similar to a 
typical QCM-D trace where upon injection of HI into the system, frequency decreases 
with a corresponding dissipation increase, which is indicative of an adsorbed layer. 
This also correlates with a desorption event attributed to a buffer rinse, as the 
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frequency increases and dissipation decreases. The HI adsorbed C6 functionalised 
surface at pH 7 (Figure 58b) is similar to pH 2 (Figure 58a), with respect to adsorption 
and desorption events but with a larger decrease in frequency which implies a larger 
adsorbed mass, however there are peaks present at the point of solution change.  
 The HI adsorbed C18 functionalised surface at pH 2 (Figure 58c) also shows 
similarity to C6 at pH 2 and a typical QCM-D trace, however there is a larger C18 
frequency decrease which suggests a thicker adsorbed layer. At pH 7 (Figure 58d), 
the frequency decreases further, suggesting an increased adsorbed layer thickness 
than at pH 2. Similarly, to C6 pH 7 (Figure 58b), the peaks located at the solution 
change locations are also present for C18 pH 7 (Figure 58d), which supports the 
assumption that the peaks are associated to the pH 7 conditions as opposed to the 
functionalised surface. As the peaks were present across all the data acquired for 
pH 7, but not for pH 2, the implication is these peaks arise from the HI oligomeric 
state. In both traces (Figure 58b and d), the peaks are observed in both frequency 
and dissipation which is indicative of increased protein mass and viscosity change, 
implying that it is attributed to the HI oligomeric association and dissociation. The 
first peak which is the introduction of HI into the system is likely attributed to HI 
adsorption, dissociation and diffusion on the surface, whilst the second peak 
correlates with the buffer rinse implying reassociation of the HI. 
  verall, there are no observed changes between the “adsorption” and 
“desorption” events in any of the representative traces (Figure 58), as both 
frequency and dissipation remain stable, which implies that no structural 
rearrangement occurs to the adsorbed layer or multi-layer formation. The adsorption 
of HI to the hydrophobically functionalised gold sensor occurs over a very short 
timeframe, therefore unlikely to undergo any extensive structural reorganisation 
without any thermal activation.33 Furthermore, the frequency does not return to 
baseline in any trace, which implies a very rigid HI monolayer adsorbed or residual 
trace amount. The frequency variations across all four traces suggests that both pH 
and surface functionalisation affect the layer thickness, however quantification is 
necessary to ascertain thickness information (5.3.1.1. Quantification of the adsorbed 
human insulin layer thickness, page 180). 
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5.3.1.1. Quantification of the adsorbed human insulin layer thickness 
  The thickness of the adsorbed HI layer on the C6 and C18 functionalised gold 
surfaces was quantified by using both the Sauerbrey and Voigt models, the results of 
which are shown in Figure 59. 
 
Figure 59: Quantification of the adsorbed human insulin (HI) layer thickness on the hexyl (C6) or 
octadecyl (C18) functionalised gold substrate at pH 2 (20% acetic acid and 137.9 mM NaCl) and 
pH 7 (0.01 M PBS) as determined by the (red) Sauerbrey equation or (blue) Voigt model. All data shown 
consisted of N>8, (*) statistical significance was determined by ANOVA with Tukey post-hoc analysis 
at p < 0.05. 
 The adsorbed HI layer thickness as quantified by the Sauerbrey and Voigt 
models (Figure 59) show that the layer thickness differs with respect to; pH 
condition, surface functionalisation and the model used. The mean results show that 
there is a thicker adsorbed HI layer at pH 7 compared to pH 2, across both 
functionalised surface types determined by either Sauerbrey (red) or Voigt (blue) 
models. This increased layer thickness for pH 7 implies that it is the HI oligomeric 
species which adsorbs to the interface, whereas for pH 2 the reduced thickness 
corresponds to monolayer adsorption. The effect of pH on the C18 functionalisation 
highlights that the oligomers provide an increased layer thickness compared to the 
monomers, however this is not observed for the C6 functionalisation. 
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 The C6 functionalisation results in a thinner adsorbed HI layer compared to 
the C18 surface and only a minor increase for pH 7 is observed, which implies that 
there are other factors affecting the HI adsorption other than pH. It is possible that 
the C6 functionalised surface was inhomogeneous or unstable resulting in areas of 
exposed gold, which can destabilise the HI particularly the monomer through 
unfolding as previously reported by Welinder et al.7 Unfolding of the HI monomer, 
will reduce the adsorbed HI layer thickness in both pH conditions. Conversely, the C18 
functionalisation shows a thicker adsorbed HI layer for pH 2, which increases for the 
pH 7 conditions implying that either the C18 functionalisation is more stable or 
homogeneous than C6, or that the increasing alkyl chain length leads to greater 
hydrophobicity thus adsorption.8 Another possible explanation is a result of the 
functionalisation, where the silica microparticles in Chapter 4 were endcapped to 
reduce the potential for hydrophobic collapse,34 which results in the functionalised 
groups falling onto the surface therefore increasing layer thickness. 
 The quantification of adsorbed layer thickness (Figure 59) highlights that the 
Sauerbrey (red) and Voigt (blue) models provide differing layer thickness, although 
the general trends of increased layer thickness for pH 7 and the C18 functionalised 
surface compared to C6 remain true. Layer thickness as determined by Sauerbrey is 
shown to have higher mean values than the Voigt model, which is confirmation that 
the models do not produce comparable results. The Sauerbrey model calculates layer 
thickness using the acquired frequency only, which assumes that the adsorbed layer 
is rigid and a thin film,9  therefore this model is likely overestimating the adsorbed HI 
layer thickness since HI is a soft protein.35 Conversely the Voigt model considers the 
dissipation and is better suited for soft proteins, which implies the ideal modelling 
system for HI. However, as observed with the C6 functionalised surface at pH 2 if HI 
monomers are adsorbing directly to the exposed gold surface then unfolding may 
occur,7 therefore resulting in a rigid thin film that is better suited for the Sauerbrey 
model. 
Overall, the QCM-D results have shown that HI suspended in pH 7 conditions 
results in the largest amount of adsorbed species as shown by the increased layer 
thickness compared to pH 2, as this is likely due to the oligomeric state. An increased 
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thickness for C18 compared to C6, which suggests that either the C6 functionalisation 
is unstable or that the hydrophobicity attributed to alkyl length promotes HI 
adsorption. If the C6 surface is unstable resulting in degradation of the functionalised 
interface thus exposure of the gold surface, then HI distortion is likely to occur as 
evidenced by Welinder et al.7 This can be investigated by using Raman spectroscopy 
to probe whether the disulfide bonding is intact. 
5.3.2. Investigating adsorbed protein structural rearrangement by Raman 
spectroscopy 
 The QCM-D results have shown on average an increased layer thickness for 
the pH 7 samples compared to the pH 2, which likely arises from the HI oligomeric 
state, whilst the C18 functionalised gold surfaces are generally thicker than the C6 at 
both pH conditions. A possible explanation for the difference in layer thickness for 
the functionalised surfaces, with an observed thickness reduction for the C6 surfaces, 
arises from stability of the interface specifically whether the functionalisation was 
inhomogeneous or removed from the surface therefore rending an exposed gold 
surface. Adsorption of HI onto an exposed gold surface, may induce protein unfolding 
because of the gold – sulfur interactions (1.5.1. Protein interaction at the liquid-solid 
interface, page 52), therefore Raman spectroscopy is used here to investigate the HI 
structural features. 
5.3.2.1. The effect of hydrophobic functionalisation on Raman spectroscopy 
 Raman spectra of the three control surfaces; gold, C6 and C18 functionalised, 
with no HI adsorbed are shown in Figure 60. 
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Figure 60: Raman spectra for the control surfaces; (grey) bare gold, and disulfide functionalised 
(green) hexyl (C6) and (blue) octadecyl (C18). 
 The Raman spectra for the gold (grey) and C6 functionalised (green) control 
surfaces (Figure 60) show a flat baseline with limited Raman intensity, whereas the 
C18 functionalised (blue) surface has an overall higher Raman intensity with a sloping 
background. The sloping background for the C18 interface (blue) is indicative of 
fluorescence,36 which implies that the long chain alkyl group contributes to this 
effect. Ideally the observed fluorescence would be resolved by changing the 
excitation wavelength of the laser used,37 however as only a 785 nm probe was 
available this was not possible. Baseline correction of the spectra is therefore 
necessary (5.2.2.2. Raman Spectroscopy, page 176), which results in the normalised 
Raman spectra as shown in Figure 61. 
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Figure 61: Baseline corrected and spectra normalised (490 cm-1) for the control surfaces; (grey) bare 
gold, and disulfide functionalised (green) hexyl (C6) and (blue) octadecyl (C18). 
 Removal of the fluorescence background and normalisation of the control 
surface spectra to the similar 490 cm-1 peak, results in the similar spectra shown in 
Figure 61. Overall there is a lack of signal clarity across the three surfaces, particularly 
the C18 functionalised, which is very noisy and difficult to study. The sharp feature 
present at 1556 cm-1 corresponds to the atmospheric oxygen Raman peak.38 The 
appearance of the atmospheric oxygen and nitrogen Raman peaks are evidence that 
there is a significant lack of Raman signal present on these surfaces, which is 
expected since metals are Raman in-active. 
5.2.2.2. The effect of pH on human insulin adsorption at the functionalised interface 
 Raman spectra for the adsorption of HI at both pH 2 and 7 conditions on the 
C6 functionalised surface is shown in Figure 62. 
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Figure 62: Raman spectra for the adsorbed human insulin (HI) on the hexyl (C6) functionalised gold 
surface at (pink) pH 2 (20% acetic acid and 137.9 mM NaCl) and (green) pH 7 (0.01 M PBS). 
 Raman spectra of the HI adsorbed onto C6 functionalised gold surface at 
pH 2 (pink) and pH 7 (green) shows a strong similarity to the control 
C6 surface (Figure 60). Similarly to the control spectra, there is limited Raman 
intensity for adsorbed HI at either pH 2 or pH 7, as the atmospheric peaks are also 
observed. The corresponding Raman spectra for the adsorption of HI at both 
pH 2 and 7 conditions on the C18 functionalised surface is shown in Figure 63. 
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Figure 63: Raman spectra for the adsorbed human insulin (HI) on the octadecyl (C18) functionalised 
gold surface at (orange) pH 2 (20% acetic acid and 137.9 mM NaCl) and (purple) pH 7 (0.01 M PBS). 
 Equally the Raman spectra of HI adsorbed onto the C18 functionalised gold 
surface (Figure 63) at pH 2 (blue) and pH 7 (red), also resembles the corresponding 
C18 functionalised control surface (Figure 60). The characteristic fluorescence 
background is present in both pH 2 and 7 spectra, with an increased intensity for 
pH 7, which further implies that the fluorescence is a result of C18 functionalisation. 
 The Raman spectra for HI adsorbed to both C6 and C18 functionalised gold 
surfaces regardless of pH conditions is very similar to the control spectra, implying 
that there is trace amount of adsorbed HI, which is confirmed in QCM-D (Figure 59). 
A challenge due to the limited Raman-active species present, is the lack of signal 
intensity or low signal-to-noise, which increases the difficulty in discerning the 
Raman signal thus enhancement is necessary. One method for signal enhancement 
is through surface roughening, however this will damage the sensor therefore 
preventing normal QCM-D operation and influence functionalisation and HI 
adsorption mechanisms at the interface. A better solution is to utilise metallic 
particles onto the surface, in order to exploit the surface enhanced Raman effects 
such as EM or CE. In this research programme, gold nanoparticles with a citrate shell 
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are preferable since the core correlates to the gold substrate thus reducing any 
potential variability arising from different substrate properties. 
5.3.2.3. The need for surface enhanced Raman scattering (SERS)  
 In this work, gold nanoparticles with a citrate shell were used to enhance the 
Raman intensity by SERS which resulted in a ten-fold increase in Raman intensity. The 
SERS spectra for the HI at pH 2 or pH 7 conditions adsorbed to C6 or C18 functionalised 
surfaces, is shown in Figure 64 and the non-baseline corrected or normalised in 
Figure S17. 
 
Figure 64: Surface enhanced Raman spectra (SERS), which have been baseline corrected and 
normalised (1000 cm-1) for the adsorbed human insulin (HI) on the hexyl (C6) or octadecyl (C18) 
functionalised gold surface at either pH 2 (20% acetic acid and 137.9 mM NaCl) or pH 7 (0.01 M PBS) 
conditions. (pink) C6 pH 2, (green) C18 pH 2, (orange) C6 pH 7 and (purple) C18 pH 7. 
 The use of gold nanoparticles to generate SERS spectra, has a clear 
enhancement on the Raman spectra (Figure 64) with elucidation of structural 
features for the adsorbed HI samples on the; C6 pH 2 (pink), C18 pH 2 (green), 
C6 pH 7 (orange) and C18 pH 7 (purple) surfaces. The SERS spectra (Figure 64) have 
been baseline corrected and normalised to the phenylalanine peak (1000 cm-1) to 
correlate the wavelength shifts and intensity changes for the adsorbed HI samples. It 
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is apparent from the normalisation that the Amide I band (1650 cm-1) varies in 
intensity across all four samples, however discrimination of the various modes 
contributing to this peak is not suitable due to the lack of signal and resolution. The 
key characteristic peaks of the SERS spectra are correlated with literature as detailed 
in Table 3, with additional assignments provided in Figure S18. 
Table 3: The key vibrational assignments for the SERS Raman spectra that differentiate between the 
four samples; adsorbed human insulin (HI) on the hexyl (C6) or octadecyl (C18) functionalised gold 




pH 2 pH 7 
C6 C18 C6 C18 
500 – 530 S – S stretch39 - 510 510 510 
640 Tyrosine (Tyr)39 645 645 645 645 
830 – 853. Tyr stretch and ring breathing39,40 825, 855 825, 855 825, 855 825, 855 
938 – 940 C – C skeletal α-helical stretch39,40 950 950 950 950 
1007 Phe stretch and ring breathing39,40 1003  1003, 1003  1003  
1028 Phe stretch and ring breathing39,40 1023 1027 1027 1027 
1050 β-sheet stretch (Amide III)40 - - 1040 1040 
1066 – 1162 C – N stretch39,40 1161 1161 1161 1161 
1209 Tyr - 1208 1208 1208 
1276 - 1277 
Tyr/Phe, Amide III α or random 
coil, CH deformation39,40 
1285    
 
 The key Raman vibrational modes of the adsorbed HI samples (Table 3), 
highlight the structural differences between the samples with respect to the pH and 
functionalised surface. The vibrational modes associated to HI are present in the 
spectra therefore it is evident that the Raman spectroscopy is probing the HI 
adsorbed layer and any wavelength shifts are associated to differences in the HI 
structure.41,42 There is a noticeable spectral deviation between the surface 
functionalisation as shown within the disulfide region (~510 cm-1), specifically its 
absence within the HI adsorbed to the C6 surface at pH 2. The disulfide region is 
significant because the HI monomer consists of three disulfide bonds connecting the 
cysteine residues, which are retained during fibrillation43,44, but have been shown to 
fragment upon adsorption to bare gold.7 The absence of the disulfide Raman signal 
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for the C6 surface at pH 2 indicates that the HI monomer has adsorbed to the gold 
surface, which correlates with the QCM-D data (Figure 59) showing that the C6 
functionalised surface at pH 2 resulted in the thinnest adsorbed HI layer. The 
presence of the disulfide region in the C18 surface at pH 2, supports the implication 
that the C6 functionalisation is unstable or inhomogeneous thus exposing the bare 
gold substrate allowing HI monomer adsorption. Further evidence that the HI 
adsorbed on the C6 surface at pH 2 is structurally different to the other samples is 
the absence of the tyrosine peak (1209 cm-1) which implies the tyrosine residue is 
located in a different environment to that other the other HI adsorbed to C6 at pH 7 
or C18 surfaces. 
 Differences in the secondary structure of HI adsorbed to the C6 functionalised 
surface at pH 2 are also observed in the Amide III region (1220 – 1300 cm-1), which is 
studied in lieu of the Amide II region (1520 – 1570 cm-1) because this is not observed 
due to the weak signal from near-IR excitation (785 nm),44,45 and the Amide I 
region (1640 – 1678 cm-1) is suppressed as an effect of SERS.46 There is a sharp 
α-helical peak (1276 – 1277 cm-1) for the C6 functionalised surface at pH 2 that is not 
observed for the other surfaces, which implies α-helical structural rearrangement or 
alignment on the surface as the surfaces have not been thermally activated.33 These 
results overall show that the adsorbed HI on the C6 functionalisation at pH 2, is 
structurally different to the other three conditions studied, which supports the 
QCM-D data that the C6 functionalisation layer is unstable as shown by HI monomers 
adsorbing to the exposed gold surface and unravelling.7 
 The other three surfaces are not spectrally identical, with deviations 
associated to the p  conditions specifically the presence of a β-sheet stretch 
peak (1050 cm-1) for the C6 and C18 functionalisation at pH 7. The shape of the C-N 
peak (1066 – 1162 cm-1) also varies with pH for both C6 and C18 functionalisation, with 
a singlet shape for pH 2 and doublet for pH 7. These spectral differences indicate that 
the adsorbed HI is of different oligomeric states for pH 2 and pH 7, which is consistent 
with the results obtained by QCM-D. 
 In summary, these results show that although Raman spectroscopy is suitable 
to probe the adsorbed HI layer on hydrophobically functionalised gold surfaces, SERS 
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is necessary in order to characterise the surface. The SERS spectra have shown that 
there are subtle differences across all four sample sets, which indicate that the 
hydrophobic functionalisation (specifically alkyl chain length) and pH affect the 
adsorbed HI structural arrangement. The C6 functionalised surface, specifically at 
pH 2, appears to be unstable or inhomogeneous as shown by the absent disulfide 
bonding region and a defined α-helical peak (1276 – 1277 cm-1) which correlates with 
the QCM-D data implying a proportion of the adsorbed HI is to an exposed gold 
surface. It is likely that the spectroscopic profile is an amalgamation of structural 
features consistent with HI adsorbed to the hydrophobic C6 functionalisation and 
hydrophilic bare gold, with the latter affecting HI stability. Conversely the C6 
functionalised surface at pH 7, does not exhibit the same characteristics as pH 2 but 
similar to the C18 functionalised surface, this is likely due to the oligomeric state of 
the HI adsorbed as the hydrophobic domain is buried within the oligomer thus 
protected from fragmentation. The C18 surface functionalisation spectra are similar, 
with differences arising from the pH conditions. 
 Differences in the pH conditions are observed in the SERS spectra (Figure 64), 
where both pH 7 show a Raman feature (1050 cm-1) that is not within the pH 2 
spectra. This feature corresponds to the β-sheet stretch,40 which implies that the pH 7 
adsorbed HI layer consists of oligomeric species. This confirms that the HI is of a 
different oligomeric state at pH 2 and pH 7 conditions, which correlates with the 
QCM-D that implicated the thicker HI adsorbed layers for pH 7 were attributed to 
oligomeric adsorption. 
 Overall, the Raman spectra are still noisy and present limited opportunities 
to study the surfaces due to the acquisition parameters, as any increase in acquisition 
times or laser power led to degradation of the sample through localised heating.47 
The excitation wavelength used (785 nm) also limited the investigation as the 
samples exhibited a fluorescence background, thus baseline correction was 
necessary to reduce this effect from overwhelming the spectra. Ideally other 
techniques, such as change in wavelength, would be used to avoid or reduce this 
effect in future. 
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5.4. Conclusion 
 The work in this chapter has shown that the hydrophobically 
functionalised (C6 or C18) gold surfaces differ in the adsorption of HI with respect to 
pH 2 and pH 7 conditions. Observation of the HI adsorption layer to the surface by 
QCM-D showed greater HI adsorption for C18 than for C6 functionalised surfaces at 
both pHs, which implied that the increased alkyl length promoted adsorption. A 
similar trend was also observed with the pH conditions, where pH 7 had an increased 
adsorbed HI layer thickness as opposed to C6, which was associated to the oligomeric 
state. Conversely, the C6 functionalised surface at pH 2 conditions resulted in thin 
layers, which the modelling showed were a rigid layer because of HI unfolding. 
 Raman spectroscopy was used to investigate structural changes of the 
adsorbed HI, however the results showed minimal Raman intensity therefore SERS 
was necessary. The Raman spectra corresponded with the QCM-D data, with the 
adsorbed C6 surface at pH 2 conditions having lost the disulfide bonding region which 
confirmed that the HI had unfolded on adsorption to the surface. Conversely the 
thicker adsorbed layer associated to pH 7 adsorption, exhibited a β-sheet feature 
which was not present for pH 2, therefore implying oligomeric adsorption. The 
oligomeric adsorption is correlated with the two strong peaks in the frequency and 
dissipation shown in QCM-D at pH 7, and attributed to the structural reorganisation 
of the oligomeric species on adsorption. 
  




Figure S15: Representative images of the samples used for contact angle measurement, (a) piranha 
cleaned gold, (b) C6 functionalised and (c) C18 functionalised. 
 
Figure S16: The Ultraviolet-Visible (UV-Vis) spectra of the aliquots (g0 – g6, pink – green) from the gold 
nanoparticle (50 nm) synthesis, showing the increasing gold nanoparticle diameter size with respect 
to increasing surface plasmon resonance (SPR) wavelength. The synthesis was terminated at 532 nm 
corresponding with 50 nm diameter particles. 
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Figure S17: Non-baseline corrected or normalised SERS spectra for the four representative samples; 
(red) C6 and (black) C18 at pH 2 (20% acetic acid and 137.9 mM NaCl), with (green) C6 and (blue) C18 at 
pH 7 (0.01 M PBS). 
  





pH 2 pH 7 
C6 C18 C6 C18 
500 – 530 S – S stretch39 - Present 
600 – 620 Phe or COO- wag39,40 Present 
640 Tyr39 Present 
662 – 687, 
705 – 765, 
C-S stretch39,40 Not present 
830 – 853. 
863 
Tyr stretch and ring breathing39,40 Low Present 
938 – 940 C – C skeletal α-helical stretch39,40 Present 
959 – 963 C – C skeletal β-sheet stretch39,40 Present 
1007, 1028 Phe stretch and ring breathing39,40 Low Present 
1050 β-sheet stretch (Amide III)40 - Present - Present 
1066 – 1162 C – N stretch39,40 - Present - Present 
1121 NH3+ deformation40 Possibly 
1130 CH2 stretch Possibly 
1150 Phe Present 
1151 NH3+ deformation40 Possibly 
1209 Tyr Low Present Low Present 
1220 – 1300 Amide III α β 
1236 
Tyr/Phe, Amide III β or random coil, C  
deformation39 
- Present 
1276 - 1277 
Tyr/Phe, Amide III α or  random coil, C  
deformation39,40 
Present Possibly 
1311 CH2 wag40 Possibly 
1316, 1343 CH deformation39 - 
1396 COO- sym stretch39 - Present 
1400 – 1480 CH2 stretch, scissoring or bending39,40 Shoulder Present shoulder 
1494 Tyr39 Present 
1560 COO- asym stretch39 Possibly 
1584 - 1585 Phe39 Possibly 
1590 Tyr39 Possibly 
1594 COO- asym stretch40 Possibly 
1630 – 1700 Amide I39 - 
1750 Carbonyl48 - Present 
Figure S18: Comparison of typical protein adsorbed SERS assignments available in literature with the 
experimentally acquired data for both functionalised interfaces hexyl (C6), octadecyl (C18), with 
adsorbed human insulin from acidic (pH 2) and neutral (pH 7) conditions. 
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Chapter 6: Interrogating Human Insulin Adsorption on 
Hydrophobically Functionalised Gold Interfaces with Infrared 
Scanning Near-field Optical Microscopy (IR-SNOM)  
6.1. Introduction 
 For the work in this chapter to be possible, a collaboration with 
Mr Conor Whitley (CW), Physics Ph.D Student, Department of Physics, University of 
Liverpool, was established. I (Nathan Cumberbatch, NC) formulated the project 
outline, prepared specimens and evaluated the data, whilst Mr Whitley performed 
the infrared-scanning near-field optical microscopy (IR-SNOM) measurements. 
 The objective of this chapter is to study analogous samples representative of 
those used in Chapter 5 and probe the secondary structure further using microscopic 
techniques. Importantly the results obtained will be the first study of adsorbed 
human insulin (HI) on functionalised gold substrates to be resolved using IR-SNOM 
instrumentation in reflection with a quantum cascade laser (QCL). This technique will 
be used to characterise the adsorbed HI layer across the surface to determine 
whether the surface architecture is homogeneous, any preferential adsorption sites 
exist across the hydrophobic interface and any influence attributed to the oligomeric 
state. 
 The previous chapters have shown that all hydrophobic interfaces are not 
equal, Chapter 4 investigated the effects of functionalised mesoporous silica 
microparticles on the HI amyloid-like fibrillation pathway, whilst adsorption was 
similar the fibrillation kinetics and resultant fibril morphology were disrupted. In 
Chapter 5 the HI adsorption state at a functionalised gold surface was studied, and 
while protein changes were observed between the functionalised interfaces there 
was no definitive evidence that the critical nucleation phase was induced by the 
hydrophobic adsorption. This previous work did not definitively conclude how 
homogeneous the adsorbed HI layer was and thus no evidence for divergent 
fibrillation routes was determined. This chapter aims to combine spectroscopic and 
microscopic methods to assess the secondary structural features present relative to 
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surface position, thus determining whether preferential structural rearrangement is 
derived from hydrophobic sites. 
6.1.1. What is infrared scanning near-field optical microscopy? 
 Optical microscopy is an essential tool within many fields of science, because 
it is non-destructive, fast and able to resolve objects which cannot be viewed with 
the naked eye. There have been extensive uses for optical microscopy some of which 
are; semiconductor, education, food industry, pharmaceuticals, forensics, 
biochemistry, medical and pathology.1 Another term for optical microscopy is a light 
microscope, because visible light is utilised to illuminate the specimens, however this 
poses an issue. The resolution of optical microscopy is physically limited not only by 
the quality of the optics but also by the diffraction limit, defined in 1873 ‘as the 
smallest resolvable distance between two points may never be smaller than half the 
wavelength of the imaging light’.2 For visible light this results in an obtainable 
resolution of ~200 nm,3 this is on a similar scale to cell nuclei and any smaller 
structures are difficult to resolve. 
 The challenge to break this diffraction limit, led to the development of 
near-field imaging which demonstrated spatial resolution of λ/60. Scanning 
near-field optical microscopy (SNOM) was established as a means of imaging a 
surface through use of an optical fibre with a small aperture (a < λ), which when 
brought close enough to the sample acquired images by illumination or light 
collection from the surface.4,5 
 Recent SNOM instrumentation developments are apertureless SNOM; where 
a metal cantilever tip in the near-field is used to influence the far field, and scattering 
SNOM which scatters the near-field component of a sample illuminated and imaged 
within the far field. Amenabar et al6 have previously reported use of a scattering 
SNOM to probe two-year-old insulin, on a gold film adhered to silicon substrate. The 
collaborators for this project have invested in an aperture SNOM as it more closely 
aligned to their purpose of studying soft biological samples.7 SNOM has been 
previously used with visible light, however the adaptability of visible to IR light is most 
significant for biological samples of interest, the IR wavelengths involved are on the 
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order of the wavelength of visible light. By circumventing the diffraction limit, sub 
wavelength imaging can give a greater insight into the sample. Aperture IR-SNOM 
has previously been applied to organic thin films8 and keratinocyte cells9–11 from 
human skin exhibiting successful imaging at length scales much less than the 
wavelength of IR light. 
 The prerequisites to obtain these IR images are an intense, tuneable IR source 
which previously required a free electron laser (FEL) whereby synchrotron radiation 
was emitted from an oscillated electron beam in a laser cavity as the lasing 
mechanism, with the capability of very high powers over a range of wavelengths.12–
14 This IR-SNOM had been previously been used for the imaging of oesophageal tissue 
biopsy samples13,15,16 and cell lines.7 Ingham et al7 showed a direct comparison 
between images of the same cancer cell in both the SNOM and an imaging Fourier-
transform IR (FTIR) microscope. This showed the strength and weakness of the two 
techniques but how they complement each other can yield information relating to 
the chemical structure of biological systems. 
 Quantum cascade lasers (QCL) are commercially available highly tuneable 
lasers with high optical power output and viable for room temperature operation, 
which have previously been used in a variety of applications.17,18 Discrete frequency 
infrared (DF-IR) methods have initially evaluated to determine the capability of 
wavelengths as analytical tools.19–21 Recent developments have coupled the QCL with 
IR imaging to study tissue samples for high throughout as a means for clinical use22,23 
and has been recently reviewed.24,25 
 The collaborators for this project, Smith et al15, have previously established a 
proof-of-principal concept that the QCL is a suitable alternative light source to the IR 
FEL by demonstrating images acquisition at four wavelengths within the Amide I of 
the protein using the SNOM in transmission mode. This thesis chapter’s main 
objective is to provide evidence that the same IR-SNOM apparatus can also be 
utilised in reflection mode and thus these are the first ever images obtained by this 
method. 
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 The Amide I region (1700 – 1600 cm-1), represented in Figure 65 is derived 
from the results of Susi and Byler,26,27 signifies the contribution of four Gaussian 
peaks associated to; (left to right) anti-parallel β-sheets (red), random coils (green), 
α-helices (blue) and parallel β-sheets (red). The QCL is able to obtain a narrow 
bandwidth (1 cm-1) as opposed to the larger IR-FEL bandwidth (20 cm-1), therefore 
allowed the acquisition of the three discrete wavenumbers (Figure 65, magenta 
dashed lines). 
 
Figure 65: The (black) Amide I (1700 – 1600 cm-1) region demonstrating the individual secondary 
structural contributions of; (red) anti- / parallel ß-sheets, (green) disordered structures and 
(blue) α-helices. The (magenta) four wavenumbers shown are attributed to the collaborators previous 
work for SNOM in transmission mode. Adapted from Jabs et al.28 
The purpose of this chapter is to acquire spectral information of the adsorbed 
HI layer, therefore only three of the wavelengths were utilised here; anti-parallel 
β-sheets (1689 cm-1), α-helices (1651 cm-1) and parallel β-sheets (1626 cm-1),29 as 
shown in Table 4. 
Table 4: Amide I wavenumbers probed by the infrared-scanning near-field optical 
microscopy (IR-SNOM) and the corresponding secondary structure feature. 
Wavenumber / cm-1 Secondary structure features 
1689 Anti-parallel β-sheet 
1651 α-helix 
1626 Parallel β-sheet 
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6.2. Materials and Methods 
 This chapter probes the HI adsorbed layer, which was prepared similarly to 
Chapter 5, therefore a brief outline of the sample preparation is written here. 
6.2.1. Sample Preparation 
 Pre-treated HI (10 mg/mL) suspended in either pH 2 (20% acetic acid and 
137.9 mM sodium chloride) or pH 7 (PBS) conditions, were adsorbed to hydrophobic 
functionalised gold substrates (dihexyl and dioctadecyl disulfide). The controls (gold 
and functionalised interfaces) and samples (adsorbed surfaces) were air-dried, 
mounted onto a glass slide and analysed using microscopic methods; IR-SNOM and 
optical microscopy. 
6.2.2. Infrared scanning near-field optical microscopy (IR-SNOM) 
 The IR-SNOM instrument utilised throughout this chapter is represented in a 
schematic in Figure 66. 
 
Figure 66: Schematic of the infrared-scanning near-field optical microscopy (IR-SNOM) operating in 
(solid line) reflection mode for the (red) IR beam from the Quantum Cascade Laser (QCL) onto the 
(purple) sample which is placed on a (grey) slide then mounted on a bidirectional x-y stage. The 
reflected light is collected into the (green) fibre and detected by the nitrogen cooled mercury cadmium 
telluride detector. Figure adapted from Smith et al.15 
 As illustrated in Figure 66, the IR SNOM measurements could be acquired in 
either reflection or transmission modes, dependent upon the initial mirror position. 
The IR-SNOM is mounted onto an inverted optical microscope (IX73, Olympus) 
however due to the restrictions of the gold substrate, which was highly reflective but 
non-transparent, this could neither be used to locate sample positions or for the 
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current transmission mode. The sample locations were obtained using a portable 
microscope (USB 400x microscope, Maplin) and the reflection mode used to collect 
IR light. 
 The mounted samples, described previously, were installed onto a 
bidirectional (x-y plane) piezo scanning stage. A cleaved (6 µm) IR transmitting fibre 
was inserted into a corresponding unidirectional z-piezo stage, situated directly 
above the centre of the sample piezo stage. The sample was then rastered with 
respect to the fibre tip (Figure 67), whereby shear-force feedback maintained a 
constant tip-to-sample distance, at a rate of 20 pixels per second. 
 
Figure 67: A cleaved tip, for the IR-SNOM, approaching the surface of a cleaned gold substrate. 
 A quantum cascade laser (QCL, MirCat, DRS Daylight Solutions, San Diego 
USA) in pulse mode (80 – 120 kHz repetition rate) was utilised as the mid-IR light 
source (~1965 to 1145 cm-1). The laser intensity was altered using the pulse duration, 
which was set at 500 – 800 ns for the data presented in this research programme. 
The QCL was calibrated by using a polystyrene calibration specimen (National 
Institute of Standards and Technology), scanning the QCL wavelength while recording 
the IR through the fibre in transmission mode. 
 The reflected signal from the sample was transmitted through the aperture 
fibre and a liquid cooled mercury-cadmium-telluride (MCT) detector collected the 
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transmitted IR-light at each pixel. The shear-force topographical data, was 
simultaneously acquired as the fibre moves along the surface (feedback loop set to 
90% of the applied voltage) whereby the piezoelectric component resisted the 
change as the tip desired to approach the surface thus producing the topographic 
images. As the topography data was collected simultaneously in situ to the spectral, 
this allowed any structural information to be concordant with the sample height 
presented within the topological data. The piezo stage moves in such a way that the 
SNOM collects a forward and backward scan over the same area such that a duplicate 
image is obtained on each experiment. 
6.2.2.1 Reproducibility of IR-SNOM Images 
 A potential concern for the IR-SNOM was the reproducibility of the system 
over time, particularly with respect to localised heating of the sample and the 
surrounding environment. To eliminate these concerns, the IR-SNOM was operated 
on the exact same area which resulted in four scans as shown in Figure 68. 
 
Figure 68: IR-SNOM images for the same location, (a – d) imaged sequentially. 
 The four scans of the same area (Figure 68) shows that there are no 
discernible differences between the four panels therefore no observed changes as a 
function of time. It was therefore determined that the system is a reliable instrument 
due to the acquisition of four very similar images of the same area with no observed 
differences associated to sample damage. In this research programme a minimum of 
N=8 images were taken for each substrate. 
6.2.2.2. Data Processing 
 The topography and IR-SNOM images have been creep corrected to correct 
for the known non-linearity in the x-y piezo stage30 then normalised to compensate 
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for the different laser power and lock-in settings. Images were prepared using 
Matlab. 
6.2.2.3. Histogram Processing 
 To attempt to quantify the images from the IR-SNOM, each image was 
converted into a histogram using MatLab. The in-built histogram function was 
used with an automatic number of bins and plotted using the same x and y scale to 
make it easier to compare values and are shown in Figure 77. The histograms without 
plotting on the same scale are shown in Figure S20. 
6.2.3. Optical Microscopy  
 The mounted samples, for the IR-SNOM, were installed onto the optical 
microscope (BX51, Olympus) stage, and imaged at all four objectives (x4, x10, x20 
and x40). Polarisation was also shifted, for certain samples at objective 
magnification (x40). 
6.2.4. Contact Angle Measurements 
 A droplet (50 µL) of water (18.2 MΩ cm-1) was added to the surface, which 
was then captured using a webcam. The images were then processed by ImageJ,31 
with the contact angle calculated. Representative images of the contact angle 
measurement are shown in Figure S19, which resulted in contact angles of; 58° for 
the piranha cleaned gold, 108° for the C6 functionalised and 107° for the C18 
functionalised surfaces. The results showed that the piranha cleaned gold was 
hydrophilic with contact angle less than 90°, whilst both functionalised surfaces were 
hydrophobic with contact angles greater than 90°. 
6.3. Results and Discussion 
 The main objective for this chapter was for the collaboration to provide 
evidence that IR-SNOM has sub-micron imaging potential for biochemical 
applications. For the physics perspective (CW) was it possible to couple the QCL with 
the correct optics to enable the light-path in reflection mode and attain suitable 
images. For the chemistry perspective (NC) to probe the biochemistry of HI adsorbed 
on functionalised gold surfaces to assess the secondary structural features present 
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relative to surface position, thus determining whether preferential structural 
rearrangement is derived from hydrophobic sites. 
6.3.1. Changing the optics of the IR-SNOM 
 Since the IR-SNOM used in this research programme was developed for use 
on the FEL on the Accelerators and Lasers in Combined Experiments (ALICE) beamline 
at Daresbury as its Mid-IR light source it had a complicated optical beam path.32 The 
initial experiments to test whether a QCL could replace the FEL as the light source 
utilised the same beam path and optics.15 When the Weightman group purchased 
the MirCat QCL and brought the IR-SNOM to Liverpool then the optics were simplified 
by removing the polarisers and replacing the ZnSe lenses with an off-axis parabolic 
gold coated mirror, which focuses the IR beam without making the focal length of 
the laser spot wavelength dependant. This was done successfully and used for the IR-
SNOM in transmission mode, however in reflection mode it was not as simple.  
To develop an optical beam path for the IR light in reflection two major 
considerations have to be taken into account, (i) the focal length such that the beam 
is tightly focused onto the sample below the fibre and (ii) the angle at which light hits 
the sample. The success of the parabolic mirror in transmission mode led to the 
design of a custom-made off-axis parabolic mirror which not only should focus the IR 
light at the fibre tip but hit the sample at the Brewster angle (15˚ of horizontal) for 
maximum collection of light at the tip. This mirror was installed, and IR light was 
successfully collected at the MCT enabling the second part of the collaboration to 
proceed with imaging of the HI on functionalised gold substrates. 
6.3.2. Imaging the control surfaces with reflection IR-SNOM 
 It was first necessary to determine whether the controls (gold substrate only 
and alkyl functionalised surfaces only) affect the resulting SNOM images, this section 
therefore is provided to support any conclusions that the results obtained are directly 
attributed to the adsorbed insulin layer as opposed to the substrate or 
functionalisation thereof.  
 The images from the specimens, both substrates and adsorbates, are 
presented in four-panel figures which are acquired from the same region; 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 6 
Page 206 
(a) shear-force topography and (b, c, d) three IR images. The three IR images are 
acquired at the three wavenumbers which correspond to secondary structural 
features; (b) anti-parallel β-sheets at 1689 cm-1, (c) α-helices at 1651 cm-1 and 
(d) parallel β-sheets at 1626 cm-1. A non-hydrophobically functionalised or HI 
adsorbed gold substrate, which had been piranha cleaned, was first analysed by 
IR-SNOM as shown in Figure 69. 
 
Figure 69: IR-SNOM images of a 500 µm  500 µm area of the gold substrate only; (a) shear-force 
topography, (b) 1689 cm-1, (c) 1651 cm-1 and (d) 1626 cm-1. 
 In Figure 69, a sloped gradient (from left to right) of decreasing shear-force 
topography and IR image maps for three wavenumbers is observed for the gold-only 
control over a large area (2.5 x 1005 µm2). The colour scaling used provides a strong 
contrast across all four images (Figure 69a – d), which implies content, however the 
images are consistent with no profound features therefore suggesting a control 
surface. The observed tilt in the images is often seen in scanning probe microscopy, 
but here the images have not been processed to correct for this.33 The clear surface 
shown in the images with no adsorbed species present or IR-activity is consistent 
with the expectation that a piranha cleaned gold substrate has no adsorbed species. 
This consistent imagery shows promise that the IR-SNOM in reflection mode can be 
used to image the samples. Imaging the functionalised-only control samples are the 
next priority, to investigate whether the functionalisation provides a response in the 
IR-SNOM. The hexyl-functionalised (C6) gold substrate was also imaged by IR-SNOM, 
as shown in Figure 70. 
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Figure 70: IR-SNOM images of a 500 µm  500 µm area of the hexyl-functionalised (C6) gold substrate 
only; (a) shear-force topography, (b) 1689 cm-1, (c) 1651 cm-1 and (d) 1626 cm-1. 
 Similarly to the gold-only control IR-SNOM images (Figure 69), the C6 
functionalised-only control (Figure 70) also displayed a consistent and clear surface, 
which implied that there no adsorbed species or IR-activity present on the surface. 
There are image banding present in the IR-SNOM images, particularly observed for 
the 1626 cm-1 (Figure 70d) wavelength, which is likely attributed to the challenges 
faced with imaging using a coherent laser source as it provides a diffraction 
pattern (coherence fringes).34 However, the C6 functionalised-only control also 
shows that the functionalisation can be used as a substrate for IR-SNOM in reflection 
mode. The octadecyl-functionalised (C18) gold substrate was also imaged by 
IR-SNOM, as shown in Figure 71. 
 
Figure 71: IR-SNOM images of a 500 µm  500 µm area of the octadecyl-functionalised (C18) gold 
substrate only; (a) shear-force topography, (b) 1689 cm-1, (c) 1651 cm-1 and (d) 1626 cm-1. 
 The C18 functionalised-only control exhibits consistent and clear surface 
topography (Figure 71a) as previously observed for the gold-only (Figure 69a) and 
C6-only (Figure 70a) controls. There is a variable colour contrast across the three 
IR-SNOM images (Figure 71b – d), which implies content on the surface, however 
similarly to the gold-only images this is due to the scaling used. The consistent 
IR-SNOM images obtained for the C18 functionalised-only control surface, shows that 
this functionalisation is also suitable as a substrate for IR-SNOM in reflection mode. 
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 Overall, the control surfaces are shown to be suitable for use as substrates in 
IR-SNOM, as they exhibit clear and consistent surface topography and IR-SNOM 
imagery, with no adsorbed species or IR-activity. The colour scaling used within the 
spectral images, can portray differences however these differences are attributed to 
colour scaling as they are scaled from the individual minimum to maximum 
absorbance values. 
6.3.2.1. Optical microscopy of the control surfaces 
 In addition to the IR-SNOM, optical microscopy images of the surface were 
acquired (Figure 72) although these regions do not correspond to the regions studied 
above however, they are representative of the surface. 
 
Figure 72: Optical microscopy images acquired at x20 magnification of the controls; (a) gold, (b) C6 and 
(c) C18 functionalised surfaces. No adsorbed species are observed in any of the optical images. 
 The optical images acquired (Figure 72) correlate with the IR-SNOM images 
acquired previously (Figure 69, Figure 70 and Figure 71) whereby there are no 
observed adsorbed species present at the surfaces, which was to be expected. 
Optical microscopy however does appear to show a dull orange colour for the larger 
functionalisation (C18 surface, Figure 72c) as opposed to the other surfaces 
microscopically attained, which exhibited a bright orange colour. There were no 
apparent differences observed visually, therefore these colour changes are more 
likely to be an effect of the microscopic illumination and thus contrast balance. 
6.3.3. Imaging the human insulin adsorbed surfaces with reflection IR-SNOM 
 The previous section demonstrated that disulfide functionalisation does not 
affect the IR-SNOM images, therefore enabling the objective to be pursued; 
acquisition of the first reflection IR-SNOM images of HI at a hydrophobic 
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functionalised gold surface. The data presented in this thesis has been subsequently 
confirmed with additional images and these did not change the interpretation. 
6.3.3.1. The hexyl-functionalised (C6) surface 
Adsorbed with human insulin at pH 2 
 Following confirmation that the hydrophobically functionalised surfaces and 
gold substrate were suitable for IR-SNOM in reflection mode, the first sample studied 
was HI adsorbed on C6 functionalised surface at pH 2, as shown in Figure 73. 
 
Figure 73: IR-SNOM images of a 150 µm  150 µm area of the hexyl-functionalised (C6) gold substrate 
with human insulin (10 mg/mL, HI) adsorbed at acidic conditions (pH 2); (a) shear-force topography, 
(b) 1689 cm-1, (c) 1651 cm-1 and (d) 1626 cm-1. 
 The IR-SNOM images of the C6 functionalised surface at pH 2 (Figure 73) 
appears to show that this sample was inhomogeneous. The topography (Figure 73a) 
shows this inhomogeneity with a sharp transition between white and black, which is 
correlated with a boundary in the IR-SNOM images (Figure 73b – d). The IR-SNOM 
images for the 1689 cm-1 and 1626 cm-1 (Figure 73b and d) show regions of β-sheet 
structure on the left side of the image with decreased absorbance shown on the right 
of the image. This is contrasted with 1651 cm-1 (Figure 73c) which shows the opposite 
trend, regions of α-helical structure where there is reduced absorbance for the 
β-sheet structures. These observations imply that there are two distinct regions of 
differing structural features of HI on this surface. 
 Chapter 5 showed using QCM-D and Raman that the C6 functionalisation at 
pH 2 was unstable, as evidenced through a reduced adsorbed HI layer thickness 
compared to the other surfaces and the loss of the disulfide bonding region in Raman. 
It is possible that the IR-SNOM images presented (Figure 73) demonstrate that the 
functionalisation has been removed on the left section, exposing the gold surface, 
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which results in a reduced absorbance associated with α-helical structure due to 
insulin distortion.35 
Adsorbed with human insulin at pH 7 
 The next sample to be studied was the C6 functionalised surface at pH 7, as 
shown in Figure 74. 
 
Figure 74: IR-SNOM images of a 150 µm  150 µm area of the hexyl-functionalised (C6) gold substrate 
with human insulin (10 mg/mL, HI) adsorbed at neutral conditions (pH 7); (a) shear-force topography, 
(b) 1689 cm-1, (c) 1651 cm-1 and (d) 1626 cm-1. 
 The IR-SNOM images of the C6 functionalised surface at pH 7 (Figure 74) 
contrasts with the pH 2 images (Figure 73), as the pH 7 topography (Figure 74a) 
shows a relatively even topography which implies a consistent adsorbed HI coverage 
across the surface. The IR-SNOM images (Figure 74b – d) are comparable, with 
contrasting 1651 cm-1 and 1626 cm-1 (Figure 74c and d) areas, which implies regions 
of α-helices with reduced absorbance whilst the same regions show increased 
absorbance for parallel β-sheets. There is an overall reduced absorbance for the 
1689 cm-1 (Figure 74b) as shown with limited dark areas, which implies reduced 
anti-parallel β-sheet structure present on the surface. 
 The presence of the α-helical content, contrasts with the pH 2, implying that 
the surface is not degraded in this sample and the adsorbed HI is not degraded by 
the surface functionalisation. As discussed in Chapter 5, the QCM-D measured 
thicker HI adsorbed layers for the pH 7 conditions which were attributed to the HI 
adsorption in the oligomeric state, therefore the adsorbed HI layer likely consists of 
both structural features as shown. 
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6.3.3.2. Octadecyl functionalised (C18) surface 
Adsorbed with human insulin at pH 2 
 Figure 75 shows the IR-SNOM images of HI adsorbed on the C18 functionalised 
surface at pH 2. 
 
Figure 75: IR-SNOM images of a 150 µm  150 µm area of the octadecyl-functionalised (C18) gold 
substrate with human insulin (10 mg/mL, HI) adsorbed at acidic conditions (pH 2); (a) shear-force 
topography, (b) 1689 cm-1, (c) 1651 cm-1 and (d) 1626 cm-1. 
 The IR-SNOM images of the C18 functionalised surface at pH 2 (Figure 75) 
show a similar topography (Figure 75a) to that of the C6 functionalised surface at 
pH 2 (Figure 73a). This topography shows contrast, which would imply regions of 
variation in the thickness of adsorbate, however the topography areas do not have 
corresponding regions in the IR-SNOM images (Figure 75b – d). The IR-SNOM images 
for the 1689 cm-1, 1651 cm-1 and 1626 cm-1 (Figure 75b, c, d) show similar variation, 
with the same trend of regions of α-helical absorbance contrasting with regions of β-
sheet absorbance. This contrast suggests a consistent adsorbed HI coverage across 
the surface with pockets of α-helical and β-sheet character attributed to the HI. There 
are also no distinct regions of structural change observed which correlate with the 
topography, therefore this suggests that the surface functionalisation is stable and 
does not degrade due to pH 2, as was shown for the C6 functionalised surface at pH 2.  
Adsorbed with human insulin at pH 7 
 Figure 76 shows the IR-SNOM images of HI adsorbed onto the C18 
functionalised surface at pH 7. 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 6 
Page 212 
 
Figure 76: IR-SNOM images of a 150 µm  150 µm area of the octadecyl-functionalised (C18) gold 
substrate with human insulin (10 mg/mL, HI) adsorbed at neutral conditions (pH 7); (a) shear-force 
topography, (b) 1689 cm-1, (c) 1651 cm-1 and (d) 1626 cm-1. 
 The IR-SNOM images of the C18 functionalised surface at pH 7 (Figure 76), 
shows an uneven flat topography (Figure 76a). The IR-SNOM images (Figure 76b – d) 
show similar variation, particularly with 1651 cm-1 and 1626 cm-1 (Figure 76c and d) 
which showed the same trend; where α-helices absorbance increases, β-sheets 
absorbance decreases. However, the 1689 cm-1 (Figure 76b) shows a larger colour 
contrast with an increased absorbance, which implies that the C18 functionalised 
surface at pH 7 consists of anti-parallel β-sheet structure. This observation correlates 
with the assumption that at pH 7 the adsorbed species is predominantly oligomeric, 
as dimerization of monomeric HI results in anti-parallel β-sheets,36 therefore the 
image (Figure 76a) shows areas of high oligomeric content. 
 Overall, the IR-SNOM images acquired of the samples show that the 
secondary structure of the adsorbed HI layer is not entirely consistent across the 
hydrophobically functionalised gold surfaces at either pH 2 or pH 7. The IR-SNOM 
images also show, the inhomogeneity of the C6 functionalised surface at pH 2, which 
was observed from QCM-D and Raman analysis in Chapter 5. The effect of pH is 
visually observed in IR-SNOM, where there are larger areas of α-helical content 
present at pH 2 compared to pH 7. However, the IR-SNOM has shown that the 
discrete wavelengths used show areas of high α-helical content contrasted with low 
β-sheet content. 
6.3.3.3. Quantification of the IR-SNOM data 
 The acquired IR-SNOM data shows variation between the three wavelengths, 
corresponding to the secondary structure of HI; (1689 cm-1) anti-parallel β-sheets, 
(1651 cm-1) α-helices and (1626 cm-1) parallel β-sheets. These images were 
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processed into histograms (6.2.2.3. Histogram Processing, page 204), as shown in 
Figure 77 with the non-scaled histogram in Figure S20. 
 
Figure 77: Histograms of the IR-SNOM images of the (blue) 1689 cm-1 (anti-parallel ß-sheets), 
(red) 1651 cm-1 (α-helices) and (green) 1626 cm-1 (parallel ß-sheets) wavelengths. The samples 
represented are human insulin (HI) adsorbed to; (a) C6 functionalised at pH 2, (b) C6 functionalised at 
pH 7, (c) C18 functionalised at pH 2 and (d) C18 functionalised at pH 7. Figure courtesy of Conor Whitley. 
 Histogramming the IR-SNOM images of the four samples (Figure 77) for the 
three wavelengths used; 1689 cm-1 (blue), 1651 cm-1 (red) and 1626 cm-1 (green), 
resulted in an attempted quantification of the amount of HI secondary structure 
present in each image obtained. The main trend observed is that both pH 7 for C6 
and C18 functionalised surfaces (Figure 77b and d) result in higher mean absorbance 
values for the three wavelengths compared to pH 2, which implies that there is more 
HI content at pH 7 compared to pH 2. Increased HI content at pH 7 compared to pH 2 
on either C6 or C18 surface was also observed in Chapter 5, as shown with an 
increased adsorbed HI layer thickness. There is a sizeable overlap in the histograms 
for all the wavelengths, for all samples except the C6 functionalised in 
pH 2 (Figure 77a), which implies that there are similar amounts of structural features 
present on the surface. 
 The C6 functionalised surface at pH 2 (Figure 77a) exhibits the lowest overall 
absorbance which implies the least HI content adsorbed to the surface. The mean 
value for the α-helices is less than the other three samples, implying that there is 
some α-helical structure present on the surface. The mean value for the anti-parallel 
β-sheets exhibits the least absorbance value, which implies that there is minimal 
anti-parallel β-sheet structure on the surface. This is contradicted by the mean value 
for the parallel β-sheets which has the absorbance of the three wavenumbers, which 
suggests that there is predominantly parallel β-sheet structure absorbed on the 
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surface. A possible explanation is that for this surface, there is a higher contribution 
of disordered structure than the typical parallel β-sheets maxima (Figure 65), which 
is plausible since for the other samples the histograms of both 
wavenumbers (1689 cm-1 and 1626 cm-1) overlap whereas they do not 
here (Figure 77a). If there was a higher contribution of disordered structure as 
opposed to β-sheet, this would correspond with the implication that the C6 
functionalisation is unstable resulting in regions of C6 functionalisation and bare gold 
across the surface, as shown in the IR-SNOM images (Figure 73) which showed a 
phase transition. This observation and quantification of HI secondary structure across 
the surface, correlates with the data acquired in Chapter 5 from QCM-D and Raman 
spectroscopy which showed the distortion of HI monomers on the exposed gold 
surface. 
 Conversely the C6 functionalised surface at pH 7 (Figure 77b) resulted in the 
three wavenumbers exhibiting similar mean absorbance values which were overall 
highest across all the samples studied, implying the most HI content adsorbed to the 
surface. The 1651 cm-1 (α-helices) wavenumber exhibited the highest absorbance 
value, followed by 1626 cm-1 (parallel β-sheets) then 1689 cm-1 (anti-parallel 
β-sheets) with the smallest distribution range between histograms. The highest 
absorbance and similar histogram distributions implies that the adsorbed HI consists 
of comparable quantities of secondary structure in various states which correlates to 
adsorbed HI oligomeric states. Similar high absorbance values were observed for the 
C18 samples also. 
 The C18 functionalisation at pH 2 (Figure 77c) exhibited similar histograms to 
pH 7 (Figure 77d), with increased absorbance for pH 7 compared to pH 2. The 
individual wavenumber trend differed to that of C6 functionalisation at pH 2, with the 
1651 cm-1 (α-helices) wavenumber exhibiting the highest absorbance value, followed 
by 1689 cm-1 (anti-parallel β-sheets) and then 1626 cm-1 (parallel β-sheets). These 
trends suggest that although there is a higher adsorbed HI species at pH 7 compared 
to pH 2, both exhibit similar structural composition by IR-SNOM. 
 Overall histogramming has shown that there are trends present in the 
IR-SNOM data acquired, which support data obtained by QCM-D and Raman in 
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Chapter 5. The results show that surface functionalisation and pH conditions affect 
the adsorption of HI onto the hydrophobic interface, with the C6 functionalised 
surface at pH 2 highlighting possible issues with the functionalisation process. There 
is a noticeable increase in secondary structure content on both C6 and C18 
functionalisation which corresponds with a change in pH from pH 2 to pH 7, which is 
likely attributed to oligomeric adsorption as discussed further in Chapter 5. 
Quantitative assessment of the IR-SNOM images by histogramming allows for a 
better interpretation of the IR-SNOM images, without the challenge of biased 
imaging or scaling, however further improvements are possible to increase the 
reliability of this technique. 
6.3.3.4. Optical microscopy of the adsorbed surfaces 
 In addition to the IR-SNOM, optical microscopy images of the samples were 
acquired (Figure 78) although these regions do not correspond to the regions studied 
by IR-SNOM, they are representative of the surface. 
 
Figure 78: Optical microscopy images acquired at x20 magnification of the samples studied within the 
IR-SNOM; (a) C6 pH 2, (b) C18 pH 2, (c) C6 pH 7 and (d) C18 pH 7. 
 The optical microscopy images (Figure 78a) clearly indicate visual differences 
in the adsorbed HI between the four samples. A discrete adsorbed species for the HI 
adsorbed on the C6 functionalised surface at pH 2 (Figure 78a), in contrast to the 
other three images which show crystalline structures (Figure 78b and d) or an 
amalgamated species (Figure 78c). The visually different adsorbed layer on the C6 
functionalised surface at pH 2 (Figure 78a) provides a possible explanation as to the 
differences observed in the IR-SNOM images, since there does not appear to be 
continuous adsorbed layer present. 
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6.3.4. Induction of fibrillation orientation as a result of structural morphology? 
 In addition to the optical images acquired, polarisation optical microscopy 
was used on the four samples to provide a preliminary observation into whether 
anisotropy was present,37 as shown in Figure 79. 
 
Figure 79: Comparison of the (a – d) optical microscopy images and the corresponding (e – h) polarised 
images, acquired at x40 magnification, for the samples studied within the IR-SNOM; (a, e) C6 pH 2, 
(b, f) C18 pH 2, (c, g) C6 pH 7 and (d, h) C18 pH 7. 
 Optical images (Figure 79a – d) were acquired of the samples, with polarised 
images (Figure 79e – h) captured at the same location. The polarised microscopy 
resulted in structural features of the surfaces, which was previously not observed. 
This polarisation effect demonstrates that there is surface anisotropy present on the 
surfaces, attributed to the orientation of the adsorbed HI layer. These results provide 
a possible application for studying these samples in Reflection Anisotropy 
Spectroscopy (RAS), to investigate whether the hydrophobic functionalisation 
facilitates the specific orientation of HI adsorption. 
6.4. Conclusion 
 This chapter uses the novel technique of infrared scanning near-field optical 
microscopy (IR-SNOM) in a preliminary investigation to determine the effect of 
hydrophobic functionalised gold surfaces on the secondary structure of HI. The optics 
of the SNOM were changed in order to use the QCL as the Mid-IR light source 
enabling the reflection mode to be utilised.  
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 IR-SNOM images have shown variations in the secondary structure of the 
adsorbed HI layer across the hydrophobically functionalised surfaces at both pH 2 
and pH 7. The effect of pH is observed in the IR-SNOM images, which resulted in high 
α-helical content contrasted with low β-sheet content for pH 2 compared to pH 7. 
Quantitative assessment of the IR-SNOM images by histogramming removed the bias 
of image visualisation, however further improvements are possible to increase the 
reliability of this technique.  
 Promisingly the IR-SNOM results are consistent with the results obtained in 
Chapter 5, from conventional techniques, thereby validating this methodology. 
  




Figure S19: Representative images of the samples used for contact angle measurement, (a) piranha 
cleaned gold, (b) C6 functionalised and (c) C18 functionalised. 
 
Figure S20: Non-scaled histograms of the IR-SNOM images of the (blue) 1689 cm-1 (anti-parallel 
β-sheets), (red) 1651 cm-1 (α-helices) and (green) 1626 cm-1 (parallel β-sheets) wavelengths. The 
samples represented are human insulin (HI) adsorbed to; (a) C6 functionalised at pH 2, (b) C6 
functionalised at pH 7, (c) C18 functionalised at pH 2 and (d) C18 functionalised at pH 7. Figure courtesy 
of Conor Whitley. 
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Chapter 7: Utilising Intrinsic Fluorescence to Probe a Potential 
Amyloid-like Signature 
7.1. Introduction 
In Chapter 2, Reflection Anisotropy Spectroscopy (RAS) showed that a large 
amount of inhomogeneous protein adsorption had occurred on the silicon (Si) 
surface, which resulted in the adsorbed protein exhibiting a blue colouration. The 
blue haze-like colouration led to an investigation to determine the cause for this 
colouration. A literature search revealed a widely debated phenomenon for the 
aggregation of proteins exhibiting a fluorescence signature in the blue visible region.1 
This phenomenon is termed; deep-blue autofluorescence (dbAF) which has been 
reported to originate from protein amyloidogenicity,1–4 although there has been no 
consensus for where this phenomenon originates with various suggestions from 
aggregation state,2,5 carbonyl interactions6 and labile hydrogen bonding.7 This 
provides a potential application of this phenomenon, as a tool to detect pre-fibrillar 
aggregates before fibrillation is apparent. 
The fibrillation of proteins in bulk solution is an important factor in industrial 
processing or clinical drug delivery system because of the unintentional 
consequences resulting from fibrillation such as; decreased drug stability8,9 or 
adverse aggregation.10,11 There is a significant need to develop a non-invasive 
diagnostic technique for the detection of pre-fibrillar aggregates, to reduce 
inadvertent fibrillation within these scenarios. The use of fluorescence spectroscopy 
is advantageous because it provides a typically non-destructive and widely used 
highly sensitive biophysical technique, to probe species of biological or chemical 
interest. 
The experimental change for this chapter was because of the synergy 
between bulk protein solutions and adsorption on substrate surfaces, as both are 
important for fibrillation events,12 with the potential of dbAF to be used in both 
situations. The dbAF phenomenon is an exciting prospective diagnostic tool for 
pre-fibrillar detection, however its applicability is currently limited because of 
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uncertainty surrounding its origin. This chapter will use HI as a model protein and 
intrinsic fluorescence as a known spectroscopic technique, to investigate dbAF 
further. 
7.1.1. Introduction to Fluorescence Spectroscopy 
Fluorescence is the emission of light from electronically excited states of an 
aromatic species or fluorophore and is a specific type of luminescence. Luminescence 
is broadly defined as “the spontaneous emission of radiation from an electronically 
excited state or from a vibrationally excited species not in thermal equilibrium with 
its environment”.13 The other type of luminescence is phosphorescence, which is 
broadly defined as long-lived fluorescence derived from electronic transitions 
through a metastable excited state. Fluorescence and phosphorescence differ in the 
lifetime of their excited state, whether the promotion of the electron occurs to either 
the excited singlet (Sx) or triplet states (Tx), respectively. Fluorescence, 
singlet-excited state only, retains the same spin of its paired ground state, whereas 
phosphorescence, triplet-excited state only, has the same spin as that of the 
unpaired ground state electron. The process of luminescence can be fundamentally 
explained by using a simplified Jablonski-Perrin diagram (Figure 80) to describe these 
electronic transitions.14 
As shown in the Jablonksi-Perrin diagram (Figure 80), when a photon is 
absorbed by an aromatic species or fluorophore, an absorption event occurs, which 
leads to an electron being promoted to an excited state. This excited state is unstable 
thus a rapid non-radiative energy decay of the electron occurs, which is typically 
vibrational relaxation and leads to energy dissipation from the electron as kinetic 
energy, either within the molecule or via neighbouring molecules between 
vibrational levels. In Figure 80 at the lowest energy level of the excited state (S2), 
there are two possible non-radiative decay process which can occur, either internal 
conversion or intersystem crossing. Internal conversion is where an electron can only 
transfer between vibrational energy states from a higher energy state to a lower 
energy state, for example between singlet-excited states (S2 to S1). Intersystem 
crossing, a reversible process, is where an electron changes spin multiplicity from an 
excited singlet (Sx) to an excited triplet state (Tx), this process is usually slow. 
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Emission of a photon from the singlet-excited (S1) or triplet-excited state (T1) to 
ground electronic state (S0) results in either fluorescence or phosphorescence 
respectively. 
 
Figure 80: Simplified Jablonski-Perrin Diagram; (red arrows) photon absorption promotes the electron 
from the (S0) ground electronic state to a (S1 or S2) singlet-excited state, followed by non-radiative 
decay either; (blue arrows) vibrational relaxation or (magenta arrows) internal conversion. Emission 
of a photon from the (S1) singlet-excited state to (S0) ground electronic state, results in (green 
arrows) fluorescence. Alternatively, (gold arrows) a change in electronic spin multiplicity leads to 
intersystem crossing, emission of a photon from the (T1 or T2) triplet-excited state to (S0) ground 
electronic state resulting in (lilac arrows) phosphorescence. Adapted from Valeur et al.15 
 Steady state fluorescence spectroscopy probes fluorescence intensity as a 
function of wavelength, whereby the fluorophore can be located external or internal 
to the system of interest. The addition of a dye molecule or fluorophores (known as 
extrinsic fluorescence) can be used to enhance the fluorescence signal. Alternatively, 
the use of specific molecules internal to the system of interest (known as intrinsic 
fluorescence, IF) such as; aromatic amino acids,14 neurotransmitters,16 porphyrins17 
and green fluorescent protein have been used.18 
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7.1.1.1. Detection of aggregation using small molecule dyes 
 Extrinsic fluorescence occurs externally to the system or molecule, by the 
addition of dyes or fluorophores to enhance the fluorescence signal and observation 
of wavelength or intensity changes. The amyloidogenic fibrillation pathway is 
measured using extrinsic fluorescence techniques, notably the addition of two 
amyloid-specific dyes; Congo-Red (CR) and Thioflavin-T (ThT), shown in Figure 81. 
 
Figure 81: Chemical structures for (a) Congo-Red (CR) and (b) Thioflavin-T (ThT). 
 CR is used as the gold-standard for amyloid diagnosis. For a protein to be 
defined as amyloidogenic, suspected amyloid fibrils are stained with CR, 
identification is then confirmed if apple-green birefringence is observed under 
polarised light.19 In ThT assays a characteristic blue-shift of emission maxima from 
510 nm as a free dye molecule to 480 nm when bound to amyloid fibrils is observed.20 
 Extrinsic fluorescence is a powerful technique because consecutive readings 
on a multi-well plate, with an increase in sample size, can be acquired within a 
short-time frame. Although a powerful technique for reducing the likelihood of 
further fibrillation events occurring between reads, extrinsic fluorescence does have 
some disadvantages. The major issue with the use of these dyes for amyloid-research 
is their potential to affect the fibrillation pathway. This issue is compounded by the 
currently unknown mechanism by which ThT binds. Recent literature stresses the 
need to control the ThT concentrations, as delayed fibrillation has been reported due 
to ThT.21,22 The use of extrinsic fluorescence provides many benefits, however the 
addition of dye fluorophores produce an additional variable to consider, therefore it 
would be desirable to utilise an alternative non-invasive fluorescence method which 
acquires analogous information. 
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7.1.1.2. Detection of aggregation using structural-specific fluorescence 
 Intrinsic fluorescence (IF) is a specific property of the protein originating from 
the aromatic amino acid residues present within the peptide primary sequence. The 
aromatic amino acid residues responsible for IF are; tryptophan (Trp, W), 
tyrosine (Tyr, Y) and phenylalanine (Phe, F) as illustrated in Figure 82. IF is highly 
sensitive to the local environment of the residue that gives rise to the fluorescence, 
which can yield structural data for the protein without introducing an external 
fluorophore as a probe. 
 
Figure 82: The chemical structures of intrinsic fluorescence (IF) active aromatic amino acids; 
(a) L-tryptophan, (b) L-tyrosine and (c) L-phenylalanine. The colours correspond to the 
(black) amino-carboxy groups and the R-groups for; (red) tryptophan, (blue) tyrosine and 
(green) phenylalanine. 
 Tryptophan is typically used as a probe to monitor the aggregation state of 
the protein because it has the highest quantum yield as shown in Table 5,23 but the 
use of tyrosine has also been reported.24 The strong fluorescence profile of 
tryptophan arises from delocalisation in the indole group,25 and becomes blue-
shifted to shorter wavelengths when buried compared to the longer wavelengths 
when unfolded. This blue-shift can be approximately 35 nm, dependent upon the 
solvent and protein studied,26 although the intensity may be affected through the 
quenching mechanisms related to the protein or solvent system. This blue-shift can 
be utilised for studying the local environmental change, whereby the solvent 
accessible residue becomes buried within the hydrophobic core thus resulting in 
lower wavelength emission.27 Giancotti et al28 observed that histone emission blue-
shifted from 360 nm to 345 nm as the residue becomes buried within the folded 
structure. This effect is also observed with changes in pH, since the amino acids are 
subject to protonation events and thus can exhibit an analogous effect.29 
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Table 5: Spectroscopic properties of the intrinsic amino acid residues, dissolved in water. The 
(ΦF) quantum yield is defined as the ratio of the emitted to adsorbed photons. Adapted from 










Tryptophan 348 0.2 280 5600 
Tyrosine 303 0.14 274 1400 
Phenylalanine 282 0.04 257 200 
 
The fluorescence intensity is proportional to the product of fluorescence 
quantum yield and extinction coefficient, thereby resulting in tryptophan having 
approximately five times higher fluorescence than tyrosine. This intensity difference 
leads to the preferential use of tryptophan for IF, although the other aromatic 
residues will still contribute if present, as the overall IF is an ensemble effect making 
disentanglement of residues often difficult unless restrictions are in-place. Overall 
the IF in general is significantly far less intense than extrinsic fluorescence, and 
therefore requires instrumentation fitted with detectors capable of higher sensitivity 
to distinguish the IF from the background noise. 
Typically increasing the species concentration results in higher fluorescence 
intensity, however this is compounded by both a fundamental fluorescence principle 
and a physical property; the inner filter and scattering effects respectively. The inner 
filter effect (IFE) is where the excitation beam enters the media, exciting a higher 
proportion of fluorophores which decreases across the beam pathlength, therefore 
resulting in a graduated fluorescence emission.14 In the scattering effect, increasing 
concentrations leads to reduced transparency of the solution. At extreme 
concentrations it becomes optically dense and opaque thereby preventing the beam 
from penetrating the media and thus resulting in lack of fluorescence.32 
A major limitation for intrinsic fluorescence is the pre-requisite for aromatic 
residues to be present in the analyte, therefore reducing the universal applicability 
of this technique. A technique of similar sensitivity and specificity to IF, which delivers 
comparable results, is necessary. 
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7.1.1.3. Deep-blue autofluorescence 
 Deep-blue autofluorescence (dbAF) is a recently discovered phenomenon, 
whereby excitation (Ex) occurs in the ultraviolet (UV) region (λEx ~350 nm) and 
emits (Em) in the visible blue region (λEm ~450 nm).33 This phenomenon was first 
discovered by Shukla et al33 in 2004, by probing protein crystals using a UV 
laser (λEx 341 or 364 nm) which resulted in visible fluorescence (λEm 400 – 500 nm). 
The origins of this phenomenon were initially proposed to be a property of protein 
aggregation, which was attributed to the amyloid fibrillar state because of the 
increasing fluorescence intensity as aggregation proceeded,34,35 however the 
phenomenon origins are still widely debated. 
 There have been various potential origins proposed recently for this 
intrinsic-type fluorescence such as; hydrogen lability,4,7,36 carbonyl interactions,6 
fibril size.37, charge and pH3,38. This phenomenon has been recently reported to exist 
for other molecules such as; for amyloid-β peptide (Aβ40 and Aβ42),34 
β-lactoglobulin (BLG),6 bovine serum albumin (BSA),6 hen egg white 
lysozyme (HEWL),6 human lysozyme,34 insulin,39 phenylalanine di-peptide39 and 
protein Tau K18.1 The observation of this intrinsic-type phenomenon in the various 
molecules studied, has led to variations on the terminology proposed namely; Non-
Traditional Intrinsic Luminescence (NTIL),40 autofluorescence,6 intrinsic amyloid 
fluorescence34 and Protein Charge Transfer Spectra.41 For this thesis, the 
phenomenon will be referred to as deep-blue autofluorescence. 
 The aim of this chapter is to utilise IF and dbAF to probe amyloid-like 
fibrillation of  I, α-synuclein (αS) and several small molecules. This dbAF 
phenomenon has the potential to be used as a non-invasive fluorescence technique 
to assess pre-fibrillar aggregation state, which has the possibility for use in industrial 
processes as a first line detection tool for situations where aggregation is to be 
avoided. As the origins of dbAF are widely debated with various factors proposed, 
this study will investigate whether; increasing oligomeric size, single-point mutations, 
protein oxidation and nitration, or homogeneous fibrillation affect the dbAF and 
whether they are the cause of the phenomenon. 
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7.1.2. α-Synuclein (αS) 
 In addition to investigating the HI fibrillation pathway by IF, this chapter also 
includes another physiologically important protein of interest, α-synuclein (αS). αS, 
a 140 amino acid (17 kDa) unstructured single chain polypeptide (Figure 83), is an 
intrinsically disordered protein (IDP)42 and its aggregation pathway is a hallmark of 
α-synucleinopathies; Parkinson’s disease (PD)43 and dementia with Lewy bodies.44 
IDPs are functional and highly water-soluble proteins but lack an absolute fixed 
spatial structure.45 Intrinsic disorder is attributed to a completely unstructured 
protein or more likely one which contains partial structural architecture.46 
 
Figure 83: A visual molecular dynamics (VMD)47 representation of α-synuclein (PDB: 1XQ8)48, 
illustrating; (purple) amphipathic region, (orange) non-amyloid-ß component, (green) acidic tail and 
(cyan) the single-point mutation sites. 
 The visual molecular dynamics (VMD)47 representation shown in Figure 83, 
was micelle-bound to resolve the non-mutated (wild-type, WT) αS structure by 
nuclear magnetic resonance (NMR) spectroscopy.48 αS is comprised of three distinct 
regions (Figure 83); the amphipathic region (purple) is a long helical structure critical 
for membrane binding, the non-amyloid-β component (NAC, orange) which is vital 
for fibrillation events, and the acidic tail (green) situated at the C-terminus.43,49–51 The 
cyan coloured segments shown within the amphipathic region, denote the 
single-point mutation sites in WT αS which gives rise to the six familial 
mutations (A30P, A53E, A53T, E46K, G51D and H50Q) investigated in this chapter. 
The difference in amino acids between the WT αS and the corresponding site within 
the mutation are shown in Figure 84, with the entire WT αS primary sequence 
provided in Figure S21. 
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Figure 84: The various biophysical property differences between the wild-type α-synuclein (WT αS) and 
the six familial αS mutations; A30P, A53E, A53T, E46K, G51D and H50Q, where each corresponding 
difference is backlit with the mutation site. For example, in the WT sequence at residues 30 and 53 
alanine is present, however alanine is replaced at residue 30 in A30P by proline and at residue 53 in 
A53E and A53T by glutamic acid and threonine, respectively. 
 The specific point mutations in the familial αS strains result in differing 
biophysical properties at the mutation sites, as shown in Figure 84. A steric effect of 
the mutations is observed in all cases, particularly; A30P, and A53T, where proline 
remains hydrophobic but sterically restricted in the five-membered ring, and 
threonine is a polar residue. The electronic states of αS are modified in; A53E, E46K, 
G51D and H50Q, whereby A53E and G51D become negatively charged, E46K switches 
from negative to positive polarity and H50Q loses a positive charge. These seven 
strains of αS are physiologically important as they differ in the severity and onset of 
the associated disease.52,53 WT was first characterised, followed by the early onset 
mutations (A30P, A53T and E46K).54–59 Recently additional early onset (A53E and 
G51D) and late onset (H50Q) mutations have been discovered.54–59 
 The age of onset differs between the various single-point mutations of αS, 
and is illustrated in Figure 85, for example the age of onset for G51D (yellow) is 
between 19 and 61 years of age. These pathologies however do not correlate with 
the experimental data surrounding fibrillation and oligomerisation whereby 
increased fibrillation rates and accelerated oligomerisation found in A53T, E46K and 
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H50Q do not have similar onsets.60,61 This would suggest that other factors are 
affecting the varying pathologies, which may include differing aggregation pathways 
accounting for toxicity. In this chapter, αS has been used to further investigate the 
dbAF phenomenon by providing a second amyloidogenic protein of interest in 
addition to HI.62 
 
Figure 85: An illustration showing the age of onset for Parkinson’s disease across the α-synuclein (αS) 
strains; (black) WT, (red) A30P, (blue) A53E, (green) A53T, (purple) E46K, (yellow) G51D and 
(teal) H50Q. Adapted from Iadanza et al63 and Meade et al.61 
7.1.3. Small molecules 
The investigation of the six small molecules shown in Figure 86, comprised of 
four amino acids (purple border) and two nucleic acids (teal border), were studied to 
ascertain whether dbAF is present in homogeneous small molecular assemblies. 
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Figure 86: The small molecules, (teal) nucleic acids and (purple) amino acids, investigated in this 
fluorescence study, showing the one-letter and three-letter abbreviations where appropriate. 
The four amino acids, which were investigated in the L-isomeric form were; 
L-alanine, L-cysteine, L-phenylalanine and L-tyrosine. The two nucleic acids 
investigated, adenine and uracil, are critical in the messenger ribonucleic 
acid (mRNA) transcription process, which dictates protein synthesis as determined 
by the deoxyribonucleic acid (DNA) sequence.64 These six small molecules were 
investigated because of their ability to aggregate through amyloid-like fibrillation 
pathways,65–67 and their physiological importance in metabolic diseases such as; 
adenine phosphoribosyltransferase deficiency,68 cystinuria,69 phenylketonuria,70 
tyrosinemia71 and ornithine transcarbamylase deficiency.72 
7.2. Materials and Methods 
7.2.1. Sample Preparation 
All glassware was cleaned either in an acidic Piranha solution (30% hydrogen 
peroxide and 70% sulfuric acid, 30 minutes) to remove any hard deposits or in a basic 
10% Decon 90 overnight and then dried in an oven. The quartz cells used were 
thoroughly rinsed with water (Milli-Q, 18.2 MΩ cm-1) and ethanol several times 
between measurements, air-dried before use and wiped clean using a lint-free tissue. 
7.2.1.1. α-synuclein 
 The αS proteins used were kindly provided by James Torpey, Institute of 
Integrative Biology (University of Liverpool), and had been pre-suspended in either 
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7.2.1.2. Human insulin 
 The protocol developed in Chapter 3 was followed with all reagents of 
analytical grade or better. HI (100 µM) was suspended in a pH 2 
buffer (20% acetic acid and 139.7 mM sodium chloride) in a lo-bind Eppendorf 
tube (2 mL), briefly vortexed to ensure complete dissolution, and then immediately 
syringe-filtered (0.22 µm, polyethersulfone - PES). The HI suspensions were agitated 
at 37°C, after 24 hours aliquots were taken for studying the pre-fibrillar state and 
after 72 hours final aliquots, which were visibly cloudy, were taken for the fibrillar 
state. All aliquots and samples were stored in a lo-bind Eppendorf (2 mL) and 
immediately frozen (-20°C for short durations or -77°C for longer durations). Frozen 
samples were thawed back to laboratory temperature before being analysed. All 
peptides and proteins only underwent a maximum of one thaw cycle to reduce any 
potential freezing influences, as continual freeze-thaw cycles have significant effect 
on aggregation.74–78 
7.2.1.3. Small molecules 
 The small molecules (~100 µM); adenine, L-alanine, L-cysteine, 
L-phenylalanine, L-tyrosine and uracil were prepared in nitration buffer, by the 
addition of sodium bicarbonate (25 mM) and diethylenetriaminepentaacetic 
acid (0.1 mM, DTPA) to a potassium phosphate buffer (100 mM). The stock 
potassium phosphate buffer (0.1 M, pH 7.4) was formulated by; dibasic potassium 
phosphate (80.2 mL, 1 M), monobasic potassium phosphate (19.8 mL, 1 M) and 
water (900 mL, 18.2 MΩ cm-1). After the amino acids were suspended within the 
nitration buffer, the solutions were syringe-filtered (0.22 µm, PES) into lo-bind 
Eppendorf tubes (2 mL). 
7.2.1.4. Oxidation 
The peptides and protein samples were oxidised by addition of sub-molar 
quantities of hydrogen peroxide (30%) to each sample. 
7.2.1.5. Nitration 
The peptides and protein samples were nitrated using a peroxynitrite 
solution, following an adapted procedure from Beckman et al79 and Hughes et al.80 
All solutions were cooled in ice-baths and efforts made to retain their low 
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temperatures until nitration was complete because of the low nitration agent 
lifetime (1 s). In a beaker (250 mL), sodium nitrite (50 mL, 50 mM) and hydrogen 
peroxide (50 mM, 30%) were rapidly agitated. Hydrochloric acid (25 mL, 1 M) was 
added immediately into the beaker followed by sodium hydroxide (25 mL, 1.5 M). 
Aliquots of the synthesised peroxynitrite solution were immediately added to the 
peptide/protein samples in excess, successful nitration was recognised with an 
observed colour change from colourless to yellow, and increased absorbance at 
430 nm in the ultraviolet-visible (UV-Vis) spectra. 
7.2.2. Spectroscopic Methods 
7.2.2.1. Ultraviolet-visible Spectroscopy 
Ultraviolet-visible (UV-Vis) spectroscopy was performed on a GENESYS UV-Vis 
spectrometer (ThermoFisher). Transmission spectra were acquired through the short 
pathlength (0.2 cm) of the micro fluorescence quartz cuvette (700 µL), and the 
concentration of the species calculated using the Beer-Lambert Law, which was an 
average of the number of scans taken. 
7.2.2.2. Fluorescence Spectroscopy 
 The fluorescence work was carried out using a FluoroMax-4 
spectrofluorometer (HORIBA), using the same micro fluorescence quartz 
cuvettes (700 µL) as for UV-Vis analysis. 
 The fluorescence measurements were acquired with the cuvette’s small 
slit (0.2 cm) facing the incoming beam and the larger sample window (1 cm) directed 
towards the detector. The parameters of the Fluoromax were set at; excitation 
wavelengths (λEx 245 to 600 nm), emission wavelengths (λEm 270 to 700 nm), 
bandpasses (5 nm for both incoming and outgoing beam path), integration 
time (0.1 s), Rayleigh masking slit width (12.5 nm) and measurements acquired at 
5 nm intervals. The fluorimeter was programmed to acquire sample and reference 
channel measurements simultaneously, which allows for automatic correction of 
instrumental variations using a built-in algorithm. The final spectra acquired from the 
instrument were the corrected sample channel divided by the corrected reference 
channel, which were then manually buffer subtracted before further analysis was 
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performed. Fluorescence spectra were normalised using the probed species 
concentration. 
7.2.2.3. Data processing 
Origin (2016 64-bit) was used in the analysis of the one-dimensional (1D) 
fluorescence and UV-Vis spectra, and IgorPro (v6.7.3.2) was utilised for the 
three-dimensional (3D) fluorescence spectra. All spectra presented, unless otherwise 
stated, have had controls subtracted. The fluorescence is displayed using a 
logarithmic scale in the excitation-emission matrices (EEMs). 
7.3. Results and Discussion 
 This objective of this chapter was to investigate whether the reported dbAF 
phenomenon is observed in HI, to determine the origins of this phenomenon and 
assess the potential application as a diagnostic tool to study the pre-fibrillar state of 
proteins. 
7.3.1. The fluorescence profile for the human insulin fibrillation states 
 The IF analysis for HI was undertaken at 275 nm excitation and emission 
collected between 290 to 570 nm30 as these IF parameters have previously been 
reported for insulin fibrillation studies.24,81,82 The IF spectra of the oligomeric state of 
HI is shown in Figure 87. 
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Figure 87: Fluorescence spectra of the (a) intrinsic fluorescence (IF) emission and (b) normalised IF for 
human insulin (HI) fibrillation showing; (black) monomer, (red) oligomer and (blue) fibril. The spectra 
in (b) are normalised to the maximum peak intensity in each series. 
 The IF for the HI fibrillation pathway as shown in Figure 87a, shows a 
decreasing fluorescence intensity from the HI monomer (black) to the HI fibril (blue) 
state. There is no apparent shift for the IF peak maxima (λEm 305 nm) as HI fibrillation 
proceeds, as shown in the normalised fluorescence spectra (Figure 87b). All 
normalised spectra for IF and dbAF, have been minimum-maximum normalised using 
the maximum peak intensity in each series, i.e. for Figure 87a the monomer, oligomer 
and fibril peak maxima are made to unity, thus allowing for peak shifts to be 
perceived. 
 Figure 88 shows the dbAF on the same samples, as a function of emission 
wavelength (375 – 600 nm) with an excitation wavelength fixed at 350 nm, to probe 
the phenomenon for the HI aggregation state. 
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Figure 88: Fluorescence spectra of the (a) deep-blue autofluorescence (dbAF) emission and 
(b) normalised dbAF for human insulin (HI) fibrillation showing; (black) monomer, (red) oligomer and 
(blue) fibril. 
 The dbAF for the HI fibrillation pathway as shown in Figure 88a, shows an 
increasing fluorescence intensity from the HI monomer (black) to the HI fibril (blue) 
state. The fibrillar state has a strong fluorescence background present but there is 
still an overall intensity increase for the fibril. There is also a wavelength shift for the 
dbAF peak maxima and peak narrowing as HI fibrillation proceeds from the 
monomeric and oligomeric state (λEm 450 nm) to the fibril (λEm 430 nm), as shown in 
the normalised fluorescence spectra (Figure 88b). The shift in emission wavelength 
insinuates that there is a possible corresponding shift in excitation wavelength, 
therefore these 1D emission scans are not ideal. 
7.3.1.1. Building the Excitation-Emission Matrix (EEM) 
The IF and dbAF spectra (Figure 87 and Figure 88) were acquired by fixing the 
excitation whilst collecting the resulting fluorescence emission wavelengths, which 
results in a 1D emission spectrum. An emission spectrum can be used to characterise 
peak changes such as intensity and wavelength shifts, however the peak maxima 
could change in the excitation wavelength and is therefore not characterised in the 
emission spectra. An Excitation-Emission Matrix (EEM) is a 3D scan, which acquires 
both emission and excitation spectra concurrently within the same sample,83 
therefore fluorescence changes in both excitation and emission wavelengths are 
recorded. The use of EEMs in fluorescence studies is increasing and have previously 
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been reported for HI investigation of the dbAF39 and fibril surface interactions.84 A 
schematic for an acquired EEM is shown in Figure 89. 
 
Figure 89: A schematic showing a representative excitation-emission matrix (EEM). (a – c) Lines 
correspond to correction features for Rayleigh and Raman scattering; (a) λEx = λEm, (b) λEx = 2λEm and 
(c) Raman scattering. (i – iv) Coloured regions correspond to the fluorescence signatures of; (i) intrinsic 
fluorescence (IF), (ii) deep-blue autofluorescence (dbAF), (iii) dityrosine and (iv) tyrosinate. The colour 
bar is used to display the normalised fluorescence intensity in the z-axis, on a logarithmic scale. 
In the EEM schematic (Figure 89), the two solid black lines (Figure 89a and b) 
correspond to scattering effects attributed to first and second order Rayleigh 
scattering. Rayleigh scattering is an elastic effect, where the electronic energy 
remains unchanged, and the terminology first and second order are derived from 
whether the emission wavelength is equal to once or twice the excitation 
wavelength. The Rayleigh scattering peak is broad and intense, therefore for clarity 
the EEMs presented in this thesis’ chapter result in a smaller trapezoidal shape to 
remove any artefacts attributed to the broad scattering. The dashed line (Figure 89c) 
corresponds to water Raman scattering,85 which is an inelastic effect where the 
incoming and outgoing electronic energy is different, which is termed as either 
Stokes (higher wavelengths) or anti-Stokes (lower wavelengths). The coloured 
regions (Figure 89i – iv) distinguish; IF (i), dbAF (ii), dityrosine (iii) and tyrosinate (iv). 
The tyrosine derivatives, including 3-nitrotyrosine which is nonfluorescent, are 
characteristic biomarkers of oxidation and nitration within neurodegenerative 
disease.86–88 The colour scale shown for all EEMs is for the z-axis normalised 
fluorescence intensity, with the lowest (blue) to highest (red). 
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7.3.1.2. Investigating the human insulin fibrillation pathway by EEMs 
 The HI fibrillation pathway was investigated by EEMs, with 
excitation (250 – 470 nm) and emission (290 – 570 nm) wavelengths acquired 
concurrently for the three aggregation states, as shown in Figure 90. 
 
Figure 90: The human insulin (HI) EEMs, normalised to the aggregation states intrinsic fluorescence (IF) 
signal maxima, for the (a) monomer, (b) oligomer and (c) fibril states. The exhibited fluorescence is 
shown as (red) highest to (blue) lowest. 
 Figure 90 shows the HI aggregation states of the fibrillation pathway for the; 
monomer (Figure 90a), oligomer (Figure 90b) and fibril (Figure 90c), where each EEM 
has been normalised to the IF peak maxima to observe the relationship between IF 
and dbAF. The IF peak region decreases in intensity as fibrillation proceeds, which is 
shown by a colour change from red to orange, with a corresponding increase for the 
dbAF shown from blue to green. The fluorescence intensity for the HI fibrillation is 
low as the water Raman scattering band can be seen, in both the monomer and 
oligomer EEMs (Figure 90a and b). 
 In HI both IF and dbAF are observed but exhibit inverse fluorescence trends 
as fibrillation proceeds. The HI IF is an ensemble effect which is attributed to the four 
tyrosine (A14, A19, B16, and B26) and three phenylalanine residues (B1, B24, and B25) in 
both chains, as there are no tryptophan residues in HI. A reduction in IF intensity was 
observed for the increasing aggregation states as HI fibrillation proceeds (Figure 87), 
which implies that the residues are quenched, however there is no change in the 
peak maxima (λEm 305 nm). The HI IF results are consistent with previous work that 
suggested the tyrosine residues are non-hydrogen bonded in the fibrillar state.24 An 
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inverse fluorescence trend was shown for dbAF, where IF intensity increased as HI 
fibrillation proceeded (Figure 88) and a change in the emission peak maxima was 
observed for the fibrillar state suggesting a change in the fluorophore environment. 
The correlation between increased dbAF intensity and aggregation state, suggests 
that the phenomenon is influenced by aggregation and supports the possibility that 
it is a property of amyloidogenicity,34 however because of the emission wavelength 
shift an associated change in the excitation wavelengths was considered, leading to 
the use of EEMs. 
 The EEMs for the HI fibrillation pathway (Figure 90) showed that the dbAF 
peak maxima is located at different excitation and emission wavelengths (~10 nm) 
than previously reported (λEx ~350 nm, λEm ~450 nm).39 This has a significant impact 
on research into this phenomenon because by fixing the excitation wavelength, the 
dbAF may be missed or result in biased fluorescence intensities attributed to the 
fluorescence slope as opposed to the peak maxima. It is therefore essential to use 
EEMs in the investigation of dbAF, since changes in both excitation and emission 
wavelengths are attained. This investigation also uses the 1D IF and dbAF spectra, 
with the purpose of determining the origin of the dbAF phenomenon through known 
and previously reported parameters.  
 Overall, the existence of dbAF in HI and the correlation between the increased 
dbAF intensity and aggregation state provides support to the theory that 
amyloidogenicity enhances the dbAF,34 however the presence of dbAF in the 
monomeric state albeit at a reduced intensity implies other factors may also 
contribute.  I is a structured protein with three α-helices consisting of two chains. It 
is possible that the secondary structure of HI gives rise to the dbAF in the monomeric 
state as a result of carbonyl6 or hydrogen bonding interactions.89 To investigate the 
dbAF phenomenon further, an amyloidogenic protein lacking structure is needed to 
assist in the phenomenon’s origins by eliminating the structural factor. 
7.3.2. The fluorescence profile for the α-synuclein fibrillation states 
 It was established that the dbAF phenomenon was observed in the HI 
fibrillation pathway, however this could be attributed to the properties of the 
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structured protein rather than the fibrillation pathway itself. In this section, αS is 
studied as it also undergoes amyloid-like fibrillation but as it is an IDP, this will 
ascertain whether the dbAF arises from a property of protein structure or the result 
of fibrillation. 
7.3.2.1. Investigating the wild-type α-synuclein fibrillation pathway by fluorescence 
 The IF for the WT αS fibrillation pathway is shown in Figure 91, and shows the 
same behaviour as HI with a decreasing fluorescence intensity from monomer (black) 
to fibril (blue) state. There is no apparent shift for the IF peak maxima (λEm 305 nm) 
but there is the emergence of two additional peaks (λEm 360 nm and 450 nm) as 
fibrillation proceeds, as shown in the normalised fluorescence spectra (Figure 91b). 
 
Figure 91: Fluorescence spectra of the (a) intrinsic fluorescence (IF) emission and (b) normalised IF for 
wild-type α-synuclein fibrillation showing the; (black) monomer, (red) oligomer and (blue) fibril states. 
 The investigation of the dbAF for the WT αS aggregation state, as shown in 
Figure 92, was undertaken using the same emission scan parameters as for 
HI (Figure 87). 
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Figure 92: Fluorescence spectra of the (a) deep-blue autofluorescence (dbAF) emission and 
(b) normalised dbAF for wild-type α-synuclein fibrillation showing the; (black) monomer, 
(red) oligomer and (blue) fibril states. 
 The dbAF for the WT αS fibrillation pathway (Figure 92a), shows an increasing 
fluorescence intensity from the monomer (black) to the fibril (blue) state, with a 
decreased fluorescence for the oligomeric (red) state. There is no apparent 
wavelength shift for the dbAF peak maxima, unlike for HI, however a peak narrowing 
is observed at the lower wavelengths as fibrillation proceeds, as shown in the 
normalised fluorescence spectra (Figure 92b). 
 Similarly, to the I fibrillation pathway, αS was investigated by EEMs as shown 
in Figure 93 with the same conditions as previously stated for HI. 
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Figure 93: The wild-type α-synuclein EEMs, normalised to the intrinsic fluorescence (IF) signal maxima, 
for the (a) monomer, (b) oligomer and (c) fibril. The exhibited fluorescence intensity is shown as 
(red) highest to (blue) lowest. 
 Figure 93 shows the WT αS aggregation states of the fibrillation pathway for 
the; monomer (Figure 93a), oligomer (Figure 93b) and fibril (Figure 93c), where each 
EEM has been normalised to the IF peak maxima to observe the relationship between 
IF and dbAF. The IF peak region decreases in intensity as fibrillation proceeds, which 
is shown by a colour change from red to orange but is not as dramatic as previously 
observed for HI, whilst there is also a corresponding increase observed from blue to 
yellow for the dbAF. The two peaks seen in Figure 91 (λEm 360 nm and 450 nm) are 
further confirmed in Figure 93, as shown by the increased intensity around the 
tyrosine and tyrosinate spectral regions. 
 In WT αS both IF and dbAF are observed but exhibit differing fluorescence 
trends to  I, as fibrillation proceeds. The IF for the WT αS fibrillation 
pathway (Figure 91) was similar to HI (Figure 87), where the IF intensity decreased as 
aggregation increased, with no observed changes in the peak maxima (λEm 305 nm). 
A notable difference was the appearance of two additional peaks (λEm 360 nm and 
450 nm) in the WT αS IF spectra (Figure 91b), which correlate to the fluorescence 
profiles of tyrosinate and dityrosine. The WT αS dbAF (Figure 92a) also showed an 
increase from monomer to fibril state, as shown in HI (Figure 88), however with 
reduced intensity for the WT αS oligomeric state. The normalised dbAF (Figure 92b) 
showed peak narrowing as aggregation proceeded, which suggests possible 
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two-dimensional (2D) peak shifts specifically shifts in the excitation wavelengths, 
therefore requiring EEMs to characterise the dbAF phenomenon. 
 The EEMs for the WT αS fibrillation pathway (Figure 93) showed a significant 
shift in the excitation wavelengths for the dbAF peak maxima (λEx ~370 nm, 
λEm ~450 nm) than previously acquired for HI or reported. This peak shift suggests 
that the dbAF signature for WT αS differs from  I, which implies that the factors 
which govern dbAF are not equivalent in both proteins, therefore EEMs are an 
essential technique to investigate the origins of dbAF. In addition to measuring the 
dbAF peak shifts, the dityrosine and tyrosinate peaks (λEm 360 nm and 450 nm) 
shown in the IF spectra are observed in the WT αS fibrillar state EEM (Figure 93c). 
Interestingly the oligomeric state EEM (Figure 93b) showed that the dbAF intensity 
increased with respect to the IF, which was not apparent in the 1D spectra as the 
dbAF intensity decreased with respect to monomer and fibril states. 
  verall the dbAF phenomenon is shown to exist for WT αS and a similar trend 
to that of HI was observed; dbAF intensity increased from the monomer to fibrillar 
state, which would suggest that aggregation influences the phenomenon. These 
results show that dbAF is present in all three aggregation states, albeit reduced 
intensities for the monomer and oligomer, therefore dbAF does not arise from the 
ordered protein structure. The reduced dbAF intensity for the WT αS oligomeric 
state, implies that the phenomenon is aggregation dependent, therefore to 
investigate this a chemically similar protein with a diverging fibrillation pathway is 
necessary. 
7.3.2.2. The effect of α-synuclein single-point mutations on the fluorescence profile 
 It is well documented that single-point mutations of α-synuclein have a 
significant effect upon both the age of onset and severity of the associated disease,63 
as shown in Figure 85. These mutations are still amyloidogenic but give differing 
fibrillation pathways to WT and are used to investigate whether the dbAF 
phenomenon can detect differences in the pre-fibrillar state for each mutation, 
potentially providing a diagnostic application for dbAF. The fluorescence profiles of 
the six familial mutations (A30P, A53E, A53T, E46K, G51D, and H50Q) are compared 
to the WT in the following IF and dbAF spectra. 
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 The IF for the effect of single-point mutations on monomeric WT αS are 
shown in Figure 94, where all the mutations have increased in IF intensity with the 
exception of H50Q. The three mutations with the lowest IF intensities (Figure 94a), 
which are WT, A30P and H50Q, all give rise to a second peak (λEm 360 nm) and for all 
seven strands there are no apparent IF peak maxima shifts observed in the 
normalised fluorescence spectra (Figure 94b). 
 
Figure 94: Fluorescence spectra of the (a) intrinsic fluorescence (IF) emission and (b) normalised IF for 
α-synuclein monomeric state; (black) WT, (red) A30P, (blue) A53E, (green) A53T, (purple) E46K, 
(yellow) G51D and (teal) H50Q. 
 The IF for the effect of single-point mutations on oligomeric WT αS are shown 
in Figure 95, where all the mutations have increased in IF. Overall the oligomeric IF 
has decreased in intensity compared to monomeric IF for all αS strands, except for 
G51D which increased and A30P which remained constant. The secondary 
peak (λEm 360 nm) for H50Q has increased in intensity and there is no change in 
intensity for WT and A30P, compared to the IF peak. 
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Figure 95: Fluorescence spectra of the (a) intrinsic fluorescence (IF) emission and (b) normalised IF for 
α-synuclein oligomeric state; (black) WT, (red) A30P, (blue) A53E, (green) A53T, (purple) E46K, 
(yellow) G51D and (teal) H50Q. 
 The IF for the effect of single-point mutations on fibril WT αS are shown in 
Figure 96, where all the mutations have increased in IF. Overall the fibril IF has 
decreased in intensity compared to both the monomeric and oligomeric IF for all αS 
strands, except for A53E and H50Q which have increased. The secondary 
peak (λEm 360 nm) has reduced in intensity, compared to the IF peak, for the three 
strands (WT, A30P and H50Q). A third peak (λEm 450 nm) arises for the same three 
strands, particularly noticeable for the WT, however due to the fibrillar scattering 
this could be a background artefact present for the mutations. 
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Figure 96: Fluorescence spectra of the (a) intrinsic fluorescence (IF) emission and (b) normalised IF for 
α-synuclein fibrillar state; (black) WT, (red) A30P, (blue) A53E, (green) A53T, (purple) E46K, 
(yellow) G51D and (teal) H50Q. 
 The dbAF for the effect of single-point mutations on monomeric WT 
αS (Figure 97), shows an increased fluorescence intensity for three mutations (A30P, 
A53T and E46K) and decreased intensity for the other three mutations (A53E, G51D 
and  50Q) compared to WT αS dbAF. There is a dbAF peak maxima wavelength shift 
for the G51D (~30 nm) to lower wavelengths, and a shift to higher wavelengths for 
A30P (~10 nm). All αS mutations show a narrowing of the dbAF peak compared to 
the WT. 
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Figure 97: Fluorescence spectra of the (a) deep-blue autofluorescence (dbAF) emission and 
(b) normalised dbAF for α-synuclein monomeric state; (black) WT, (red) A30P, (blue) A53E, 
(green) A53T, (purple) E46K, (yellow) G51D and (teal) H50Q. 
 The dbAF for the oligomeric αS mutations (Figure 98) shows an increased 
fluorescence intensity for all mutations compared to WT αS dbAF.  verall the 
oligomeric dbAF intensity compared to monomeric varies in all αS strands; three 
decrease (WT, A30P and E46K), two remain similar (A53E and A53T) and two 
increase (G51D and  50Q). All αS mutations show a broadening of the dbAF peak 
compared to WT, with only G51D exhibiting a peak maxima shift. 
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Figure 98: Fluorescence spectra of the (a) deep-blue autofluorescence (dbAF) emission and 
(b) normalised dbAF for α-synuclein oligomeric state; (black) WT, (red) A30P, (blue) A53E, 
(green) A53T, (purple) E46K, (yellow) G51D and (teal) H50Q. 
 The dbAF for the fibrillar αS mutations (Figure 99), shows an increased 
fluorescence intensity for all αS mutations compared to WT αS dbAF. verall the fibril 
dbAF intensity has increased in all αS strands, however there is a strong sloping 
background consistent with the fibrillar physical properties. All αS mutations show a 
peak maxima shift with corresponding doublet (λEm ~415 nm and ~440 nm), and a 
new feature (λEm ~470 nm). 
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Figure 99: Fluorescence spectra of the (a) deep-blue autofluorescence (dbAF) emission and 
(b) normalised dbAF for α-synuclein fibrillar state; (black) WT, (red) A30P, (blue) A53E, (green) A53T, 
(purple) E46K, (yellow) G51D and (teal) H50Q. 
 The EEMs are used here to probe the effect of single-point αS mutations on 
the aggregation states (monomer, oligomer and fibril) for the αS fibrillation pathway. 
These EEMs provide context for the associated 1D peak shifts which were previously 
shown to highlight the effect of the mutations had on the WT αS IF and dbAF spectra 
as fibrillation proceeds. In each EEM presented here, the fluorescence intensity has 
been normalised to the IF peak maxima to observe the relationship between IF and 
dbAF, for each mutation. 
 Figure 100 shows the A30P αS aggregation states of the fibrillation pathway 
for the monomer (Figure 100a), oligomer (Figure 100b) and fibril (Figure 100c). In 
both monomer and oligomeric states, four peaks (IF, dbAF, dityrosine and tyrosinate) 
which correlate to those observed in the WT αS EEM (Figure 93) are observed, 
however interestingly, the third peak (dityrosine, λEx ~295 nm, λEm ~455 nm) is not 
present in the A30P fibril EEM (Figure 100c). The IF peak is present in all the A30P 
aggregation states, maintaining a red colour on the intensity scale, however the dbAF 
peak region increases in fluorescence intensity, as shown by a colour change from 
blue to green, which is particularly prominent for the oligomer to fibril state. The 
A30P mutation exhibits a strong fluorescence scattering in the fibril 
EEM (Figure 100c) emanating from the lower wavelengths, which is to be expected 
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because of the strong scattering shown in the 1D fibril spectra (Figure 96 and 
Figure 99) previously shown for all the αS mutations. 
 
Figure 100: The A30P α-synuclein EEMs, normalised to the intrinsic fluorescence (IF) signal maxima, 
for the (a) monomer, (b) oligomer and (c) fibril. The exhibited fluorescence is shown as (red) highest to 
(blue) lowest. 
 Figure 101 shows the A53E αS aggregation states of the fibrillation pathway 
for the monomer (Figure 101a), oligomer (Figure 101b) and fibril (Figure 101c). In all 
three EEMs, only two peaks are observed which correspond to the IF and dbAF. The 
IF peak maintains a similar red colour for all states, however, becomes diffuse in the 
fibrillar EEM which is attributed to the fibril scattering effects. The dbAF peak is barely 
observed in the EEMs, as shown by the dark blue colour, which corresponds to the 
1D spectra (Figure 97 and Figure 98) where the fluorescence intensity is similar for 
both the monomeric and oligomeric states. The intensity increases for the fibrillar 
state but on a sloping gradient due to the aforementioned fibril scattering effects. 
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Figure 101: The A53E α-synuclein EEMs, normalised to the intrinsic fluorescence (IF) signal maxima, for 
the (a) monomer, (b) oligomer and (c) fibril. The exhibited fluorescence is shown as (red) highest to 
(blue) lowest. 
 Figure 102 shows the EEMs for the aggregation states of the A53T 
monomer (Figure 102a), oligomer (Figure 102b) and fibril (Figure 102c). Similarly to 
the A53E EEMs (Figure 101), only the IF and dbAF peaks are observed, whilst the IF 
maintains a similar red colour intensity for all three EEMs the dbAF increases in 
intensity from dark blue to light blue as fibrillation proceeds. 
 
Figure 102: The A53T α-synuclein EEMs, normalised to the intrinsic fluorescence (IF) signal maxima, for 
the (a) monomer, (b) oligomer and (c) fibril. The exhibited fluorescence is shown as (red) highest to 
(blue) lowest. 
 Figure 103 shows the EEMs for the aggregation states of the E46K for the 
monomer (Figure 103a), oligomer (Figure 103b) and fibril (Figure 103c). Similarly to 
the A53E and A53T EEMs (Figure 101 and Figure 102), the IF and dbAF are observed 
with comparable intensity trends to A53T (consistent red for IF and increasing blue 
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for dbAF). In both the E46K monomer and oligomer states, there is a distinctly higher 
intensity around the dityrosine peak region which was previously observed in the 
A30P monomer and oligomer EEMs (Figure 100a and b). 
 
Figure 103: The E46K α-synuclein EEMs, normalised to the intrinsic fluorescence (IF) signal maxima, for 
the (a) monomer, (b) oligomer and (c) fibril. The exhibited fluorescence is shown as (red) highest to 
(blue) lowest. 
 Figure 104 shows the EEMs for the aggregation states of the G51D 
monomer (Figure 104a), oligomer (Figure 104b) and fibril (Figure 104c). As shown in 
the other αS mutations, the G51D IF peak also remains a consistent red colour 
throughout the aggregation EEMs. In contrast to the other αS mutation EEMs, G51D 
does not exhibit a peak in the dbAF region until the fibrillar state and the observed 
peak is shifted (~30 nm) in both excitation and emission wavelengths from the dbAF 
location observed for the other strands. In addition to the appearance of the dbAF 
peak, a third peak (tyrosinate, λEx ~300 nm, λEm ~395 nm) is observed as a shoulder 
to the IF peak, which suffers from the physical fibril scattering effects. 
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Figure 104: The G51D α-synuclein EEMs, normalised to the intrinsic fluorescence (IF) signal maxima, 
for the (a) monomer, (b) oligomer and (c) fibril. The exhibited fluorescence is shown as (red) highest to 
(blue) lowest. 
 Figure 105 shows the EEMs for the aggregation states of the H50Q for the 
monomer (Figure 105a), oligomer (Figure 105b) and fibril (Figure 105c). In all three 
EEMs, three peaks (IF, dbAF, and tyrosinate) can be observed which are similar to the 
A30P EEMs (Figure 100). The dbAF and tyrosinate peaks increase as fibrillation 
proceeds, which is shown by the colour changes from blue to yellow, and red to a 
diffused red respectively. 
 
Figure 105: The H50Q α-synuclein EEMs, normalised to the intrinsic fluorescence (IF) signal maxima, 
for the (a) monomer, (b) oligomer and (c) fibril. The exhibited fluorescence is shown as (red) highest to 
(blue) lowest. 
 The single-point αS mutations exhibit both IF and dbAF phenomena. A similar 
IF trend to WT αS and I is observed for most mutations where IF intensity decreases 
as fibrillation proceeds, however for the A53E and H50Q mutations an increased IF 
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intensity is observed for the fibrillar states (Figure 96). The A30P and H50Q mutations 
are of similar intensities to WT αS (Figure 91) and give rise to the two additional 
peaks (λEm 360 nm and 450 nm), which were identified previously as tyrosinate and 
dityrosine. The dbAF intensity trend correlates with both  I and WT αS, where an 
increased dbAF intensity is observed for all αS mutations from the monomeric to 
fibrillar states. Similarly, to the WT αS, the oligomeric state intensity (Figure 98) 
varies for the mutations; two decrease (A30P and E46K) which is comparable to 
WT (Figure 92), two remain similar (A53E and A53T) and the final two increase (G51D 
and H50Q). In the case of both A53E and A53T mutations, a broadening of the dbAF 
peak is observed (Figure 98b). There is no apparent dbAF peak maxima shift 
observed, until the fibrillar state where all the αS mutations are shifted to lower 
wavelengths, which corresponds with a significant fibril scattering which is not as 
apparent for WT αS. 
 The six familial αS mutations showed diversity in the fibrillation pathway 
EEMs, however in all fibrillar states a dispersed fluorescence emanating from lower 
wavelengths was observed which is attributed to the physical scattering effects for 
fibrils. In both A30P and H50Q EEMs (Figure 100 and Figure 105) the four 
fluorescence regions were observed, with the dbAF region becoming defined as 
fibrillation proceeds; H50Q appears linearly proportional, whereas for A30P both the 
monomeric and oligomeric EEMs appeared similar before a step change resulted in 
a defined dbAF peak in the fibril EEM. The A53T and E46K EEMs (Figure 102 and 
Figure 103) also exhibited an increased dbAF intensity as fibrillation proceeds, 
however in both cases the fluorescence signal was weak compared to the IF peak; 
small intensity increases were observed for A53T, whilst for E46K the region 
appeared more diffuse before an observed intensity increase in the fibrillar state. In 
the A53E EEM (Figure 101) dbAF was observed in all three aggregation states, 
however the intensity changes were negligible as fibrillation proceeded. In contrast, 
the G51D EEM (Figure 104) showed no dbAF for either monomeric or oligomeric 
states, however a dbAF signal was observed in the fibril state. The EEMs showed that 
all six familial mutations give rise to differing dbAF signatures, therefore the factors 
which govern the phenomenon must be affected by the differing fibrillation 
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pathways, however the fibril state which exhibits dbAF implies that the resultant 
fibrillar structure is key. 
  verall the dbAF phenomenon is shown to exist for all the αS mutations, with 
a comparable trend to  I and WT αS; dbAF intensity increased from monomeric to 
fibrillar state. These results have indicated that the dbAF is affected by the fibrillation 
pathway, as shown by the three variations in oligomeric state for the six familial 
mutations, however further work is necessary to ascertain the clinical significance of 
dbAF as a potential diagnostic tool to probe pre-fibrillar state. The ability to probe 
single-point mutational differences of αS using IF and dbAF techniques, suggests it is 
possible to probe the effect of oxidation and nitration on WT αS. Current research 
has attributed toxicity of α-synucleinopathies to oxidative and nitrative damage,90 
due to the associated progression of αS oligomerisation and / or fibrillation.91,92 
7.3.2.3. Investigating the effect of nitration on wild-type α-synuclein fibrillation 
 The nitration and oxidative stress of proteins are an important hallmark of 
neurodegenerative disease.93,94 Protein nitration is whereby a nitro group (-NO2) is 
chemically inserted into a protein, usually through nitrating agents such as 
peroxynitrite, which can both nitrate and oxidise the species.95 Importantly for 
species containing tyrosine, this process can lead to residue modification forming 
nitrotyrosine, which is often associated with cellular damage.96 The nitrated 
components are critical for amyloid research, since it is this process that often 
enhances protein aggregation97,98 whilst also preferentially stabilising amyloid 
oligomers, which are suggested to be the physiologically toxic species.99,100 
 The αS was synthetically oxidised and nitrated by hydrogen peroxide and 
peroxynitrite respectively, to investigate whether the structural modifications 
resulting from nitration can be observed through fluorescence, specifically the effect 
upon dbAF. It is known that solvent accessible tyrosine is susceptible to both effects, 
resulting in the formation of; dityrosine,101,102 tyrosinate,103 or 3-nitrotyrosine.104 
 The IF for the effect of nitration on WT αS is shown in Figure 106, which 
exhibits a similar behaviour to the WT αS fibrillation pathway with decreasing 
fluorescence intensity from the control (black) to the oxidised (red) and 
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nitrated (blue) species. It should be noted that the control is not the same WT αS as 
previously shown, since all nitration experiments were studied in a nitration buffer 
and not PBS. There is a significant peak shift for the IF peak maxima (control, 
λEm ~305 nm) across the oxidised and nitrated species, in addition to the emergence 
of a large secondary peak (λEm ~455 nm) for the nitrated species, as shown in the 
normalised fluorescence spectra (Figure 106b). 
 
Figure 106: Fluorescence spectra of the (a) intrinsic fluorescence (IF) emission and (b) normalised IF for 
wild-type α-synuclein fibrillation showing; (black) control, (red) oxidised and (blue) nitrated states in a 
nitration buffer. 
 The dbAF for the effect of nitration on WT αS (Figure 107), shows an 
increasing fluorescence intensity from the control (black) to the nitrated (blue) state, 
whilst the oxidised species displays a reduced fluorescence. Similarly, to the WT αS 
fibrillation pathway, there is no apparent wavelength shift for the dbAF peak maxima 
as shown in the normalised fluorescence spectra (Figure 107b). 
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Figure 107: Fluorescence spectra of the (a) deep-blue autofluorescence (dbAF) emission and 
(b) normalised dbAF for WT α-synuclein fibrillation showing; (black) control, (red) oxidised and 
(blue) nitrated states in a nitration buffer. 
 Figure 108 shows the effect of nitration on the WT αS for the 
control (Figure 108a), oxidised (Figure 108b) and nitrated (Figure 108c) species. The 
IF peak region is present across all three EEMs, however as shown in Figure 106 the 
IF intensity has decreased. In contrast to the IF, the dbAF peak region has increased 
across the EEMs as shown by the observed colour change from blue to orange. There 
are four additional peak regions in the oxidised and nitrated EEMs, which were not 
observed in the control EEM. 
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Figure 108: The effect of oxidation and nitration on wild-type (WT) α-synuclein EEMs, normalised to 
the intrinsic fluorescence (IF) signal maxima, showing the (a) control, (b) oxidised and (c) nitrated WT 
states in a nitration buffer. The exhibited fluorescence is shown as (red) highest to (blue) lowest. 
 The IF and dbAF phenomena are observed in both the WT αS oxidised and 
nitrated states with similar trends as previously observed to the aggregation states; 
IF intensity decreased in the nitrated and oxidised states (Figure 106) whilst dbAF 
intensity increased from the control to nitrated state (Figure 107). The 1D IF 
spectra (Figure 106) showed significant peak shifts for the control (λEm ~305 nm) to 
oxidised (λEm ~325 nm) to nitrated states (λEm ~345 nm), and the emergence of a 
second peak in the nitrated species only (λEm ~455 nm). This shift in peak maxima, 
which has not previously been observed, suggests a change in the environment which 
is potentially hydrogen bonding of the tyrosine residues, therefore this implies that 
the oxidised and nitrated fibrils here are different to the seven αS fibril states 
previously shown. The 1D dbAF spectra (Figure 107) showed an increased intensity 
for the nitrated state but a decreased intensity for the oxidised state, compared to 
the control, therefore the presence of a nitro group enhances the phenomenon, 
whilst oxidation reduces the propensity of the phenomenon. The resultant 
EEMs (Figure 108) show the emergence of the dityrosine and tyrosinate species, 
which is expected as both are characteristic biomarkers of oxidation and nitration 
processes. The effect of nitration on WT αS shows enhancement of the dbAF 
phenomenon and results in IF changes not previously observed. Rather than 
changing protein, five of the six familial mutations of αS were subjected to nitration, 
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with the aim to determine whether nitrated dbAF offers analogous results to the 
typical fibrillation EEMs. 
7.3.2.4. The effect of nitration on the α-synuclein mutations 
 Figure 109 shows the effect of nitration on the αS mutations for 
A30P (Figure 109a), A53E (Figure 109b), E46K (Figure 109c), G51D (Figure 109d) and 
H50Q (Figure 109e). The αS mutants were nitrated with peroxynitrite, to investigate 
whether the mutated strands also give rise to the fluorescence features previously 
observed for nitrated WT αS (Figure 108). 
 
Figure 109: The effect of nitration on selected single-point mutation α-synuclein EEMs, normalised to 
the intrinsic fluorescence (IF) signal maxima, showing the (a) A30P, (b) A53E, (c) E46K, (d) G51D and 
(e) H50Q nitration states. The exhibited fluorescence is shown as (red) highest to (blue) lowest. 
 There are two distinct peak regions observed in all the nitrated αS 
mutants (Figure 109), which correspond to the dbAF and tyrosinate peak regions, 
with a strong fluorescence observed at the lower wavelengths attributed to the IF 
and fibril scattering effects. The nitrated EEMs show variable intensity for the dbAF, 
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from the lowest to highest; H50Q, A53E, A30P, E46K and the highest at G51D. This 
trend for the nitrated dbAF is the inverse of the aggregation state (Figure 99) with 
H50Q exhibiting the highest intensity followed by E46K, G51D, A30P and finally the 
lowest for A53E. The tyrosinate peak, although present in all the EEMs at a similar 
fluorescence intensity, appears to be elongated in the excitation wavelengths which 
was not previously observed in the associated aggregation EEMs but was visible in 
the WT αS nitrated EEM (Figure 108c). 
  verall, the observation of dbAF in the  I, αS and nitrated variants implies 
that the phenomenon is attributed to the protein aggregation state, however the 
amyloidogenicity factor has not been ruled out. To investigate whether the dbAF is a 
characteristic of amyloidogenicity or protein structure, the amyloid-like fibrillation of 
homogeneous small molecules will be studied. 
7.3.3. The fluorescence profile for the small molecules’ fibrillation states 
 The six small molecules (adenine, L-alanine, L-cysteine, L-phenylalanine, 
L-tyrosine and uracil) were studied to ascertain whether dbAF is present in 
homogeneous small molecular assemblies. Figure 110 shows the fibrillar state EEMs 
for the small molecules after a sixteen-day incubation. The EEMs of aliquots taken 
during the incubation period for each molecule are provided in the 
supplementary (Figure S22 – Figure S27). 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 7 
Page 261 
 
Figure 110: The deep-blue autofluorescence (dbAF) phenomenon exhibited in the EEMs for the six 
small molecules; (a) adenine, (b) L-alanine, (c) L-cysteine, (d) L-phenylalanine, (e) L-tyrosine and 
(f) uracil; in their aggregated state. The fluorescence is normalised to the maximum intensity, 
L-phenylalanine, which is shown as (red) highest to (blue) lowest. 
 Figure 110 shows the appearance of multiple fluorescence peaks, which were 
not previously observed for the proteins studied, however the dbAF is present in the 
EEMs for the aggregated; L-cysteine, L-phenylalanine, L-tyrosine and potentially in 
uracil due to the weak fluorescence intensity within the dbAF region. 
 Three of the amino acids studied exhibit the dbAF signature, which is of the 
highest intensity for L-phenylalanine but not observed for L-alanine, both of which 
are classed as hydrophobic but L-phenylalanine is aromatic due to the addition of a 
phenyl ring. The presence of the aromaticity in L-phenylalanine suggests that 
aromatic interactions in the fibrillar structure give rise to the dbAF phenomenon, 
which is supported by its presence in fibrillar L-tyrosine, another aromatic amino 
acid. 
 This phenomenon however is also observed in fibrillar L-cysteine, which is a 
non-aromatic amino acid, implying additional factors contribute to the dbAF 
phenomenon. Proteins with cysteine residues often include disulfide bridges as a 
result of disulfide bonding between two cysteine residues. The oxidation of cysteine 
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to cystine results in a disulfide bond,105 between the two cysteine residues therefore 
providing an analogous fibrillar infrastructure to that of aromatic interactions giving 
rise to the dbAF phenomenon observed in Figure 110c. In regards to uracil, although 
there is a potential weak fluorescence intensity above the background, it is diffuse 
across the dbAF region and does not change as fibrillation proceeds as shown in 
Figure S27, therefore it is likely to be a fluorescence artefact as opposed to the dbAF 
phenomenon. 
 The small molecules study therefore, whilst disproving that the dbAF 
phenomenon is a characteristic of amyloidogenic proteins, does not definitively 
determine its origin. The lack of dbAF in three of the small molecules also implies that 
aggregation is not a key factor in the presence of the phenomenon, however further 
studies are necessary to investigate why. 
7.4. Conclusions 
 This investigation has shown that the dbAF phenomenon is present in HI, and 
the use of EEMs to investigate the fluorescence profile were invaluable in this study, 
as they showed the relationship between IF and dbAF intensity changes as 
aggregation proceeded. A significant trend for HI showed that dbAF increased as 
fibrillation proceeds, as shown in the monomeric and fibrillar state spectra, which 
implies that aggregation contributes to the origin of dbAF. The presence of dbAF in 
the monomeric HI state, albeit at a reduced intensity, implied that a potential origin 
for the phenomenon was the secondary structure, therefore an IDP (αS) was studied 
to remove this variable. 
 The dbAF phenomenon was observed in αS with the same trend as shown for 
HI, where dbAF intensity increases as fibrillation proceeds, therefore confirming that 
the secondary structure of proteins was not a factor. To determine whether 
amyloidogenic aggregation was a factor, six small molecules which undergo 
amyloid-like fibrillation were studied. Three of the six molecules aggregated states 
exhibited the dbAF, which showed that the phenomenon was not an amyloidogenic 
property or the result of aggregation state. Two of the dbAF-positive molecules were 
aromatic amino acid residues, L-phenylalanine and L-tyrosine, where L-phenylalanine 
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exhibited the highest dbAF intensity of the three, which would suggest aromaticity is 
a factor in the phenomenon’s origin. The other dbAF-positive molecule however was 
not aromatic, L-cysteine, and exhibited higher intensity than L-tyrosine which does 
not follow the aromaticity theory. 
 Whilst this investigation was unable to definitively determine the root cause 
of the dbAF phenomenon, this work has shown that an ensemble of factors likely 
gives rise to the phenomenon. The variation in dbAF for the single-point αS 
mutations, which maintains the same core fibrillar structure, implies that the 
phenomenon must be attributed to the side group infrastructure as opposed to the 
core framework. The nitration results, which showed the inverse trend for dbAF 
compared to the αS aggregation state, further complicates the interpretation of this 
phenomenon as it is implied that the origin of the dbAF is not directly associated to 
the fibrillar state. In summary the work in this investigation proposes that the dbAF 
arises as aggregation proceeds, which results in orientated stacking of side groups 
within the fibrillar structure, consequently generating a fluorescence effect 
attributed to the infrastructure interactions such as; aromatic, carbonyl and 
hydrogen. 
 The sensitivity of the dbAF phenomenon, in distinguishing differences 
between the various single-point mutations of αS, amplifies the potential 
applications for dbAF as a technique to detect pre-fibrillar state. Overall, there is 
further work necessary prior to widespread usage as an analytical fluorescence 
technique with investigations such as; pinpointing the phenomenon’s origin, or 
studying whether there is a concentration dependence effect, or to probing 
mutations in HI. 




Figure S21: The primary sequence for wild-type α-synuclein, showing the regions; 
(purple) amphipathic, (orange) non-amyloid-ß component and (green) acidic tail regionsm and (cyan 
highlighted) the specific single-point mutation sites. 
 
Figure S22: Adenine EEMs, showing the effect of increasing aggregation states over incubation times; 
(a) day 0, (b) day 4 and (c) day 16. The exhibited fluorescence, shown as (red) highest to (blue) lowest, 
is normalised to the maximum at day 16. 
 
Figure S23: L-alanine EEMs, showing the effect of increasing aggregation states over incubation times; 
(a) day 0, (b) day 4 and (c) day 16. The exhibited fluorescence, shown as (red) highest to (blue) lowest, 
is normalised to the maximum at day 16. 
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Figure S24: L-cysteine EEMs, showing the effect of increasing aggregation states over incubation 
times; (a) day 0, (b) day 4 and (c) day 16. The exhibited fluorescence, shown as (red) highest to 
(blue) lowest, is normalised to the maximum at day 16.  
 
Figure S25: L-phenylalanine EEMs, showing the effect of increasing aggregation states over incubation 
times; (a) day 0, (b) day 4 and (c) day 16. The exhibited fluorescence, shown as (red) highest to 
(blue) lowest, is normalised to the maximum at day 16. 
 
Figure S26: L-tyrosine EEMs, showing the effect of increasing aggregation states over incubation times; 
(a) day 0, (b) day 4 and (c) day 16. The exhibited fluorescence, shown as (red) highest to (blue) lowest, 
is normalised to the maximum at day 16.  
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Figure S27: Uracil EEMs, showing the effect of increasing aggregation states over incubation times; 
(a) day 0, (b) day 4 and (c) day 16. The exhibited fluorescence, shown as (red) highest to (blue) lowest, 
is normalised to the maximum at day 16. 
  
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 7 
Page 267 
Bibliography 
1. Chan, F. T. S. et al. Protein amyloids develop an intrinsic fluorescence signature during aggregation. Analyst 138, 2156 
(2013). 
2. Tcherkasskaya, O. Photo-activity induced by amyloidogenesis. Protein Sci. 16, 561–571 (2007). 
3. del Mercato, L. L. et al. Charge transport and intrinsic fluorescence in amyloid-like fibrils. Proc. Natl. Acad. Sci. 104, 
18019–18024 (2007). 
4. Pinotsi, D., Buell, A. K., Dobson, C. M., Kaminski Schierle, G. S. & Kaminski, C. F. A Label-Free, Quantitative Assay of 
Amyloid Fibril Growth Based on Intrinsic Fluorescence. ChemBioChem 14, 846–850 (2013). 
5. Johansson, P. K. & Koelsch, P. Label-free imaging of amyloids using their intrinsic linear and nonlinear optical 
properties. Biomed. Opt. Express 8, 743 (2017). 
6. Niyangoda, C., Miti, T., Breydo, L., Uversky, V. & Muschol, M. Carbonyl-based blue autofluorescence of proteins and 
amino acids. PLoS One 12, e0176983 (2017). 
7. Grisanti, L., Pinotsi, D., Gebauer, R., Kaminski Schierle, G. S. & Hassanali, A. A. A computational study on how structure 
influences the optical properties in model crystal structures of amyloid fibrils. Phys. Chem. Chem. Phys. 19, 4030–
4040 (2017). 
8. Brange, J. & Langkjœr, L. Insulin Structure and Stability. in Stability and Characterization of Protein and Peptide Drugs 
315–350 (1993). doi:10.1007/978-1-4899-1236-7_11 
9. Frokjaer, S. & Otzen, D. E. Protein drug stability: a formulation challenge. Nat. Rev. Drug Discov. 4, 298–306 (2005). 
10. Majors, R. E. The role of the column in preparative HPLC. LC-GC North Am. 22, 416–428 (2004). 
11. Gusarov, D., Lasman, V. & Bayramashvili, D. Methods for protecting silica sorbents used in high-performance liquid 
chromatography from strongly adsorbed impurities during purification of human recombinant insulin. J. Chromatogr. 
B 853, 354–359 (2007). 
12. Hammarström, P. et al. An Auto-Catalytic Surface for Conformational Replication of Amyloid Fibrils—Genesis of an 
Amyloid World? Orig. Life Evol. Biosph. 41, 373–383 (2011). 
13. Braslavsky, S. E. Glossary of terms used in photochemistry, 3rd edition (IUPAC Recommendations 2006). Pure Appl. 
Chem. 79, 293–465 (2007). 
14. Lakowicz, J. R. Principles of Fluorescence Spectroscopy. Principles of Fluorescence Spectroscopy (Springer US, 2006). 
doi:10.1007/978-0-387-46312-4 
15. Valeur, B. & Berberan-Santos, M. N. Molecular Fluorescence. Wiley-VCH Verlag & Co. KGaA, Boschstr. 12, 69469 
Weinheim, Germany (Wiley-VCH Verlag GmbH & Co. KGaA, 2012). doi:10.1002/9783527650002 
16. Chattopadhyay, A., Rukmini, R. & Mukherjee, S. Photophysics of a neurotransmitter: ionization and spectroscopic 
properties of serotonin. Biophys. J. 71, 1952–1960 (1996). 
17. de Oliveira Silva, F. R. et al. Intrinsic Fluorescence of Protoporphyrin IX from Blood Samples Can Yield Information on 
the Growth of Prostate Tumours. J. Fluoresc. 20, 1159–1165 (2010). 
18. Svendsen, A., Kiefer, H. V., Pedersen, H. B., Bochenkova, A. V. & Andersen, L. H. Origin of the Intrinsic Fluorescence 
of the Green Fluorescent Protein. J. Am. Chem. Soc. 139, 8766–8771 (2017). 
19. Marcus, A., Sadimin, E., Richardson, M., Goodell, L. & Fyfe, B. Fluorescence Microscopy Is Superior to Polarized 
Microscopy for Detecting Amyloid Deposits in Congo Red–Stained Trephine Bone Marrow Biopsy Specimens. Am. J. 
Clin. Pathol. 138, 590–593 (2012). 
20. Gade Malmos, K. et al. ThT 101: a primer on the use of thioflavin T to investigate amyloid formation. Amyloid 24, 1–
16 (2017). 
21. Mauro, M. et al. Kinetics of Different Processes in Human Insulin Amyloid Formation. J. Mol. Biol. 366, 258–274 (2007). 
22. Foderà, V. et al. Thioflavin T hydroxylation at basic pH and its effect on amyloid fibril detection. J. Phys. Chem. B 112, 
15174–15181 (2008). 
23. Vivian, J. T. & Callis, P. R. Mechanisms of Tryptophan Fluorescence Shifts in Proteins. Biophys. J. 80, 2093–2109 (2001). 
24. Bekard, I. B. & Dunstan, D. E. Tyrosine Autofluorescence as a Measure of Bovine Insulin Fibrillation. Biophys. J. 97, 
2521–2531 (2009). 
25. Liu, T. et al. Ionization Potentials of Fluoroindoles and the Origin of Nonexponential Tryptophan Fluorescence Decay 
in Proteins ⊥. J. Am. Chem. Soc. 127, 4104–4113 (2005). 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 7 
Page 268 
26. Gill, H. S. Evaluating the efficacy of tryptophan fluorescence and absorbance as a selection tool for identifying protein 
crystals. Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 66, 364–372 (2010). 
27. Zhdanova, N. G., Maksimov, E. G., Arutyunyan, A. M., Fadeev, V. V. & Shirshin, E. A. Tyrosine fluorescence probing of 
conformational changes in tryptophan-lacking domain of albumins. Spectrochim. Acta Part A Mol. Biomol. Spectrosc. 
174, 223–229 (2017). 
28. Giancotti, V., Quadrifoglio, F., Lancieri, M. & Geraci, G. Separation and properties of an H2B histone variant from the 
sperm chromatin of the sea urchin Sphaerechinus granularis. Int. J. Biol. Macromol. 2, 309–312 (1980). 
29. White, A. Effect of pH on fluorescence of tyrosine, tryptophan and related compounds. Biochem. J. 71, 217–220 
(1959). 
30. Ghisaidoobe, A. & Chung, S. Intrinsic Tryptophan Fluorescence in the Detection and Analysis of Proteins: A Focus on 
Förster Resonance Energy Transfer Techniques. Int. J. Mol. Sci. 15, 22518–22538 (2014). 
31. Würth, C., Grabolle, M., Pauli, J., Spieles, M. & Resch-Genger, U. Relative and absolute determination of fluorescence 
quantum yields of transparent samples. Nat. Protoc. 8, 1535–1550 (2013). 
32. Itagaki, H. Fluorescence Spectroscopy. Experimental Methods in Polymer Science (Elsevier, 2000). 
33. Shukla, A. et al. A novel UV laser-induced visible blue radiation from protein crystals and aggregates: scattering 
artifacts or fluorescence transitions of peptide electrons delocalized through hydrogen bonding? Arch. Biochem. 
Biophys. 428, 144–153 (2004). 
34. Chan, F. T. S. et al. Protein amyloids develop an intrinsic fluorescence signature during aggregation. Analyst 138, 2156 
(2013). 
35. Chan, F. T. S., Pinotsi, D., Gabriele, S., Schierle, K. & Kaminski, C. F. Structure-Specific Intrinsic Fluorescence of Protein 
Amyloids Used to Study their Kinetics of Aggregation. in Bio-nanoimaging 147–155 (Elsevier, 2014). 
doi:10.1016/B978-0-12-394431-3.00013-4 
36. Chan, F. T. S., Pinotsi, D., Gabriele, S., Schierle, K. & Kaminski, C. F. Structure-Specific Intrinsic Fluorescence of Protein 
Amyloids Used to Study their Kinetics of Aggregation. in Bio-nanoimaging 147–155 (Elsevier, 2014). 
doi:10.1016/B978-0-12-394431-3.00013-4 
37. Ziaunys, M., Sneideris, T. & Smirnovas, V. Exploring the potential of deep-blue autofluorescence for monitoring 
amyloid fibril formation and dissociation. PeerJ 7, e7554 (2019). 
38. Prasad, S. et al. Near UV-Visible electronic absorption originating from charged amino acids in a monomeric protein. 
Chem. Sci. 8, 5416–5433 (2017). 
39. Tikhonova, T. N. et al. Dissection of the deep-blue autofluorescence changes accompanying amyloid fibrillation. Arch. 
Biochem. Biophys. 651, 13–20 (2018). 
40. Tomalia, D. A. et al. Non-traditional intrinsic luminescence: inexplicable blue fluorescence observed for dendrimers, 
macromolecules and small molecular structures lacking traditional/conventional luminophores. Prog. Polym. Sci. 90, 
35–117 (2019). 
41. Prasad, S. et al. Near UV-Visible electronic absorption originating from charged amino acids in a monomeric protein. 
Chem. Sci. 8, 5416–5433 (2017). 
42. Alderson, T.  . & Markley, J. L. Biophysical characterization of α-synuclein and its controversial structure. Intrinsically 
Disord. Proteins 1, e26255 (2013). 
43. Stefanis, L. A-Synuclein in Parkinson’s Disease. Cold Spring Harb. Perspect. Med. 2, a009399–a009399 (2012). 
44. Spillantini, M. G. et al. α-Synuclein in Lewy bodies. Nature 388, 839–840 (1997). 
45. Uversky, V. N. Intrinsically disordered proteins from A to Z. Int. J. Biochem. Cell Biol. 43, 1090–1103 (2011). 
46. Charlier, C. et al. Structure and Dynamics of an Intrinsically Disordered Protein Region That Partially Folds upon 
Binding by Chemical-Exchange NMR. J. Am. Chem. Soc. 139, 12219–12227 (2017). 
47. Humphrey, W., Dalke, A. & Schulten, K. VMD: Visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996). 
48. Ulmer, T. S., Bax, A., Cole, N. B. & Nussbaum, R. L. Structure and Dynamics of Micelle-bound Human -Synuclein. J. Biol. 
Chem. 280, 9595–9603 (2005). 
49. Bisaglia, M. et al. Structure and topology of the non-amyloid-β component fragment of human α-synuclein bound to 
micelles: Implications for the aggregation process. Protein Sci. 15, 1408–1416 (2006). 
50. Fusco, G. et al. Structural basis of synaptic vesicle assembly promoted by α-synuclein. Nat. Commun. 7, 12563 (2016). 
51. Braun, A. R., Lacy, M. M., Ducas, V. C.,  hoades, E. & Sachs, J.  . α-Synuclein’s Uniquely Long Amphipathic  elix 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 7 
Page 269 
Enhances its Membrane Binding and Remodeling Capacity. J. Membr. Biol. 250, 183–193 (2017). 
52. Pawar, A. P. et al. Prediction of “Aggregation-prone” and “Aggregation-susceptible”  egions in Proteins Associated 
with Neurodegenerative Diseases. J. Mol. Biol. 350, 379–392 (2005). 
53. Chiti, F. & Dobson, C. M. Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over 
the Last Decade. Annu. Rev. Biochem. 86, 27–68 (2017). 
54. Proukakis, C. et al. A novel -synuclein missense mutation in Parkinson disease. Neurology 80, 1062–1064 (2013). 
55. Krüger, R. et al. AlaS Pro mutation in the gene encoding α-synuclein in Parkinson’s disease. Nat. Genet. 18, 106–108 
(1998). 
56. Zarranz, J. J. et al. The  ew Mutation, E46K, of α-Synuclein Causes Parkinson and Lewy Body Dementia. Ann. Neurol. 
55, 164–173 (2004). 
57. Nishioka, K. et al. Clinical heterogeneity of α-synuclein gene duplication in Parkinson’s disease. Ann. Neurol. 59, 298–
309 (2006). 
58. Lesage, S. et al. G51D α-synuclein mutation causes a novel Parkinsonian-pyramidal syndrome. Ann. Neurol. 73, 459–
471 (2013). 
59. Pasanen, P. et al. A novel α-synuclein mutation A53E associated with atypical multiple system atrophy and Parkinson’s 
disease-type pathology. Neurobiol. Aging 35, 2180.e1-2180.e5 (2014). 
60. Ghosh, D., Mehra, S., Sahay, S., Singh, P. K. & Maji, S. K. Α-Synuclein Aggregation and Its Modulation. Int. J. Biol. 
Macromol. 100, 37–54 (2017). 
61. Meade, R. M., Fairlie, D. P. & Mason, J. M. Alpha-synuclein structure and Parkinson’s disease – lessons and emerging 
principles. Mol. Neurodegener. 14, 29 (2019). 
62. Guerrero-Ferreira, R. et al. Cryo-EM structure of alpha-synuclein fibrils. Elife 7, (2018). 
63. Iadanza, M. G., Jackson, M. P., Hewitt, E. W., Ranson, N. A. & Radford, S. E. A new era for understanding amyloid 
structures and disease. Nat. Rev. Mol. Cell Biol. 19, 755–773 (2018). 
64. Lodish, H. F. et al. Molecular cell biology. (Macmillan Science & Educ. USA, 2016). 
65. Shaham-Niv, S., Adler-Abramovich, L., Schnaider, L. & Gazit, E. Extension of the generic amyloid hypothesis to 
nonproteinaceous metabolite assemblies. Sci. Adv. 1, e1500137 (2015). 
66. Gazit, E. Metabolite amyloids: a new paradigm for inborn error of metabolism disorders. J. Inherit. Metab. Dis. 39, 
483–488 (2016). 
67. Gour, N. et al. Amyloid-like Structures Formed by Single Amino Acid Self-Assemblies of Cysteine and Methionine. ACS 
Chem. Neurosci. 10, 1230–1239 (2019). 
68. Bollée, G. et al. Adenine Phosphoribosyltransferase Deficiency. Clin. J. Am. Soc. Nephrol. 7, 1521–1527 (2012). 
69. Rosenberg, L. E., Downing, S., Durant, J. L. & Segal, S. Cystinuria: biochemical evidence for three genetically distinct 
diseases. J. Clin. Invest. 45, 365–371 (1966). 
70. Blau, N., van Spronsen, F. J. & Levy, H. L. Phenylketonuria. Lancet 376, 1417–1427 (2010). 
71. Russo, P. A., Mitchell, G. A. & Tanguay, R. M. Tyrosinemia: A Review. Pediatr. Dev. Pathol. 4, 212–221 (2001). 
72. Levin, B., Abraham, J. M., Oberholzer, V. G. & Burgess, E. A. Hyperammonaemia: a deficiency of liver ornithine 
transcarbamylase. Occurrence in mother and child. Arch. Dis. Child. 44, 152–161 (1969). 
73. Torpey, J.  . The aggregation of α-synuclein and its inhibtion (PhD thesis). (2019). doi:10.17638/03059871 
74. Schoonenboom, N. S. M. et al. Effects of Processing and Storage Conditions on Amyloid β (1–42) and Tau 
Concentrations in Cerebrospinal Fluid: Implications for Use in Clinical Practice. Clin. Chem. 51, 189–195 (2005). 
75. Sigurdsson, E. M., Calero, M. & Gasset, M. Amyloid proteins. methods and protocols. (Humana Press, 2012). 
76. Domigan, L. J., Healy, J. P., Meade, S. J., Blaikie, R. J. & Gerrard, J. A. Controlling the dimensions of amyloid fibrils: 
Toward homogenous components for bionanotechnology. Biopolymers 97, 123–133 (2012). 
77. Castillo-León, J. & Svendsen, W. E. Micro and Nanofabrication Using Self-Assembled Biological Nanostructures. 
(William Andrew Publishing, 2015). 
78. Liu, H.-C., Chiu, M.-J., Lin, C.-H. & Yang, S.-Y. Stability of Plasma Amyloid-β 1–40, Amyloid-β 1–42, and Total Tau Protein 
over Repeated Freeze/Thaw Cycles. Dement. Geriatr. Cogn. Dis. Extra 10, 46–55 (2020). 
79. Beckman, J. S., Chen, J., Ischiropoulos, H. & Crow, J. P. [23] Oxidative chemistry of peroxynitrite. in Methods in 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 7 
Page 270 
Enzymology 229–240 (1994). doi:10.1016/S0076-6879(94)33026-3 
80. Hughes, M. N. & Nicklin, H. G. The chemistry of peroxonitrites. Part II. Copper(II)-catalysed reaction between 
hydroxylamine and peroxonitrite in alkali. J. Chem. Soc. A Inorganic, Phys. Theor. 925 (1970). 
doi:10.1039/j19700000925 
81. Nielsen, L., Frokjaer, S., Brange, J., Uversky, V. N. & Fink, A. L. Probing the mechanism of insulin fibril formation with 
insulin mutants. Biochemistry 40, 8397–8409 (2001). 
82. Uversky, V. N. et al. Prediction of the association state of insulin using spectral parameters. J. Pharm. Sci. 92, 847–858 
(2003). 
83. Koller, E., Quehenberger, O., Jürgens, G., Wolfbeis, O. S. & Esterbauer, H. Investigation of human plasma low density 
lipoprotein by three-dimensional flourescence spectroscopy. FEBS Lett. 198, 229–234 (1986). 
84. Ziaunys, M., Mikalauskaite, K. & Smirnovas, V. Amyloidophilic Molecule Interactions on the Surface of Insulin Fibrils: 
Cooperative Binding and Fluorescence Quenching. Sci. Rep. 9, 20303 (2019). 
85. Lawaetz, A. J. & Stedmon, C. A. Fluorescence Intensity Calibration Using the Raman Scatter Peak of Water. Appl. 
Spectrosc. 63, 936–940 (2009). 
86. Reynolds, M. R., Berry, R. W. & Binder, L. I. Site-Specific  itration and  xidative Dityrosine Bridging of the τ Protein 
by Peroxynitrite: Implications for Alzheimer’s Disease †. Biochemistry 44, 1690–1700 (2005). 
87. De Filippis, V., Frasson, R. & Fontana, A. 3-Nitrotyrosine as a spectroscopic probe for investigating protein-protein 
interactions. Protein Sci. 15, 976–986 (2006). 
88. Bandookwala, M. & Sengupta, P. 3-Nitrotyrosine: a versatile oxidative stress biomarker for major neurodegenerative 
diseases. Int. J. Neurosci. 130, 1047–1062 (2020). 
89. Pinotsi, D. et al. Proton Transfer and Structure-Specific Fluorescence in Hydrogen Bond-Rich Protein Structures. J. Am. 
Chem. Soc. 138, 3046–3057 (2016). 
90. Giasson, B. I. Oxidative Damage Linked to Neurodegeneration by Selective alpha -Synuclein Nitration in 
Synucleinopathy Lesions. Science 290, 985–989 (2000). 
91. Chavarría, C. & Souza, J. M.  xidation and nitration of α-synuclein and their implications in neurodegenerative 
diseases. Arch. Biochem. Biophys. 533, 25–32 (2013). 
92. Burai, R., Ait-Bouziad, N., Chiki, A. & Lashuel, H. A. Elucidating the Role of Site-Specific  itration of α-Synuclein in the 
Pathogenesis of Parkinson’s Disease via Protein Semisynthesis and Mutagenesis. J. Am. Chem. Soc. 137, 5041–5052 
(2015). 
93. Ischiropoulos, H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem. Biophys. Res. 
Commun. 305, 776–783 (2003). 
94. Cheignon, C. et al.  xidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol. 14, 450–464 
(2018). 
95. Koppenol, W. H. 100 Years of peroxynitrite chemistry and 11 years of peroxynitrite biochemistry. Redox Rep. 6, 339–
341 (2001). 
96. Murata, M. & Kawanishi, S. Oxidative DNA damage induced by nitrotyrosine, a biomarker of inflammation. Biochem. 
Biophys. Res. Commun. 316, 123–128 (2004). 
97. Uversky, V. N. et al. Effects of nitration on the structure and aggregation of α-synuclein. Mol. Brain Res. 134, 84–102 
(2005). 
98. Abdelmegeed, M. A. & Song, B.-J. Functional Roles of Protein Nitration in Acute and Chronic Liver Diseases. Oxid. Med. 
Cell. Longev. 2014, 1–21 (2014). 
99. Stefani, M. & Dobson, C. M. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding 
diseases and biological evolution. J. Mol. Med. 81, 678–699 (2003). 
100. Glabe, C. G. Structural classification of toxic amyloid oligomers. Journal of Biological Chemistry (2008). 
doi:10.1074/jbc.R800016200 
101. Aeschbach, R., Amadoò, R. & Neukom, H. Formation of dityrosine cross-links in proteins by oxidation of tyrosine 
residues. Biochim. Biophys. Acta - Protein Struct. 439, 292–301 (1976). 
102. Radi, R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. 101, 4003–4008 (2004). 
103. Antosiewicz, J. M. & Shugar, D. UV–Vis spectroscopy of tyrosine side-groups in studies of protein structure. Part 2: 
selected applications. Biophys. Rev. 8, 163–177 (2016). 
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 7 
Page 271 
104. Souza, J. M., Castro, L., Cassina, A. M., Batthyány, C. & Radi, R. Nitrocytochrome c: Synthesis, Purification, and 
Functional Studies. in Nitric Oxide, Part G Oxidative and Nitrosative Stress in Redox Regulation of Cell Signaling (eds. 
Cadenas, E. & Packer, L. B. T.-M. in E.) 441, 197–215 (Academic Press, 2008). 
105. Di Felice, R. & Selloni, A. Adsorption modes of cysteine on Au(111): Thiolate, amino-thiolate, disulfide. J. Chem. Phys. 
120, 4906–4914 (2004). 
  
The Physical and Chemical Origins of Amyloid at Interfaces – Chapter 8 
Page 272 
Chapter 8: Conclusions and Future Work 
 This research programme has pioneered several new techniques and 
methodologies in its pursuit of studying human insulin (HI) amyloid-like fibrillation at 
a hydrophobic interface. The work has come full circle from initially working on 
surface-specific techniques using reflection anisotropy spectroscopy (RAS) on 
hydrophobically functionalised silicon (Si) surfaces, through to observing anisotropy 
in adsorbed HI on hydrophobically functionalised gold surfaces. 
 In Chapter 2 with the aim to study how HI fibrillation is induced by surface 
architecture was affected by sample reproducibility challenges raised, which were 
investigated in Chapter 3 and determined to be associated with HI treatment issues. 
Having solved the protein handling concerns in Chapter 3, Chapter 4 investigated 
how mobile hydrophobic interfaces affected the HI amyloid-like fibrillation, using 
conventional bulk spectroscopic techniques. Chapter 5 investigated the changes in 
mass and structure of adsorbed HI to hydrophobic interfaces. Chapter 6 used the 
novel infrared scanning near-field optical microscopy technique to determine the 
relative amounts of secondary structure in the adsorbed HI layer. Chapter 7 studied 
the deep-blue autofluorescence phenomenon to ascertain its origin, thus 
applicability to protein and peptide fibrillation studies.  
Chapter 2 
 Chapter 2 used reflection anisotropy spectroscopy to determine the fibrillar 
orientation of human insulin (HI), which was abandoned because of irreproducible 
samples. The issue of reproducible samples was solved in Chapter 3, by developing a 
standard HI handling protocol. Implementation of the standard HI protocol with this 
pioneering technique, would be able to follow the HI fibrillation in situ, therefore 
allowing for the fibrillation kinetics to be measured as the Si sample will then be 
aligned to the principle axes to follow the changes thereof.  
Chapter 4 
 Chapter 4 used mobile hydrophobically functionalised mesoporous silica 
microparticles to study the HI fibrillation. The results showed that HI incubation with 
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particles at pH 2 inhibited whilst at pH 7 enhancement of the typical sigmoidal curve 
occurred and these results were correlated to the transmission electron 
microscopy (TEM) images of the fibrils. This study could be improved by using 
different analytical techniques, which are not as sensitive to environmental variables, 
to determine the adsorbed HI content on the microparticles. Improvements could 
also be made regarding the microparticles, such as; a different supplier to directly 
compare with these results, monodisperse microparticles to investigate whether 
polydispersity is a factor, and microparticle functionalisation to study other 
hydrophobic interfaces whether they provide any effect on HI-fibrillation. Other 
possibilities also include; change of particle size to investigate the effects of 
sedimentation and surface area, and the use of non-alkyl groups to study other 
stabilisation effects such as aromaticity. 
Chapter 5 
 Chapter 5 showed that the increasing alkyl chain on the hydrophobic 
interface resulted in an increased HI adsorbed layer, which implies that 
hydrophobicity is affected by alkyl length. Further work should consider the use of 
other functionalisation groups, specifically whether there is a relationship between 
the layer thickness and alkyl chain length, or the use of non-alkyl groups to study the 
stabilisation between the HI and the functionalised interface. The potential 
application for increased stability may lead to advancements in coatings to reduce 
amyloid-like fibrillation within drug delivery systems.  
 A probe-based Raman system was used for this work, however the use of a 
confocal microscope may provide depth information, particularly whether adsorbed 
layers result in structural rearrangement inducing auto-catalytic fibrillation. The use 
of a microscope would also provide mapping capability in the x-y plane, over a large 
area, which provides insight into whether adsorption is consistent. Furthermore, the 
use of a different Raman excitation wavelength would be beneficial as this will allow 
for a reduction in the fluorescence background therefore reducing reliance on 
baseline correction techniques to elucidate structural information. An additional 
benefit of a lower wavelength, such as 532 nm, is the increased power thus higher 
Raman intensity to be able to define subtle changes in the HI structure. 
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Chapter 6 
 Chapter 6 used the infrared scanning near-field optical microscopy (IR-SNOM) 
to determine the effect of hydrophobic functionalised gold surfaces on the secondary 
structure of HI. The results showed that there was a higher α-helical content at pH 2, 
compared to pH 7, which correlated with the results obtained with QCM-D and 
Raman in Chapter 5. Improvements to the instrumentation such as; new software 
that would allow multiple images to be acquired simultaneously, collecting the 
equivalent of IR spectra at each pixel as opposed to one wavelength at a time, and 
the use of an etched aluminium coated fibre with an aperture of less than 100 nm to 
enable fine detail acquisition. Having established that IR-SNOM is consistent with the 
other conventional techniques, the next steps would be to probe the HI fibrillation 
pathway from pre-fibrillar to proto-fibril through to mature fibril. 
Chapter 7 
 Chapter 7 investigated the deep-blue autofluorescence (dbAF) phenomenon 
and attempted to determine the origin compared with conventional intrinsic 
fluorescence techniques by excitation-emission matrices. The results of this 
investigation did not determine the origin, however did provide additional evidence 
to support that it was not an amyloidogenic property due to the presence of dbAF 
within amino acids. Future investigations would be to; involve computational 
modelling which may provide insight into whether this effect is related to the 
chemical bonding, or study other mutations of the peptide which would provide 
information on whether this phenomenon was site-specific. 
